BE775187A - Werkwijze voor het aantonen en bepalen van laagmoleculaire verbindingenen van eiwitten die deze verbindingen specifiek kunnen binden - Google Patents

Werkwijze voor het aantonen en bepalen van laagmoleculaire verbindingenen van eiwitten die deze verbindingen specifiek kunnen binden

Info

Publication number: BE775187A
Authority: BE; Belgium
Prior art keywords: determination; compounds; proteins; low molecular; specifically bind
Prior art date: 1970-11-10

Application number

BE775187A

Other languages

English (en)

Dutch (nl)

Original Assignee

Organon Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1970-11-10

Filing date

1971-11-10

Publication date

1972-03-01

1971-11-10 Application filed by Organon Nv filed Critical Organon Nv

1972-03-01 Publication of BE775187A publication Critical patent/BE775187A/nl

Links

150000001875 compounds Chemical class 0.000 title 2
102000004169 proteins and genes Human genes 0.000 title 1
108090000623 proteins and genes Proteins 0.000 title 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/964—Chemistry: molecular biology and microbiology including enzyme-ligand conjugate production, e.g. reducing rate of nonproductive linkage
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/807—Apparatus included in process claim, e.g. physical support structures
- Y10S436/808—Automated or kit
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
- Y10S436/817—Steroids or hormones

Landscapes

Health & Medical Sciences (AREA)
Immunology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Food Science & Technology (AREA)
Biochemistry (AREA)
Cell Biology (AREA)
Biotechnology (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Microbiology (AREA)
General Health & Medical Sciences (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Enzymes And Modification Thereof (AREA)
Peptides Or Proteins (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

BE775187A 1970-11-10 1971-11-10 Werkwijze voor het aantonen en bepalen van laagmoleculaire verbindingenen van eiwitten die deze verbindingen specifiek kunnen binden BE775187A (nl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
NL707016396A NL154598B (nl)	1970-11-10	1970-11-10	Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.

Publications (1)

Publication Number	Publication Date
BE775187A true BE775187A (nl)	1972-03-01

Family

ID=19811504

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BE775187A BE775187A (nl)	1970-11-10	1971-11-10	Werkwijze voor het aantonen en bepalen van laagmoleculaire verbindingenen van eiwitten die deze verbindingen specifiek kunnen binden

Country Status (16)

Country	Link
US (1)	US3850752A (da)
AU (1)	AU468060B2 (da)
BE (1)	BE775187A (da)
BR (1)	BR7107459D0 (da)
CA (1)	CA967464A (da)
CH (1)	CH617774A5 (da)
DE (1)	DE2155658C3 (da)
DK (1)	DK140268B (da)
ES (1)	ES396741A1 (da)
FI (1)	FI54033C (da)
FR (1)	FR2113733A5 (da)
GB (1)	GB1348935A (da)
IT (1)	IT986829B (da)
NL (1)	NL154598B (da)
SE (1)	SE451162B (da)
ZA (1)	ZA717192B (da)

Families Citing this family (1713)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6630328B2 (en)	1909-07-15	2003-10-07	Genencor International, Inc.	Increasing production of proteins in gram-positive microorganisms
USRE31006E (en) *	1968-09-24	1982-08-03	Akzona Incorporated	Process for the demonstration and determination of reaction components having specific binding affinity for each other
US4046636A (en) *	1974-06-20	1977-09-06	Syva Company	Diazepam enzyme conjugates
US4191613A (en) *	1971-05-14	1980-03-04	Syva Company	Malate dehydrogenase conjugates for enzyme immunoassays
US4203802A (en) *	1971-05-14	1980-05-20	Syva Company	Inhibitable enzyme amplification assay
US3905871A (en) *	1971-05-14	1975-09-16	Syva Co	Lactam conjugates to enzymes
US4282325A (en) *	1971-05-14	1981-08-04	Syva Company	Enzyme bound corticosteroids
US4039385A (en) *	1972-05-08	1977-08-02	Syva Company	Cardiac glycoside enzyme conjugates
NL171930C (nl) *	1972-05-11	1983-06-01	Akzo Nv	Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
US3790447A (en) *	1972-07-05	1974-02-05	Abbott Lab	Streptococci diagnostic method
US3975237A (en) *	1972-11-06	1976-08-17	Syva Company	Compounds for enzyme amplification assay - - ecgonine analogs
US3966556A (en) *	1972-11-06	1976-06-29	Syva Company	Compounds for enzyme amplification assay methadone analogs
US4040907A (en) *	1974-06-20	1977-08-09	Syva Company	Iodothyronine enzyme conjugates
US4061466A (en) *	1974-10-16	1977-12-06	Ingvar Gosta Holger Sjoholm	Biologically active composition and the use thereof
NL7501215A (nl) *	1975-02-01	1976-08-03	Akzo Nv	Methode voor het aantonen en bepalen van een antigeen of antilichaam.
US4043872A (en) *	1975-02-20	1977-08-23	Syva Company	Polyiodothyronine immunoassay
USRE32696E (en) *	1975-09-04	1988-06-14	Akzona Incorporated	Enzymatic immunological method for determination of antigens and antibodies
US4096138A (en) *	1975-12-08	1978-06-20	Scherr George H	Immunological test procedure
US4166767A (en) *	1976-03-25	1979-09-04	Dainippon Pharmaceutical Co., Ltd.	Insolubilized antibody
JPS5341420A (en) *	1976-09-29	1978-04-14	Mochida Pharm Co Ltd	Immunochemically measuring methoa of hapten
GB1572220A (en) *	1976-10-07	1980-07-30	Mochida Pharm Co Ltd	Immunochemical process of measuring physiologically active substances
US4098876A (en) *	1976-10-26	1978-07-04	Corning Glass Works	Reverse sandwich immunoassay
US4134792A (en) *	1976-12-06	1979-01-16	Miles Laboratories, Inc.	Specific binding assay with an enzyme modulator as a labeling substance
IT1153999B (it) *	1977-03-15	1987-01-21	Snam Progetti	Composizione atta alla determinazione della triiodotironina e metodo diagnostico impiegante la stessa
IL51667A (en) *	1977-03-16	1979-10-31	Miles Yeda Ltd	Immunoassay for the determination of a hapten
US4156081A (en) *	1977-04-15	1979-05-22	Syva Company	Theophylline antigens and antibodies
IT1114861B (it) *	1977-05-12	1986-01-27	Sclavo Inst Sieroterapeut	Metodo per la determinazione del contenuto di costituenti di fluidi biologici e mezzi adatti allo scopo
US5605800A (en) *	1978-04-13	1997-02-25	Institut Pasteur	Method of detecting and characterizing a nucleic acid or a sequence of the latter, and enzymatic reactant for the application of this method
FR2422956A1 (fr) *	1978-04-13	1979-11-09	Pasteur Institut	Procede de detection et de caracterisation d'un acide nucleique ou d'une sequence de celui-ci, et reactif enzymatique pour la mise en oeuvre de ce procede
DE2825650C3 (de) *	1978-06-12	1981-02-05	Boehringer Mannheim Gmbh, 6800 Mannheim	Verfahren zur Bestimmung des Thyroxin-bindungsindex im Serum
US4269938A (en) *	1979-03-08	1981-05-26	Eastman Kodak Company	Assay of peroxidatively active materials
US4376825A (en) *	1979-05-07	1983-03-15	Syva Company	Enzyme amplification compounds for assays for androgens
JPS55152459A (en) *	1979-05-18	1980-11-27	Yamasa Shoyu Co Ltd	Method and reagent for measuring quantity of cyclic nucleotide
US4289748A (en) *	1979-05-31	1981-09-15	United States Of America	Ultrasensitive enzymatic radioimmunoassay method
US4299916A (en) *	1979-12-26	1981-11-10	Syva Company	Preferential signal production on a surface in immunoassays
US4391904A (en) *	1979-12-26	1983-07-05	Syva Company	Test strip kits in immunoassays and compositions therein
FI61965C (fi)	1980-01-17	1982-10-11	Suovaniemi Finnpipette	Foerfarande foer detektering av hemoglobin i avfoering
US4347312A (en) *	1980-03-20	1982-08-31	Research Triangle Institute	Detection of antibiotics in milk
JPS5714748A (en) *	1980-07-01	1982-01-26	Dainippon Pharmaceut Co Ltd	Kit for quantitative determination of valproic acid and its method for quantitative determination
US4323647A (en) *	1980-10-15	1982-04-06	University Of Miami	Steric hindrance enzyme immunoassay
JPS58500874A (ja) *	1981-06-02	1983-05-26	エレクトロ−ヌ−　クレオニツクス、インコ−ポレ−テツド	免疫沈殿分析
US4604365A (en) *	1981-06-02	1986-08-05	Electro-Nucleonics, Inc.	Immunoprecipitation assay
US5703206A (en) *	1981-09-08	1997-12-30	Univ Rockefeller	Macrophage inflammatory protein 2 (MIP-2)
US4419453A (en) *	1981-09-28	1983-12-06	The Dow Chemical Company	Immunological agglutination assays with dyed or colored latex and kits
US4506009A (en) *	1982-03-30	1985-03-19	University Of California	Heterogeneous immunoassay method
US4535057A (en) *	1982-07-26	1985-08-13	Amf Incorporated	Immunoassay employing monoclonal herpes simplex antibody and biotin-avidin detection system
US4530900A (en) *	1982-09-13	1985-07-23	Seragen Diagnostics Inc.	Soluble insoluble polymers in enzymeimmunoassay
ZA841924B (en) *	1983-07-25	1984-10-31	Becton Dickinson Co	Chromogenic tracers for use in an assay
EP0154631A4 (en) *	1983-07-27	1985-11-25	American Hospital Supply Corp	PROCESS FOR SELECTIVE NITRILE REDUCTION.
FR2550799B1 (fr) *	1983-08-17	1986-02-21	Commissariat Energie Atomique	Compose marque par une enzyme, son procede de preparation et son utilisation en enzymoimmunologie
DE3433652A1 (de) *	1984-09-13	1986-03-20	Boehringer Mannheim Gmbh, 6800 Mannheim	Immunchemisches messverfahren fuer haptene und proteine
US4713347A (en) *	1985-01-14	1987-12-15	Sensor Diagnostics, Inc.	Measurement of ligand/anti-ligand interactions using bulk conductance
US4786594A (en) *	1986-05-14	1988-11-22	Syntex (U.S.A.) Inc.	Enzyme immunoassay
DE68928124T2 (de) *	1988-09-02	1997-10-16	Chiron Corp., Emeryville, Calif.	Makrophagenabgeleiteter entzündungsmediator(mip-2)
ATE133714T1 (de)	1988-09-29	1996-02-15	Chiron Corp	Polynukleotid-bestimmung mit selektierbaren spaltstellen
CA2031109C (en) *	1990-07-27	1992-01-28	Susan J. Danielson	Ligand analogs for immunoassays derived from dicarboxylic acid oxidation products
CA2029006C (en) *	1990-07-27	2001-07-17	Michael R. Detty	Dicarboxylic acid oxidation products
US5614504A (en) *	1990-08-01	1997-03-25	The University Of South Florida	Method of making inosine monophosphate derivatives and immunopotentiating uses thereof
US5268298A (en) *	1991-04-26	1993-12-07	Life Technologies, Inc.	System for delivering oxygen to a cell culture medium
CA2113823A1 (en) *	1991-07-19	1993-02-04	Cytimmune Sciences, Inc.	Method and kit for measuring endogenous cytokines
US5965379A (en) *	1991-07-19	1999-10-12	Cytimmune Sciences Inc.	Method for measuring endogenous cytokines
US5464749A (en)	1991-07-22	1995-11-07	Bayer Corporation	Immunoassay of free substances in biological fluids
US5939524A (en) *	1991-12-09	1999-08-17	The Scripps Research Institute	Platelet GPIII P1A1 and P1A2 epitopes, their preparation and use
US5624804A (en) *	1991-12-20	1997-04-29	The Rockefeller University	Immunochemical detection of In vivo advanced glycosylation end products
US5354692A (en) *	1992-09-08	1994-10-11	Pacific Biotech, Inc.	Analyte detection device including a hydrophobic barrier for improved fluid flow
US5874423A (en) *	1992-09-10	1999-02-23	Yissum Research Development Co. Of The Hebrew University Of Jerusalem	Digitalis-like compounds
US7326535B2 (en) *	1993-09-15	2008-02-05	Ortho Diagnostic Systems Inc.	Immunoreactive peptides from Epstein-Barr virus
US7060283B1 (en)	1992-09-15	2006-06-13	Ortho Diagnostic Systems, Inc.	Immunoreactive peptides from Epstein-Barr virus
US5637467A (en) *	1992-10-13	1997-06-10	Behringwerke Ag	Heterogeneous assay using a pendulous drop
US6953573B1 (en)	1993-03-17	2005-10-11	University Of Washington	Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated
US5801005A (en) *	1993-03-17	1998-09-01	University Of Washington	Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
US5869445A (en) *	1993-03-17	1999-02-09	University Of Washington	Methods for eliciting or enhancing reactivity to HER-2/neu protein
US6562333B1 (en)	1993-06-14	2003-05-13	Schering Corporation	Purified mammalian CTLA-8 antigens and related reagents
US6638905B2 (en) *	1993-06-18	2003-10-28	The Salk Institute For Biological Studies	Cloning and recombinant production of CFR receptor(s)
US6495343B1 (en)	1993-06-18	2002-12-17	The Salk Institute For Biological Studies	Cloning and recombinant production of CRF receptor(s)
US5516639A (en) *	1993-07-22	1996-05-14	Mayo Foundation For Medical Education And Research	Antibodies specific for human prostate glandular kallkrein
US20040259113A1 (en) *	1993-07-22	2004-12-23	Mayo Foundation For Medical Education And Research, Hybritech Incorporated	Method for detection of metastatic prostate cancer
US6103237A (en) *	1993-07-22	2000-08-15	Hybritech Incorporated	Stable variant hK2 polypeptide
US5684144A (en) *	1993-07-28	1997-11-04	University Of North Texas	Escherichia coli csrA gene, protein encoded thereby, and methods of use thereof
US6884590B1 (en)	1994-02-11	2005-04-26	Cedars-Sinai Medical Center	Methods of screening for ulcerative colitis and crohn's disease
US5681699A (en) *	1994-02-11	1997-10-28	Cedars-Sinai Medical Center	Methods of diagnosing ulcerative colitis and Crohn's disease
US6335160B1 (en)	1995-02-17	2002-01-01	Maxygen, Inc.	Methods and compositions for polypeptide engineering
US6406855B1 (en)	1994-02-17	2002-06-18	Maxygen, Inc.	Methods and compositions for polypeptide engineering
WO1995030758A1 (en) *	1994-05-10	1995-11-16	Mayo Foundation For Medical Education And Research	Recombinant hk2 polypeptide
WO1995034640A1 (en) *	1994-06-13	1995-12-21	Henry Ford Health System	A novel neuronal-neonatal gene: neuronatin
US5589344A (en) *	1994-06-15	1996-12-31	Johnson & Johnson Clinical Diagnostics, Inc.	Test kit and method for competitive specific binding assay
ATE198623T1 (de)	1994-08-12	2001-01-15	Myriad Genetics Inc	Verfahren zum nachweis von prädisposition von ovarial- und brustkrebs
ATE201445T1 (de)	1994-08-12	2001-06-15	Myriad Genetics Inc	Mutationen des mit 17q verbundenen ovarial- und brustkrebs empfindlichkeitsgens
US6048837A (en) *	1994-08-17	2000-04-11	The Rockefeller University	OB polypeptides as modulators of body weight
US6001968A (en)	1994-08-17	1999-12-14	The Rockefeller University	OB polypeptides, modified forms and compositions
US6124439A (en) *	1994-08-17	2000-09-26	The Rockefeller University	OB polypeptide antibodies and method of making
US6124448A (en) *	1994-08-17	2000-09-26	The Rockfeller University	Nucleic acid primers and probes for the mammalian OB gene
US6471956B1 (en)	1994-08-17	2002-10-29	The Rockefeller University	Ob polypeptides, modified forms and compositions thereto
US6309853B1 (en)	1994-08-17	2001-10-30	The Rockfeller University	Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
US6350730B1 (en)	1994-08-17	2002-02-26	The Rockefeller University	OB polypeptides and modified forms as modulators of body weight
US6974666B1 (en) *	1994-10-21	2005-12-13	Appymetric, Inc.	Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
US8236493B2 (en)	1994-10-21	2012-08-07	Affymetrix, Inc.	Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
US5843673A (en) *	1994-10-25	1998-12-01	Curators Of The University Of Missouri	Method of screening for endometriosis
US6531277B2 (en)	1994-10-25	2003-03-11	The Curators Of The University Of Missouri	Endometriosis-specific secretory protein
US20030152909A1 (en) *	1994-11-16	2003-08-14	Mitrani Eduardo N.	In vitro micro-organs, and uses related thereto
US5633149A (en) *	1994-12-07	1997-05-27	Incyte Pharmaceuticals, Inc.	Polynucleotide encoding novel chemokine expressed in inflamed adenoid
US7005509B1 (en)	1995-02-17	2006-02-28	Incyte Corporation	Chemokine PANEC-1 polynucleotides and compositions and methods related thereto
US6506553B1 (en)	1995-03-30	2003-01-14	Ortho Diagnostics Systems, Inc.	Method for diagnosis of Epstein-Barr virus associated disease
US5728807A (en) *	1995-05-16	1998-03-17	Ramot-University Authority For Applied Research And Industrial Development, Ltd.	Mutated proteins associated with ataxia-telangiectasia
US5858661A (en)	1995-05-16	1999-01-12	Ramot-University Authority For Applied Research And Industrial Development	Ataxia-telangiectasia gene and its genomic organization
US5777093A (en) *	1995-05-16	1998-07-07	Ramot-University Authority For Applied Research & Industrial Development Ltd.	cDNAs associated with ataxia-telangiectasia
GB0112226D0 (en) *	2001-05-18	2001-07-11	Danisco	Method of improving dough and bread quality
US5977322A (en)	1995-06-14	1999-11-02	The Regents Of The University Of California	High affinity human antibodies to tumor antigens
DE69625678T3 (de)	1995-12-18	2006-11-09	The University Of Utah Research Foundation, Salt Lake City	Chromosom 13 verbundene Brustkrebsempfindlichkeitsgen BRCA2
US5837492A (en)	1995-12-18	1998-11-17	Myriad Genetics, Inc.	Chromosome 13-linked breast cancer susceptibility gene
EP0880598A4 (en)	1996-01-23	2005-02-23	Affymetrix Inc	RAPID EVALUATION OF NUCLEIC ACID ABUNDANCE DIFFERENCE, WITH A HIGH-DENSITY OLIGONUCLEOTIDE SYSTEM
US20040210045A1 (en) *	1996-01-23	2004-10-21	Mcgall Glenn	Nucleic acid labeling compounds
US20010018514A1 (en) *	1998-07-31	2001-08-30	Mcgall Glenn H.	Nucleic acid labeling compounds
US6965020B2 (en)	1996-01-23	2005-11-15	Affymetrix, Inc.	Nucleic acid labeling compounds
US7282327B2 (en) *	1996-01-23	2007-10-16	Affymetrix, Inc.	Nucleic acid labeling compounds
US7291463B2 (en)	1996-01-23	2007-11-06	Affymetrix, Inc.	Nucleic acid labeling compounds
US6864059B2 (en) *	1996-01-23	2005-03-08	Affymetrix, Inc.	Biotin containing C-glycoside nucleic acid labeling compounds
US7423143B2 (en) *	1996-01-23	2008-09-09	Affymetrix. Inc.	Nucleic acid labeling compounds
AU2189397A (en)	1996-02-08	1997-08-28	Affymetrix, Inc.	Chip-based speciation and phenotypic characterization of microorganisms
EP1728875A3 (en)	1996-02-08	2007-05-09	Affymetrix, Inc.	Chip-based speciation and phenotypic characterization of microorganisms
US6924094B1 (en)	1996-02-08	2005-08-02	Affymetrix, Inc.	Chip-based species identification and phenotypic characterization of microorganisms
US5882644A (en) *	1996-03-22	1999-03-16	Protein Design Labs, Inc.	Monoclonal antibodies specific for the platelet derived growth factor β receptor and methods of use thereof
CA2249994A1 (en) *	1996-03-22	1997-09-25	University Of Georgia Research Foundation, Inc.	Immunogenic compositions comprising porphyromonas gingivalis peptides and methods
US6942862B2 (en) *	1996-04-01	2005-09-13	University Of Washington	Methods and compositions to generate immunity in humans against self tumor antigens by immunization with homologous foreign proteins
WO1997044461A2 (en) *	1996-05-22	1997-11-27	Novopharm Biotech, Inc.	Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
US6342349B1 (en)	1996-07-08	2002-01-29	Burstein Technologies, Inc.	Optical disk-based assay devices and methods
US20050214827A1 (en) *	1996-07-08	2005-09-29	Burstein Technologies, Inc.	Assay device and method
US6331275B1 (en)	1996-07-08	2001-12-18	Burstein Technologies, Inc.	Spatially addressable, cleavable reflective signal elements, assay device and method
WO1998001533A1 (en)	1996-07-08	1998-01-15	Burstein Laboratories, Inc.	Cleavable signal element device and method
US20050069923A1 (en) *	1996-07-08	2005-03-31	Mullis Kary Banks	Dual bead assays using cleavable spacers and/or ligation to improve specificity and sensitivity including related methods and apparatus
ES2308787T3 (es)	1996-08-16	2008-12-01	Schering Corporation	Antigenos de superficie de celular de mamiferos; reactivos relacionados.
US20070299005A1 (en) *	1996-09-24	2007-12-27	Tanox, Inc.	Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
EP0932678B2 (en)	1996-09-24	2010-03-10	Genentech, Inc.	A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
US6093809A (en) *	1996-10-01	2000-07-25	University Technology Corporation	Telomerase
US6475789B1 (en) *	1996-10-01	2002-11-05	University Technology Corporation	Human telomerase catalytic subunit: diagnostic and therapeutic methods
IL129222A0 (en)	1996-10-01	2000-02-17	Geron Corp	Telomerase reverse transcriptase
US6808880B2 (en) *	1996-10-01	2004-10-26	Geron Corporation	Method for detecting polynucleotides encoding telomerase
US6610839B1 (en) *	1997-08-14	2003-08-26	Geron Corporation	Promoter for telomerase reverse transcriptase
US6261836B1 (en)	1996-10-01	2001-07-17	Geron Corporation	Telomerase
US7585622B1 (en)	1996-10-01	2009-09-08	Geron Corporation	Increasing the proliferative capacity of cells using telomerase reverse transcriptase
GB9907461D0 (en)	1999-03-31	1999-05-26	King S College London	Neurite regeneration
US6479263B1 (en)	1996-11-14	2002-11-12	Baylor College Of Medicine	Method for detection of micrometastatic prostate cancer
GB2335984B (en)	1996-11-15	2000-11-29	Univ Texas	Genetic test for equine severe combined immunodeficiency disease
PT1114864E (pt)	1996-12-13	2008-10-08	Schering Corp	Antigénios de superfície de células de mamífero, reagentes relacionados
US5840322A (en) *	1996-12-19	1998-11-24	Ramot-University Authority For Applied Research & Industrial Devel. Ltd.	Anti-oral-microbial adhesion fraction derived from vaccinium
PT966533E (pt)	1997-02-07	2010-01-26	Univ Ramot	Factor neurotrófico iii dependente da actividade (adnf iii)
US6268165B1 (en)	1997-03-19	2001-07-31	The Board Of Trustees Of The University Of Arkansas	Methods for the early diagnosis of ovarian cancer
CA2285452A1 (en) *	1997-04-01	1998-10-08	Calyx Therapeutics, Inc.	Orally active fraction of momordica charantia, active peptides thereof, and their use in the treatment of diabetes
US7622549B2 (en) *	1997-04-18	2009-11-24	Geron Corporation	Human telomerase reverse transcriptase polypeptides
US7413864B2 (en) *	1997-04-18	2008-08-19	Geron Corporation	Treating cancer using a telomerase vaccine
US20050013825A1 (en) *	1997-04-18	2005-01-20	Geron Corporation	Vaccine containing the catalytic subunit of telomerase for treating cancer
ES2331622T3 (es)	1997-05-07	2010-01-11	Schering Corporation	Proteinas receptoras humanas similares a toll, reactivos y metodos relacionados.
US7115722B1 (en)	1997-05-22	2006-10-03	Viventia Biotech, Inc.	Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
US7541151B2 (en)	1997-06-05	2009-06-02	Duke University	Single-cell biosensor for the measurement of GPCR ligands in a test sample
US5891646A (en) *	1997-06-05	1999-04-06	Duke University	Methods of assaying receptor activity and constructs useful in such methods
US6528271B1 (en) *	1997-06-05	2003-03-04	Duke University	Inhibition of βarrestin mediated effects prolongs and potentiates opioid receptor-mediated analgesia
WO1998059073A1 (en)	1997-06-20	1998-12-30	Mayo Foundation For Medical Education And Research	Method for detection of breast cancer
US20020122807A1 (en) *	1998-07-07	2002-09-05	Dan Michael D.	Antigen binding fragments, designated 4B5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
KR20010021597A (ko)	1997-07-09	2001-03-15	둘락 노먼 씨.	분리된 덴드라이틱 세포막 단백질 유전자
WO1999002721A1 (en)	1997-07-11	1999-01-21	University Of North Texas	THE ESCHERICHIA COLI csrB GENE, RNA ENCODED THEREBY, AND METHODS OF USE THEREOF
US6506579B1 (en)	1997-07-15	2003-01-14	Genencor International, Inc.	Increasing production of proteins in gram-positive microorganisms using SecG
US20030157642A1 (en) *	1997-07-15	2003-08-21	Caldwell Robert M.	Increasing production of proteins in gram-positive microorganisms
US6723550B1 (en)	1997-07-15	2004-04-20	Genencor International, Inc.	Proteases from gram-positive organisms
US6762039B2 (en) *	1997-07-15	2004-07-13	Genencor International, Inc.	Bacillus subtillis with an inactivated cysteine protease-1
US6521421B1 (en) *	1997-07-16	2003-02-18	Genencor International, Inc.	Expression vectors encoding Bacillus subtilis disulfide bond isomerase and methods of secreting proteins in gram-positive microorganisms using the same
ZA986596B (en)	1997-07-25	1999-02-08	Schering Corp	Mammalian cytokine related reagents
EP1003861B1 (en)	1997-08-01	2006-10-04	Schering Corporation	Mammalian cell membrane proteins; related reagents
US6180411B1 (en)	1997-08-01	2001-01-30	The Regents Of The University Of California	Light-triggered indicators that memorize analyte concentrations
US7252950B1 (en)	1997-09-04	2007-08-07	The Regents Of The University Of California	Assays for detecting modulators of cytoskeletal function
US6300117B1 (en) *	1997-09-15	2001-10-09	Genencor International, Inc.	Proteases from gram-positive organisms
US6521440B1 (en)	1997-09-15	2003-02-18	Genencor International, Inc.	Proteases from gram-positive organisms
US7378244B2 (en) *	1997-10-01	2008-05-27	Geron Corporation	Telomerase promoters sequences for screening telomerase modulators
US6284496B1 (en)	1997-10-03	2001-09-04	University Of South Florida	DNA vector for determining the presence of out-of-reading-frame mutations
WO1999020788A1 (en)	1997-10-17	1999-04-29	University Of South Florida	Method to diagnose and monitor cellular immune deficiencies
US6316241B1 (en) *	1997-11-20	2001-11-13	Genencor International, Inc.	Alpha/beta hydrolase-fold enzymes
GB9724629D0 (en) *	1997-11-20	1998-01-21	Genencor Int Bv	Alpha/beta hydrolase-fold enzymes
GB9724627D0 (en)	1997-11-20	1998-01-21	Genencor Int Bv	Gram positive microorganism formate pathway
US6528255B1 (en) *	1997-12-30	2003-03-04	Genencor International, Inc.	Proteases from gram positive organisms
US6599731B1 (en) *	1997-12-30	2003-07-29	Genencor International, Inc.	Proteases from gram positive organisms
GB9727470D0 (en) *	1997-12-30	1998-02-25	Genencor Int Bv	Proteases from gram positive organisms
US6465186B1 (en) *	1997-12-30	2002-10-15	Genecor International, Inc.	Proteases from gram positive organisms
US7687057B2 (en)	1998-01-09	2010-03-30	Yissum Research Development Company Of The Hebrew University Of Jerusalem	In vitro micro-organs, and uses related thereto
US6780609B1 (en)	1998-10-23	2004-08-24	Genome Therapeutics Corporation	High bone mass gene of 1.1q13.3
US6759243B2 (en)	1998-01-20	2004-07-06	Board Of Trustees Of The University Of Illinois	High affinity TCR proteins and methods
US6673914B1 (en)	1998-01-22	2004-01-06	John Wayne Cancer Institute	Human tumor-associated gene
WO2000018885A1 (en)	1998-09-29	2000-04-06	Gamida Cell Ltd.	Methods of controlling proliferation and differentiation of stem and progenitor cells
US6596501B2 (en)	1998-02-23	2003-07-22	Fred Hutchinson Cancer Research Center	Method of diagnosing autoimmune disease
US6060260A (en) *	1998-02-27	2000-05-09	Dade Behring Inc.	Methods for reducing adsorption in an assay
JP2002505108A (ja)	1998-03-04	2002-02-19	ジェネンコアインターナショナルインコーポレーテッド	プルラナーゼの修飾形態
US6869770B1 (en)	1998-03-20	2005-03-22	The Curators Of The University Of Missouri	Compositions and methods for early pregnancy diagnosis
US8062908B2 (en) *	1999-03-29	2011-11-22	Orasure Technologies, Inc.	Device for collection and assay of oral fluids
US6303081B1 (en) *	1998-03-30	2001-10-16	Orasure Technologies, Inc.	Device for collection and assay of oral fluids
AU3219099A (en) *	1998-03-30	1999-10-18	Epitope, Inc.	Collection device for single step assay of oral fluids
EP1095183B1 (en) *	1998-03-31	2012-02-22	Esoterix Genetic Laboratories, LLC	Methods for the diagnosis and treatment of lung cancer
US6337200B1 (en) *	1998-03-31	2002-01-08	Geron Corporation	Human telomerase catalytic subunit variants
US7108968B2 (en) *	1998-04-03	2006-09-19	Affymetrix, Inc.	Mycobacterial rpoB sequences
EP1071943A4 (en)	1998-04-14	2005-08-10	Univ California	DETECTION ASSAYS FOR DEPOLYMERIZATION INHIBITORS OF MICROTUBLES
US6699969B1 (en)	1998-04-14	2004-03-02	The Regents Of The University Of California	Assays for the detection of microtubule depolymerization inhibitors
US6872537B1 (en)	1998-04-14	2005-03-29	Regents Of The University Of California	Assays for the detection of microtubule depolymerization inhibitors
US20080206206A1 (en)	1998-05-07	2008-08-28	University Of South Florida	Bone marrow-derived neuronal cells
US6344443B1 (en)	1998-07-08	2002-02-05	University Of South Florida	Peptide antagonists of tumor necrosis factor alpha
US7605149B1 (en)	1998-07-13	2009-10-20	University Of South Florida	Modulation of the phospholipase A2 pathway as a therapeutic
EP1097378A2 (en) *	1998-07-21	2001-05-09	Burstein Laboratories Inc.	Optical disc-based assay devices and methods
ATE231186T1 (de)	1998-07-21	2003-02-15	Danisco	Lebensmittel
US6312689B1 (en)	1998-07-23	2001-11-06	Millennium Pharmaceuticals, Inc.	Anti-CCR2 antibodies and methods of use therefor
US6187563B1 (en)	1998-08-07	2001-02-13	Yale University	βIV-spectrin-polypeptides and nucleic acids encoding same
SE9803099D0 (sv)	1998-09-13	1998-09-13	Karolinska Innovations Ab	Nucleic acid transfer
AU6394399A (en) *	1998-09-18	2000-04-10	Rockefeller University, The	Lynx, a novel family of receptor ligands in the central nervous system, corresponding nucleic acids and proteins and uses thereof
JP2002526079A (ja)	1998-09-21	2002-08-20	シェーリングコーポレイション	ヒトインターロイキン−ｂ５０、治療的使用
EP0997476A3 (en)	1998-09-25	2000-07-19	Schering-Plough	Antibodies to a mammalian Langerhans cell antigen and their uses
EP2341144A1 (en)	1999-01-11	2011-07-06	Schering Corporation	Interleukin-17 related mammalian cytokines. Polynucleotides encoding them. Uses
BR0009403A (pt)	1999-02-04	2001-11-27	Technion Res & Dev Foundation	Método de expansão/conservação das células detronco hemopoiéticas indiferenciadas ou dascélulas progenitoras, método de preparação deum meio condicionado de célula estomacal útil naexpansão/conservação das células de troncohemopoiéticas indiferenciadas ou das célulasprogenitoras, método de transplante de célulasde tronco hemopoiéticas indiferenciadas ou decélulas progenitoras em um recipiente, tampão debiorreator e biorreator
US6156515A (en) *	1999-02-09	2000-12-05	Urocor, Inc.	Prostate-specific gene for diagnosis, prognosis and management of prostate cancer
DE60041393D1 (de)	1999-03-11	2009-03-05	Schering Corp	Cytokine aus säugetieren, verwandte reagenzien und verfahren
MXPA01011519A (es)	1999-05-13	2003-08-20	Medical Res Council	Homologos del receptor ox2.
AU5011200A (en)	1999-05-14	2000-12-05	Arbor Vita Corporation	Molecular interactions in hematopoietic cells
US6440682B1 (en) *	1999-05-28	2002-08-27	Detroit R&D Inc.	Detection of hypertension using immunoreactive metabolic products
US6787318B1 (en) *	1999-06-01	2004-09-07	Roskamp Research Institute, Llc	Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology
PT1181366E (pt)	1999-06-01	2009-05-25	Schering Corp	Proteínas receptoras de mamífero; reagentes e métodos relacionados
US7534605B2 (en)	1999-06-08	2009-05-19	Yissum Research Development Company Of The Hebrew University Of Jerusalem	CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
GB9914210D0 (en)	1999-06-17	1999-08-18	Danisco	Promoter
JP2003535025A (ja) *	1999-06-25	2003-11-25	イッサム・リサーチ・ディベロップメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシティ・オブ・エルサレム	微小器官で血管新生を誘発する方法
US20060127366A1 (en) *	1999-06-25	2006-06-15	Mitrani Eduardo N	Method and device for inducing biological processes by micro-organs
US6531130B1 (en) *	1999-07-06	2003-03-11	The Board Of Trustees Of The Leland Stanford University	Treatment of demyelinating autoimmune disease with ordered peptides
MXPA02001146A (es)	1999-07-30	2002-08-20	Schering Corp	Citosinas de mamifero, reactivos relacionados.
US6875582B1 (en)	1999-08-19	2005-04-05	Omniscience Pharmaceuticals, Inc.	Methods and targets of antibiotic resistance
US7811981B2 (en) *	1999-08-30	2010-10-12	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Methods of and compositions for inhibiting the proliferation of mammalian cells
US7101839B1 (en)	1999-08-30	2006-09-05	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Methods of and compositions for inhibiting the proliferation of mammalian cells
EP1905832A3 (en)	1999-09-09	2009-09-09	Schering Corporation	Mammalian interleukin-12 P40 and interleukin B30, combinations thereof, antibodies, uses in pharmaceutical compositions
NZ518601A (en)	1999-09-24	2004-10-29	Morphogen Pharmaceuticals Inc	Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
US6998232B1 (en)	1999-09-27	2006-02-14	Quark Biotech, Inc.	Methods of diagnosing bladder cancer
US7668658B2 (en)	1999-10-13	2010-02-23	Sequenom, Inc.	Methods for generating databases and databases for identifying polymorphic genetic markers
US7030228B1 (en) *	1999-11-15	2006-04-18	Miltenyi Biotec Gmbh	Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
US7223902B1 (en)	1999-11-19	2007-05-29	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Method of producing recombinant Aspergillus niger β-glucosidase and an aroma spreading plant
EP2261256A3 (en)	1999-11-24	2011-03-02	Schering Corporation	Methods of inhibiting metastasis
MXPA02005559A (es)	1999-12-06	2004-09-10	Univ Illinois	Proteinas de tcr de alta afinidad y metodos.
US6544792B1 (en)	1999-12-21	2003-04-08	Genencor International, Inc.	Production of secreted polypeptides
US6544506B2 (en) *	2000-01-05	2003-04-08	Yeda Research & Development Co. Ltd.	Veto cells effective in preventing graft rejection and devoid of graft versus host potential
AU2001225441A1 (en) *	2000-01-24	2001-07-31	Agricultural Research Organization The Volcani Center	Plants tolerant of environmental stress conditions, methods of generating same and novel polynucleotide sequence utilized thereby
DE10003734A1 (de) *	2000-01-28	2001-08-02	Bosch Gmbh Robert	Detektionsverfahren und -vorrichtung
AU2001239884B2 (en) *	2000-02-25	2006-08-10	Vegenics Limited	Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins and screening methods for modulators
US20040002068A1 (en)	2000-03-01	2004-01-01	Corixa Corporation	Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
US7829313B2 (en) *	2000-03-24	2010-11-09	Eppendorf Array Technologies	Identification and quantification of a plurality of biological (micro)organisms or their components
US8288128B2 (en) *	2004-11-18	2012-10-16	Eppendorf Array Technologies S.A.	Real-time quantification of multiple targets on a micro-array
US7875442B2 (en) *	2000-03-24	2011-01-25	Eppendorf Array Technologies	Identification and quantification of a plurality of biological (micro)organisms or their components
IL151860A0 (en)	2000-03-27	2003-04-10	Technion Res & Dev Foundation	Single chain class i major histocompatibility complexes, constructs encoding same and methods of generating same
US20040191260A1 (en)	2003-03-26	2004-09-30	Technion Research & Development Foundation Ltd.	Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
WO2001075078A1 (en)	2000-03-31	2001-10-11	The Scripps Research Institute	HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS
US20030108927A1 (en) *	2000-04-03	2003-06-12	Kathryn Leishman	Compositions and methods for the prevention, treatment and detection of tuberculosis and other diseases
DE60136921D1 (de)	2000-04-18	2009-01-22	Schering Corp	Medizinische Verwendung von IL-174 Agonisten und Antagonisten
IL135884A (en) *	2000-04-30	2005-08-31	Yissum Res Dev Co	Method for measuring non-transferrin bound iron
US7422743B2 (en)	2000-05-10	2008-09-09	Schering Corporation	Mammalian receptor protein DCRS5;methods of treatment
US6756481B2 (en)	2000-05-10	2004-06-29	Schering Corporation	IL-23 receptor binding compositions
NZ534666A (en)	2000-05-25	2006-01-27	Schering Corp	Mammalian DNAX Toll-like receptor protein, DTLR9, antibodies and medicaments made therefrom and use in treating immunological disorders
WO2005000087A2 (en) *	2003-06-03	2005-01-06	Chiron Corporation	Gene products differentially expressed in cancerous colon cells and their methods of use ii
US20030031675A1 (en)	2000-06-06	2003-02-13	Mikesell Glen E.	B7-related nucleic acids and polypeptides useful for immunomodulation
US6958214B2 (en) *	2000-07-10	2005-10-25	Sequenom, Inc.	Polymorphic kinase anchor proteins and nucleic acids encoding the same
HUP0300810A2 (hu)	2000-07-20	2003-08-28	M.G.V.S. Ltd.	Mesterséges értranszplantátum, valamint ennek létrehozása és alkalmazása
US20040037828A1 (en)	2002-07-09	2004-02-26	Bar-Ilan University	Methods and pharmaceutical compositions for healing wounds
EP2359854B1 (en)	2000-08-08	2013-10-09	Technion Research and Development Foundation, Ltd.	Pharmaceutical compositions and methods useful for modulating angiogenesis
WO2002012294A2 (en)	2000-08-08	2002-02-14	St. Jude Children's Research Hospital	Group b streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof
US20030114410A1 (en)	2000-08-08	2003-06-19	Technion Research And Development Foundation Ltd.	Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
GB0020498D0 (en)	2000-08-18	2000-10-11	Sterix Ltd	Compound
EP1683874A3 (en)	2000-08-29	2006-10-11	YEDA RESEARCH AND DEVELOPMENT Co. LTD.	Methods of isolating genes encoding proteins of specific function and of screening for pharmaceutically active agents
ATE549347T1 (de)	2000-09-08	2012-03-15	Schering Corp	Gene von säugetiere, und damit verbundene reagentien, methoden
EP2028187A1 (en)	2000-09-08	2009-02-25	Board Of Regents, The University Of Texas System	Human and mouse targeting peptides identified by phage display
US6673623B1 (en)	2000-09-12	2004-01-06	Novocure, Inc.	Methods and compositions that control lipid production
EP1356060B1 (en) *	2000-09-18	2005-12-14	Genencor International, Inc.	Twin-arginine translocation in bacillus
US7632522B2 (en)	2000-09-28	2009-12-15	Nanocyte Inc.	Use of stinging cells/capsules for the delivery of active agents to keratinous substances
EP1379127B1 (en) *	2000-09-28	2013-04-17	Nanocyte Inc.	Methods, compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue
US20070281037A9 (en) *	2000-09-28	2007-12-06	Nanocyte Inc.	Sterile preparations and compositions including stinging capsules and methods of producing and using same
US7045283B2 (en)	2000-10-18	2006-05-16	The Regents Of The University Of California	Methods of high-throughput screening for internalizing antibodies
US7018812B2 (en)	2000-11-03	2006-03-28	Duke University	Modified G-protein coupled receptors
US7163800B2 (en) *	2000-11-03	2007-01-16	Molecular Devices Corporation	Methods of screening compositions for G protein-coupled receptor desensitization inhibitory activity
US20050136431A1 (en) *	2000-11-03	2005-06-23	Oakley Robert H.	Methods of screening compositions for G protein-coupled receptor desensitization inhibitory activity
US6890734B2 (en)	2000-11-10	2005-05-10	Schering Corporation	Nucleic acids encoding a cytokine receptor complex
US8071740B2 (en)	2000-11-17	2011-12-06	Vascular Biogenics Ltd.	Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
ES2425321T3 (es)	2000-11-17	2013-10-14	Vascular Biogenics Ltd.	Promotores que muestran especificidad por células endoteliales y métodos de utilización de los mismos
WO2002041827A2 (en)	2000-11-24	2002-05-30	Vascular Biogenics Ltd.	Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
US20040248093A1 (en) *	2000-11-27	2004-12-09	Coombs James Howard	Magneto-optical bio-discs and systems including related methods
US20020172980A1 (en) *	2000-11-27	2002-11-21	Phan Brigitte Chau	Methods for decreasing non-specific binding of beads in dual bead assays including related optical biodiscs and disc drive systems
US20030003464A1 (en) *	2000-11-27	2003-01-02	Phan Brigitte C.	Dual bead assays including optical biodiscs and methods relating thereto
CA2430082A1 (en) *	2000-11-29	2002-06-06	Lynkeus Biotech Gmbh	Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379
US20040106120A1 (en)	2000-11-30	2004-06-03	Rachid Tazi-Ahnini	Diagnosis and treatment of disease
IL155941A0 (en) *	2000-11-30	2003-12-23	Yeda Res & Dev	Methods of utilizing cultured non-gvhd inducing t lymphocytes to treat disease
US20020165149A1 (en) *	2000-12-08	2002-11-07	Kranz David M.	Mutated class II major histocompatibility proteins
US7087395B1 (en)	2001-01-16	2006-08-08	Quest Diagnostics Investments Incorporated	Vitamin D assay
GB0101762D0 (en) *	2001-01-23	2001-03-07	Medical Res Council	Method
US20050202098A1 (en) *	2001-01-31	2005-09-15	Tolaren	Disease therapy using dying or dead cells
AU2002230061A1 (en) *	2001-01-31	2002-08-12	Tolaren	Induction of tolerance by apoptotic and/or necrotic cells
AU2002244247B2 (en)	2001-03-01	2007-12-13	Harbor Biosciences, Inc.	Use of certain steroids for treatment of blood cell deficiencies
CA2440615A1 (en) *	2001-03-12	2002-09-19	Affymetrix, Inc.	Nucleic acid labeling compounds
US20030104410A1 (en) *	2001-03-16	2003-06-05	Affymetrix, Inc.	Human microarray
US20030003454A1 (en)	2001-03-23	2003-01-02	Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science	Methods and kits for determining a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a DNA repair enzyme and a cancer
US20030220475A1 (en) *	2001-04-03	2003-11-27	Fields Howard A.	Neutralizing immunogenic hev polypepetides
AU2002254524A1 (en) *	2001-04-06	2002-10-21	The Government Of The United States Of America, Represented By The Secretary, Department Of Health A	Use of semenogelin in the diagnosis, prognosis and treatment of cancer
AU2002311919B8 (en)	2001-05-11	2007-03-22	Ludwig Institute For Cancer Research Ltd	Specific binding proteins and uses thereof
US20100056762A1 (en)	2001-05-11	2010-03-04	Old Lloyd J	Specific binding proteins and uses thereof
US20110313230A1 (en)	2001-05-11	2011-12-22	Terrance Grant Johns	Specific binding proteins and uses thereof
BR0209154A (pt)	2001-05-18	2004-07-20	Danisco	Processo de preparação de uma massa com uma enzima
CA2448142A1 (en)	2001-05-22	2002-11-28	Merck & Co., Inc.	Beta-secretase substrates and uses thereof
US7553484B2 (en) *	2001-06-05	2009-06-30	The Regents Of The University Of California	Modulating neuronal outgrowth via the major histocompatibility complex class I (MHC I) molecule
US20090324612A1 (en) *	2001-06-05	2009-12-31	Kaufman Daniel L	Modulating neuronal outgrowth via the major histocompatibility complex class i (mhc i) molecule
US6770622B2 (en)	2001-06-08	2004-08-03	Gary A. Jarvis	N-terminally truncated galectin-3 for use in treating cancer
US20070190534A1 (en) *	2001-06-11	2007-08-16	Genesis Genomics Inc.	Mitochondrial sites and genes associated with prostate cancer
IL159944A0 (en) *	2001-07-19	2004-06-20	Yissum Res Dev Co	Polypeptides having carotenoid isomerase catalytic activity, nucleic acids encoding same and uses thereof
EP1430140B1 (en) *	2001-08-01	2010-09-15	University of Utah	N-terminally truncated isoforms of pde3a cyclic phosphodiesterases
US6833441B2 (en)	2001-08-01	2004-12-21	Abmaxis, Inc.	Compositions and methods for generating chimeric heteromultimers
US20030082596A1 (en) *	2001-08-08	2003-05-01	Michael Mittmann	Methods of genetic analysis of probes: test3
US20060073530A1 (en) *	2001-08-15	2006-04-06	Olaf Schneewind	Methods and compositions involving sortase B
US7442781B2 (en)	2001-08-16	2008-10-28	Urifer Ltd.	Diagnosis, prevention and treatment of cancer
US7138144B2 (en) *	2001-09-07	2006-11-21	Nadir Askenasy	Method of inducing immune tolerance via blood/lymph flow-restricted bone marrow transplantation
US20040136972A1 (en)	2001-09-07	2004-07-15	Yeda Research And Development Co. Ltd.	Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues
JP4424987B2 (ja)	2001-09-20	2010-03-03	ボードオブリージェンツ，ザユニバーシティオブテキサスシステム	Ｅｌｉｓａアッセイを用いた循環する治療抗体、抗原および抗原／抗体複合体の測定
US7393696B2 (en) *	2001-09-28	2008-07-01	Aspenbio Pharma, Inc.	Bovine pregnancy test
US7138370B2 (en)	2001-10-11	2006-11-21	Amgen Inc.	Specific binding agents of human angiopoietin-2
US7521053B2 (en)	2001-10-11	2009-04-21	Amgen Inc.	Angiopoietin-2 specific binding agents
CA2462883A1 (en)	2001-10-12	2003-04-17	Schering Corporation	Use of bispecific antibodies to regulate immune responses
CN100506284C (zh)	2001-10-19	2009-07-01	脉管生物生长有限公司	多核苷酸构建体、药物组合物以及靶向的下调血管生成和抗癌的治疗方法
US7175983B2 (en) *	2001-11-02	2007-02-13	Abmaxis, Inc.	Adapter-directed display systems
MXPA04004880A (es)	2001-11-20	2004-09-03	Monsanto Technology Llc	Composiciones y metodos para el diagnostico temprano y preciso de prenez.
US6952704B2 (en) *	2001-11-26	2005-10-04	Microsoft Corporation	Extending a directory schema independent of schema modification
WO2003048298A2 (en) *	2001-12-05	2003-06-12	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Nanoparticles containing polymeric nucleic acid homologs, pharmaceutical compositions and articles of manufacture containing same and methods of use thereof
EP1463807A4 (en) *	2001-12-19	2006-04-12	Bristol Myers Squibb Co	FORMATHYDROGENASE FROM PICHIA PASTORIS AND USES THEREOF
US20050085432A1 (en) *	2001-12-26	2005-04-21	Aviva Lapidot	Methods of using conjugates of saccharides and acetamidino or guanidino compounds for treating bacterial infections
WO2003063110A1 (en) *	2002-01-16	2003-07-31	Regents Of The University Of Minnesota	Marker for psychiatric conditions
IL152904A0 (en)	2002-01-24	2003-06-24	Gamida Cell Ltd	Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
WO2003062404A1 (en)	2002-01-25	2003-07-31	Gamida-Cell Ltd.	Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby
US8071096B2 (en)	2002-01-25	2011-12-06	G2 Therapies Ltd	Anti-C5aR antibodies and uses thereof
US20040052928A1 (en) *	2002-09-06	2004-03-18	Ehud Gazit	Peptides and methods using same for diagnosing and treating amyloid-associated diseases
US20070021345A1 (en) *	2003-06-30	2007-01-25	Ehud Gazit	Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
US7781396B2 (en) *	2002-01-31	2010-08-24	Tel Aviv University Future Technology Development L.P.	Peptides directed for diagnosis and treatment of amyloid-associated disease
AU2003208888B2 (en)	2002-02-01	2006-10-19	Merck Sharp & Dohme Llc	Uses of mammalian cytokine; related reagents
US6992176B2 (en) *	2002-02-13	2006-01-31	Technion Research & Development Foundation Ltd.	Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
AU2003216341A1 (en) *	2002-02-20	2003-09-09	Dyax Corporation	Mhc-peptide complex binding ligands
US7053188B2 (en)	2002-02-22	2006-05-30	Purdue Research Foundation	Monoclonal antibodies specific for neoplasia-specific NADH:disulfide reductase
AU2003225589A1 (en)	2002-02-22	2003-09-09	The Government Of The United States Of America, As Represented By The Secretary, Dept. Of Health And	Brother of the regulator of imprinted sites (boris)
WO2003078567A2 (en) *	2002-03-18	2003-09-25	Gamida-Cell Ltd.	Methods of inducing differentiation in ex vivo expanded stem cells
US20030182669A1 (en) *	2002-03-19	2003-09-25	Rockman Howard A.	Phosphoinositide 3-kinase mediated inhibition of GPCRs
EP1519755B1 (en) *	2002-03-26	2008-05-07	Nanocyte Inc.	Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue
US7332585B2 (en)	2002-04-05	2008-02-19	The Regents Of The California University	Bispecific single chain Fv antibody molecules and methods of use thereof
US7534580B2 (en) *	2002-05-01	2009-05-19	Ambrilia Biopharma Inc.	PSP94 diagnostic reagents and assays
CA2391438A1 (en) *	2002-05-01	2003-11-01	Procyon Biopharma Inc.	Psp94 diagnostic reagents and assays
WO2003093296A2 (en)	2002-05-03	2003-11-13	Sequenom, Inc.	Kinase anchor protein muteins, peptides thereof, and related methods
US20040121442A1 (en) *	2002-05-05	2004-06-24	Ilan Chet	Fungal chitinase, polynucleotide sequences encoding same, promoters of same, and uses thereof
US7528116B2 (en)	2002-05-30	2009-05-05	Memorial Sloan Kettering Cancer Center	Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis
EP1532453B1 (en) *	2002-05-31	2013-08-21	Genetic Technologies Limited	Maternal antibodies as fetal cell markers to identify and enrich fetal cells from maternal blood
US7290215B2 (en) *	2002-06-03	2007-10-30	Microsoft Corporation	Dynamic wizard interface system and method
US7504215B2 (en)	2002-07-12	2009-03-17	Affymetrix, Inc.	Nucleic acid labeling methods
AU2003304195B8 (en)	2002-07-15	2008-08-28	Board Of Regents, The University Of Texas System	Combinatorial protein library screening by periplasmic expression
KR20120068769A (ko)	2002-07-15	2012-06-27	더 보드 오브 리전츠 오브 더 유니버시티 오브 텍사스 시스템	음이온성 인지질 및 아미노인지질에 결합하는 선택된 항체 및 치료하는데 있어서 이의 용도
US7794716B2 (en)	2002-07-25	2010-09-14	Glenveigh Pharmaceuticals, Llc	Antibody composition and passive immunization against pregnancy-induced hypertension
AU2003247143B2 (en)	2002-08-01	2009-07-16	Yeda Research And Development Co. Ltd.	Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels
ES2346868T3 (es) *	2002-08-10	2010-10-21	Yale University	Antagonistas de receptor nogo.
EP2298315A1 (en)	2002-08-28	2011-03-23	Harbor BioSciences, Inc.	Therapeutic treatment methods
JP4694840B2 (ja)	2002-09-09	2011-06-08	アルボービータコーポレーション	子宮頸部癌を検査する方法
AU2003273633A1 (en)	2002-09-26	2004-04-19	K.U.Leuven Research And Development	Integrase cofactor
US7267981B2 (en)	2002-10-07	2007-09-11	Technion Research & Development Foundation Ltd.	Human foreskin fibroblasts for culturing ES cells
WO2004037251A1 (en)	2002-10-24	2004-05-06	Sterix Limited	Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2
US20040146949A1 (en) *	2002-10-25	2004-07-29	Jun Tan	Methods and compounds for disruption of CD40R/CD40L signaling in the treatment of alzheimer's disease
CA2504512A1 (en)	2002-10-30	2004-05-13	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Molecules and methods using same for measuring non-transferrin bound iron
US20050054097A1 (en) *	2002-11-17	2005-03-10	Tony Peled	EX-VIVO expansion of hematopoietic system cell populations in mononuclear cell cultures
AU2002352938B8 (en) *	2002-11-26	2009-10-08	The University Of Chicago	Materials and methods for preventing and treating microbe-mediated epithelial disorders
WO2004050826A2 (en) *	2002-11-29	2004-06-17	Technion Research & Development Foundation Ltd.	Method of dynamically culturing embryonic stem cells
EP2031070B1 (en)	2002-12-04	2013-07-17	Life Technologies Corporation	Multiplex amplification of polynucleotides
US7491699B2 (en) *	2002-12-09	2009-02-17	Ramot At Tel Aviv University Ltd.	Peptide nanostructures and methods of generating and using the same
SI2338896T1 (sl)	2002-12-12	2015-08-31	R.B.T. (Rakuto Bio Technologies) Ltd.	Uporaba lignin peroksidaze za posvetlitev kože in las
AU2003303071B2 (en)	2002-12-16	2009-04-23	Technion Research & Development Foundation Ltd.	Methods of preparing feeder cells-free, xeno-free human embryonic stem cells and stem cell cultures prepared using same
AU2002953431A0 (en) *	2002-12-19	2003-01-09	Murdoch University	BmpB Novel Nucleotide and Amino Acid Sequences and Diagnostic and Therapeutic Uses Thereof
CA2512499A1 (en)	2003-01-02	2004-07-22	Rappaport Family Institute For Research In The Medical Sciences	Methods of predicting a benefit of antioxidant therapy for prevention of cardiovascular disease in hyperglycemic patients
US20040229245A1 (en) *	2003-01-06	2004-11-18	Anton Bittner	Methods and algorithms for performing quality control during gene expression profiling on DNA microarray technology
ATE426575T1 (de) *	2003-01-07	2009-04-15	Univ Ramot	Peptidenanostrukturen die fremdmaterial enthalten,und verfahren zur herstellung derselben
DK1599278T3 (da)	2003-01-17	2011-07-18	Danisco	Fremgangsmåde til fremstilling af en hydroxysyreester
US20050196766A1 (en)	2003-12-24	2005-09-08	Soe Jorn B.	Proteins
US7955814B2 (en)	2003-01-17	2011-06-07	Danisco A/S	Method
DE602004030000D1 (de) *	2003-01-17	2010-12-23	Danisco	Verfahren zur in-situ-herstellung eines emulgators in einem nahrungsmittel
CA2514179A1 (en) *	2003-01-24	2004-08-12	Duke University	Modified trafficking patterns for arrestin and g-protein-coupled receptors via arrestin-ubiquitin chimera
CA2518677A1 (en) *	2003-03-03	2004-12-09	Nagaoka & Co., Ltd.	Methods and apparatus for use in detection and quantitation of various cell types and use of optical bio-disc for performing same
EP2319857A3 (en)	2003-03-04	2012-06-27	Yeda Research And Development Co., Ltd.	Pon polypeptides, polynucleotides encoding same and compositions and methods utilizing same
EP1599608A4 (en) *	2003-03-05	2007-07-18	Genetic Technologies Ltd	Identification of fetal DNA and fetal cell marker in maternal plasma or serum
JP5438886B2 (ja)	2003-03-07	2014-03-12	タフツメディカルセンターインコーポレイテッド	ＩｇＡ１沈着症の治療
US20050054103A1 (en) *	2003-03-07	2005-03-10	Tony Peled	Expansion of renewable stem cell populations using modulators of PI 3-kinase
US8017113B2 (en)	2003-03-12	2011-09-13	Rappaport Family Institute For Research In The Medical Sciences	Compositions and methods for diagnosing and treating an inflammation
US7294701B2 (en) *	2003-04-02	2007-11-13	Technion Research & Development Foundation Ltd.	Antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same
ATE517926T1 (de)	2003-04-04	2011-08-15	Yeda Res & Dev	Antikörper zur hemmung der aktivität von mmp-2 und mmp-9
EP1611233B1 (en)	2003-04-08	2016-01-06	Yeda Research And Development Co., Ltd.	Stem cells having increased sensitivity to sdf-1 and methods of generating and using same
FR2853551B1 (fr)	2003-04-09	2006-08-04	Lab Francais Du Fractionnement	Formulation stabilisante pour compositions d'immunoglobulines g sous forme liquide et sous forme lyophilisee
US20040209246A1 (en) *	2003-04-15	2004-10-21	Agouron Pharmaceuticals, Inc.	Dual reporter/dye reduction methodology for evaluating antiviral and cytotoxicity of hepatitis C virus inhibitors
EA009643B1 (ru) *	2003-04-16	2008-02-28	Йейл Юниверсити	Лечение состояний, включающих амилоидные бляшки
US7321065B2 (en) *	2003-04-18	2008-01-22	The Regents Of The University Of California	Thyronamine derivatives and analogs and methods of use thereof
CA2978152C (en)	2003-05-22	2021-01-26	Evogene Ltd.	Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby
US7554007B2 (en)	2003-05-22	2009-06-30	Evogene Ltd.	Methods of increasing abiotic stress tolerance and/or biomass in plants
AU2005234725B2 (en)	2003-05-22	2012-02-23	Evogene Ltd.	Methods of Increasing Abiotic Stress Tolerance and/or Biomass in Plants and Plants Generated Thereby
US20050020499A1 (en) *	2003-05-27	2005-01-27	Bar Ilan University	Methods of attenuating cocaine seeking behavior employing glial cell-derived neurotrophic factor (GDNF) and pharmaceutical compositions and articles of manufacture suited for use in practice of the method
US8129514B2 (en) *	2003-06-19	2012-03-06	Evogene Ltd.	Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
EP1636333A4 (en) *	2003-06-19	2007-10-24	Evogene Ltd	NUCLEOTIDE SEQUENCES FOR REGULATING GENE EXPRESSION IN VEGETABLE TRICHROMES, AND HYBRID GENES AND METHODS IN WHICH THEY INTERVENE
EP2128270B1 (en)	2003-08-08	2012-10-03	Genenews Inc.	Osteoarthritis biomarkers and uses thereof
US20050064479A1 (en) *	2003-08-12	2005-03-24	Affymetrix, Inc.	Compounds and methods for post incorporation labeling of nucleic acids
CA2535951A1 (en) *	2003-08-14	2005-03-03	The Bio Balance Corporation	Bacterial strains, compositions including same and probiotic use thereof
JP2007502119A (ja)	2003-08-14	2007-02-08	エクセリクシス，インク．	βカテニン経路のモディファイヤーとしてのＵＰｓ及び使用方法
ATE491953T1 (de)	2003-09-15	2011-01-15	Oklahoma Med Res Found	Verfahren zur verwendung von cytokintests zur diagnose, behandlung und beurteilung von ankyloider spondylitis
US20050064435A1 (en) *	2003-09-24	2005-03-24	Xing Su	Programmable molecular barcodes
WO2005031362A2 (en)	2003-10-02	2005-04-07	Ramot At Tel Aviv University Ltd.	Novel antibacterial agents and methods of identifying and utilizing same
PT1678209E (pt)	2003-10-07	2011-06-30	Yeda Res & Dev	Anticorpos para a nik, a sua preparação e a sua utilização
IL158287A0 (en)	2003-10-07	2004-05-12	Yeda Res & Dev	Antibodies to nik, their preparation and use
JP2007508837A (ja) *	2003-10-23	2007-04-12	ファイザー・プロダクツ・インク	歯周疾患のためのワクチン
US20050227251A1 (en)	2003-10-23	2005-10-13	Robert Darnell	Method of purifying RNA binding protein-RNA complexes
AR046833A1 (es)	2003-11-10	2005-12-28	Schering Corp	Anticuerpos anti-interleuquina-10
ES2469670T3 (es)	2003-11-30	2014-06-18	Yeda Research And Development Co., Ltd.	Métodos y agentes para inmunomodulaci�n y métodos para identificar inmunomoduladores
MXPA06000176A (es)	2003-12-10	2006-06-27	Millennium Pharm Inc	Anticuerpos anti-ccr2 humanizados y sus metodos de uso.
WO2005059100A2 (en) *	2003-12-12	2005-06-30	New York University	Methods and compositions relating to cystatin c
US20100221233A1 (en) *	2003-12-15	2010-09-02	University Of South Florida	Compositions and methods for enhancing neuroprotection via administration of stem cells and blood brain barrier permeabilizers
EP1722834B1 (en)	2003-12-22	2012-06-27	Regentis Biomaterials Ltd.	Matrix comprising naturally-occurring crosslinked protein backbone
WO2005063286A1 (en)	2003-12-23	2005-07-14	Arbor Vita Corporation	Antibodies for oncogenic strains of hpv and methods of their use
GB0716126D0 (en) *	2007-08-17	2007-09-26	Danisco	Process
US7718408B2 (en) *	2003-12-24	2010-05-18	Danisco A/S	Method
BRPI0417533B1 (pt)	2003-12-24	2016-03-01	Danisco	enzima variante glicolipídio aciltransferase, uso e método para sua produção, método para o preparo de um produto alimentício e produto assado de farinha, processo de refinamento enzimático
WO2008090395A1 (en)	2007-01-25	2008-07-31	Danisco A/S	Production of a lipid acyltransferase from transformed bacillus licheniformis cells
US8007847B2 (en)	2004-01-13	2011-08-30	Eytan Biderman	Feeding formula appliance
US7423139B2 (en) *	2004-01-20	2008-09-09	Insight Biopharmaceuticals Ltd.	High level expression of recombinant human erythropoietin having a modified 5′-UTR
US20050186646A1 (en) *	2004-01-26	2005-08-25	Cruz Miguel A.	Rapid assay to detect ADAMTS-13 activity
EP1713900A4 (en) *	2004-01-27	2009-06-17	Compugen Ltd	METHOD AND SYSTEMS FOR COMMENTING BIOMOLECULAR SEQUENCES
US20070178462A1 (en) *	2004-02-18	2007-08-02	Uebele Victor N	Nucleic acid molecules encoding novel murine low-voltage activated calcium channel proteins, designated-alpha1h, encoded proteins and methods of use thereof
GB0403864D0 (en)	2004-02-20	2004-03-24	Ucl Ventures	Modulator
US7767792B2 (en)	2004-02-20	2010-08-03	Ludwig Institute For Cancer Research Ltd.	Antibodies to EGF receptor epitope peptides
WO2005085475A1 (en)	2004-03-01	2005-09-15	Applera Corporation	Methods, compositions and kits for use in polynucleotide amplification
EP3006039B1 (en)	2004-03-02	2021-01-06	Acceleron Pharma Inc.	Alk7 polypeptides for use in promoting fat loss
US8352031B2 (en)	2004-03-10	2013-01-08	Impulse Dynamics Nv	Protein activity modification
GB0405637D0 (en)	2004-03-12	2004-04-21	Danisco	Protein
CN101072797B (zh)	2004-03-12	2012-05-09	瓦斯基因治疗公司	结合ephb4、抑制血管发生和肿瘤生长的抗体
CN1964725A (zh) *	2004-04-20	2007-05-16	芝加哥大学	包含高分子量peg－样化合物的治疗输送系统
EP2400030B1 (en)	2004-05-18	2016-01-20	The Board of Trustees of the Leland Stanford Junior University	Detection of protein translocation by beta-galactosidase reporter fragment complementation
NZ551627A (en)	2004-05-28	2010-02-26	Agensys Inc	Antibodies and related molecules that bind to PSCA proteins
EP2343373B1 (en) *	2004-06-14	2017-05-10	Evogene Ltd.	Polynucleotides and polypeptides involved in plant fiber development and methods of using same
US8034553B2 (en)	2004-06-24	2011-10-11	Kimberly-Clark Worldwide, Inc.	Biomarkers for wound healing
ITBO20040412A1 (it) *	2004-07-01	2004-10-01	Eurodent Spa	Lampada dentale particolarmente per ambulatori medico-dentistici
US8680062B2 (en)	2004-07-06	2014-03-25	Deliversir Ltd.	System for delivering therapeutic agents into living cells and cells nuclei
US20090156471A1 (en) *	2004-07-15	2009-06-18	Ramot At Tel Aviv University Ltd.	Use of anti-amyloid agents for treating and typing pathogen infections
CN101052702B (zh) *	2004-07-16	2013-01-09	杜邦营养生物科学有限公司	脂肪分解酶及其在食品工业中的应用
US20090233986A1 (en) *	2004-07-27	2009-09-17	Mount Sinai School Of Medicine	Methods and compositions for using sax2
EP1789437A4 (en) *	2004-07-30	2008-11-05	Sinai School Medicine	INHIBITORS OF NPC1L1 AND NPC1L1 AND METHODS OF USE THEREOF
US20060073168A1 (en) *	2004-08-11	2006-04-06	Stephens David S	Neisseria meningitidis serogroup a capsular polysaccharide acetyltransferase, methods and compositions
HUE024999T2 (en)	2004-08-26	2016-02-29	Engeneic Molecular Delivery Pty Ltd	Introducing functional nucleic acids into mammalian cells with bacterial intact minicells
FI20050753A7 (fi)	2004-09-03	2006-03-04	Licentia Oy	Uudet peptidit
CA2581086C (en)	2004-09-14	2023-11-07	The Regents Of The University Of Colorado, A Body Corporate	Method for treatment with bucindolol based on genetic targeting
WO2006030442A2 (en)	2004-09-16	2006-03-23	Gamida-Cell Ltd.	Methods of ex vivo progenitor and stem cell expansion by co-culture with mesenchymal cells
EP1802313B1 (en)	2004-09-18	2010-11-03	University of Maryland, Baltimore	Therapeutic agents trageting the ncca-atp channel and methods of use thereof
JP5085326B2 (ja)	2004-09-18	2012-11-28	ユニバーシティオブメリーランド，ボルチモア	ＮＣＣａ−ＡＴＰチャネルを標的とする処置剤およびその使用方法
WO2006036834A2 (en) *	2004-09-24	2006-04-06	Amgen Inc.	MODIFIED Fc MOLECULES
ES2524601T3 (es) *	2004-09-29	2014-12-10	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	RNasa T2 humana recombinante y usos de la misma
DE602005023332D1 (de)	2004-09-29	2010-10-14	Collplant Ltd	Kollagenproduzierende pflanzen sowie verfahren zu deren erzeugung und verwendung
GB0422052D0 (en)	2004-10-04	2004-11-03	Dansico As	Enzymes
US7390489B2 (en) *	2004-10-08	2008-06-24	Komed Co., Ltd.	Monoclonal antibody selectively recognizing listeria monocytogenes, hybridoma producing the antibody, test kit comprising the antibody and detection method of listeria monocytogenes using the antibody
EP1809374A4 (en) *	2004-10-12	2008-09-10	Closed Loop Therapies Ltd	IMPLANTABLE METHODS AND DEVICES FOR TREATING SUPRAVENTRICULAR ARRHYTHMIAS
GB0423139D0 (en)	2004-10-18	2004-11-17	Danisco	Enzymes
JP5525689B2 (ja) *	2004-11-02	2014-06-18	ザガバメントオブザユナイテッドステイツオブアメリカアズリプレゼンティッドバイザセクレタリーデパートメントオブヘルスアンドヒューマンサービシーズ	過剰増殖性障害を処置するための組成物および方法
GB0424940D0 (en)	2004-11-11	2004-12-15	Danisco	Transcription factors
EP1704258B1 (en)	2004-11-18	2010-09-22	Eppendorf Array Technologies	Real-time pcr of targets on a micro-array
PT1828249E (pt)	2004-12-03	2011-02-25	Schering Corp	Biomarcadores para a pré-selecção de pacientes para terapêutica anti-igf1r
WO2008109782A2 (en) *	2007-03-06	2008-09-12	Cedars-Sinai Medical Center	Diagnosis of inflammatory bowel disease in children
US7504769B2 (en) *	2004-12-16	2009-03-17	E. I. Du Pont De Nemours + Company	Aromatic chalcogen compounds and their use
US20060134680A1 (en) *	2004-12-22	2006-06-22	Alexander Kotlyar	Homogeneous populations of nucleic acids, methods of synthesyzing same and uses thereof
WO2006075335A2 (en) *	2005-01-16	2006-07-20	Zlango Ltd.	Communications network system and methods for using same
JP2008527563A (ja)	2005-01-16	2008-07-24	ズランゴーリミテッド	アイコニック通信
US9101927B2 (en)	2005-01-31	2015-08-11	Realbio Technologies Ltd.	Multistep reaction lateral flow capillary device
CN103497993A (zh)	2005-02-07	2014-01-08	基因信息公司	轻度骨关节炎生物标志物及其用途
WO2006087722A1 (en)	2005-02-17	2006-08-24	Hadasit Medical Research Services And Development Ltd.	Bisphosphonates for treating endometriosis
GB0503546D0 (en) *	2005-02-21	2005-03-30	Hellenic Pasteur Inst	Antibody
JP5432455B2 (ja)	2005-02-25	2014-03-05	ザステートオブイスラエル、ミニストリーオブアグリカルチャーアンドルーラルディベロップメント、アグリカルチュラルリサーチオーガナイゼイション、（エー．アール．オー．）、ボルカニセンター	炎症治療用の果実細胞培養抽出物
US7695927B2 (en) *	2005-03-18	2010-04-13	Detroit R & D	Detection of hypertension using glucuronidated metabolic products
RU2413735C2 (ru)	2005-03-31	2011-03-10	Эдженсис, Инк.	Антитела и родственные молекулы, связывающиеся с белками 161p2f10b
DK2645106T4 (da)	2005-04-04	2024-12-02	Biogen Ma Inc	Fremgangsmåder til evaluering af et immunrespons på et terapeutisk middel
EP1874334A4 (en) *	2005-04-15	2011-03-30	Vascular Biogenics Ltd	COMPOSITIONS WITH BETA 2-GLYCOPROTEIN I-PEPTIDES FOR THE PREVENTION AND / OR TREATMENT OF VASCULAR DISEASES
US20130022979A1 (en)	2005-04-18	2013-01-24	Genesis Genomics Inc.	3.4kb MITOCHONDRIAL DNA DELETION FOR USE IN THE DETECTION OF CANCER
EP1877559B1 (en)	2005-04-18	2010-10-13	Mitomics Inc.	Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers
US8834862B2 (en) *	2005-04-19	2014-09-16	Nanocyte Inc.	Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent
PE20061441A1 (es)	2005-05-12	2007-01-18	Novartis Ag	Genes y proteinas novedosos de brachyspira hyodysenteriae y uso de los mismos para diagnostico y terapia
US9943481B2 (en)	2005-05-26	2018-04-17	Biorest Ltd.	Compositions and methods using same for delivering agents into a target organ protected by a blood barrier
US20070021433A1 (en)	2005-06-03	2007-01-25	Jian-Qiang Fan	Pharmacological chaperones for treating obesity
EP2465924A3 (en)	2005-06-16	2013-01-02	Ramot at Tel-Aviv University Ltd.	Isolated cells and populations comprising same for the treament of cns diseases
DK2500439T4 (da)	2005-06-20	2017-11-13	Advanced Cell Diagnostics Inc	Kits og produkter til detektering af nukleinsyrer i individuelle celler og til identifikation af sjældne celler fra store heterogene cellepopulationer
US20070225242A1 (en) *	2005-06-21	2007-09-27	The Board Of Trustees Of The Leland Stanford Junior University	Method and composition for treating and preventing tumor metastasis in vivo
US9051379B2 (en)	2005-07-07	2015-06-09	Fulcrum Sp Ltd.	Sp1 polypeptides, modified Sp1 polypeptides and uses thereof
ES2435774T3 (es) *	2005-07-07	2013-12-23	Yissum Research Development Company, Of The Hebrew University Of Jerusalem	Agentes de ácido nucleico para la regulación negativa de H19, y métodos de uso del mismo
EP2484768A3 (en)	2005-07-18	2012-11-21	Protalix Ltd.	Mucosal or enteral administration of biologically active macromolecules
CA2616766A1 (en)	2005-07-26	2007-02-01	University Of Medicine And Dentistry Of New Jersey	Antibody profiles characteristic of tuberculosis state
JP2009504659A (ja) *	2005-08-08	2009-02-05	オンコノン・リミテッド・ライアビリティ・カンパニー	抗体組成物、腫瘍性疾患の処置方法、および受胎能の調節方法
US8008453B2 (en)	2005-08-12	2011-08-30	Amgen Inc.	Modified Fc molecules
US8916147B2 (en)	2005-08-24	2014-12-23	Yeda Research and Devolpment Co. Ltd.	Universal donor-derived tolerogenic cells for inducing non-syngeneic transplantation tolerance
EP1962719A4 (en)	2005-08-29	2011-05-04	Technion Res And Dev Of Foundation Ltd	MEDIA FOR BREEDING STEM CELLS
PT1931710T (pt)	2005-08-31	2017-03-28	Merck Sharp & Dohme	Anticorpos anti-il-23 manipulados
US7608395B2 (en) *	2005-09-15	2009-10-27	Baylor Research Institute	Systemic lupus erythematosus diagnostic assay
WO2007034487A1 (en)	2005-09-22	2007-03-29	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Nucleic acid constructs, pharmaceutical compositions and methods of using same for treating cancer
WO2007041340A2 (en) *	2005-09-30	2007-04-12	The Trustees Of Columbia University In The City Of New York	Microfluidic cells with parallel arrays of individual dna molecules
WO2007047408A2 (en) *	2005-10-12	2007-04-26	Pathologica, Llc.	Promac signature application
US20070087437A1 (en) *	2005-10-14	2007-04-19	Jifan Hu	Methods for rejuvenating cells in vitro and in vivo
TW200730825A (en)	2005-10-21	2007-08-16	Genenews Inc	Method and apparatus for correlating levels of biomarker products with disease
MX338183B (es)	2005-10-24	2016-04-06	Evogene Ltd	Polipeptidos aislados, polinucleotidos que los codifican, plantas transgenicas quie expresan los mismos y metodos para usarlos.
US7842823B2 (en) *	2005-10-27	2010-11-30	The Regents Of The University Of California	Fluorogenic probes for reactive oxygen species
CN101346393B (zh)	2005-11-02	2015-07-22	普洛体维生物治疗公司	修饰的siRNA分子及其应用
NZ568762A (en)	2005-11-07	2011-11-25	Scripps Research Inst	Use of an inhibitor of tissue factor signaling in the manufacture of a medcament for inhibiting or suppressing tissue factor/tissue factor VIIa signaling involving protease activated receptor 2 in a mammal
DE212006000071U1 (de)	2005-11-18	2008-07-24	Board of Regents, The University of Texas System, Austin	Quantifizierung von Fusionsproteinen und ihrer Aktivität in Folge chromosomaler Translokation
US8846393B2 (en)	2005-11-29	2014-09-30	Gamida-Cell Ltd.	Methods of improving stem cell homing and engraftment
KR20080072748A (ko)	2005-11-29	2008-08-06	가미다-셀 리미티드	줄기세포 귀소 및 생착을 향상시키는 방법
KR20080080525A (ko)	2005-12-08	2008-09-04	노파르티스 아게	유전자 전사에 대한 ｆｇｆｒ３의 억제제의 효과
US20070134814A1 (en) *	2005-12-09	2007-06-14	Kajander E O	Methods and compositions for the detection of calcifying nano-particles, identification and quantification of associated proteins thereon, and correlation to disease
EP2674440B1 (en)	2005-12-16	2019-07-03	IBC Pharmaceuticals, Inc.	Multivalent immunoglobulin-based bioactive assemblies
CN101374860A (zh)	2005-12-23	2009-02-25	技术转让合伙人公司	用作神经递质分泌抑制剂和肌肉松弛诱导物的合成肽
US7465544B2 (en) *	2006-01-11	2008-12-16	Wisconsin Alumni Research Foundation	Synthetic cofactor analogs of S-adenosylmethionine as ligatable probes of biological methylation and methods for their use
EP1977312A2 (en)	2006-01-16	2008-10-08	Zlango Ltd.	Iconic communication
EP1982450A2 (en) *	2006-01-16	2008-10-22	Zlango Ltd.	Communications network system and methods for using same
PT1981902E (pt)	2006-01-27	2015-11-02	Biogen Ma Inc	Antagonistas dos recetores nogo
EP1991577A2 (en)	2006-01-31	2008-11-19	Parkinson, John F.	Modulation of mdl-1 activity for treatment of inflammatory disease
US9458444B2 (en)	2006-02-03	2016-10-04	Opko Biologics Ltd.	Long-acting coagulation factors and methods of producing same
US20140113860A1 (en)	2006-02-03	2014-04-24	Prolor Biotech Ltd.	Long-acting polypeptides and methods of producing and administering same
US7553941B2 (en)	2006-02-03	2009-06-30	Modigene Inc	Long-acting polypeptides and methods of producing same
US10351615B2 (en)	2006-02-03	2019-07-16	Opko Biologics Ltd.	Methods of treatment with long-acting growth hormone
US8450269B2 (en)	2006-02-03	2013-05-28	Prolor Biotech Ltd.	Long-acting growth hormone and methods of producing same
US20150038413A1 (en)	2006-02-03	2015-02-05	Opko Biologics Ltd.	Long-acting polypeptides and methods of producing and administering same
US8048849B2 (en)	2006-02-03	2011-11-01	Modigene, Inc.	Long-acting polypeptides and methods of producing same
US8476234B2 (en)	2006-02-03	2013-07-02	Prolor Biotech Inc.	Long-acting coagulation factors and methods of producing same
US8946155B2 (en)	2006-02-03	2015-02-03	Opko Biologics Ltd.	Long-acting polypeptides and methods of producing and administering same
US10221228B2 (en)	2006-02-03	2019-03-05	Opko Biologics Ltd.	Long-acting polypeptides and methods of producing and administering same
US8048848B2 (en)	2006-02-03	2011-11-01	Prolor Biotech Ltd.	Long-acting interferons and derivatives thereof and methods thereof
US8759292B2 (en)	2006-02-03	2014-06-24	Prolor Biotech, Llc	Long-acting coagulation factors and methods of producing same
US9249407B2 (en)	2006-02-03	2016-02-02	Opko Biologics Ltd.	Long-acting coagulation factors and methods of producing same
CN101416063A (zh)	2006-02-06	2009-04-22	拉帕波特家族医学科学研究所	用于诊断t1dm的方法和试剂盒
AR059371A1 (es)	2006-02-08	2008-03-26	Genzyme Corp	Terapia genica para la enfermedad de niemann-pick tipo a
SG169395A1 (en)	2006-02-09	2011-03-30	Univ South Florida	Detection of cancer by elevated levels of bcl-2
US20070207141A1 (en)	2006-02-28	2007-09-06	Ivan Lieberburg	Methods of treating inflammatory and autoimmune diseases with natalizumab
MX2008011176A (es)	2006-03-03	2008-09-10	Elan Pharm Inc	Metodos para tratar padecimientos inflamatorios y autoinmunes con natalizumab.
AU2007224386B2 (en)	2006-03-06	2013-12-19	Zetiq Technologies Ltd.	Methods and compositions for identifying a cell phenotype
WO2007109733A2 (en)	2006-03-21	2007-09-27	The Johns Hopkins University	Diagnostic and prognostic markers and treatment strategies for multiple sclerosis
EP2366775B1 (en)	2006-03-23	2015-04-22	Pluristem Ltd.	Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy
WO2007110869A2 (en)	2006-03-28	2007-10-04	Tel Hashomer Medical Research Infrastructure And Services Ltd.	Methods and kits for determining predisposition to warfarin resistance
US20070232556A1 (en) *	2006-03-31	2007-10-04	Montine Thomas J	Methods and compositions for the treatment of neurological diseases and disorders
KR20090029184A (ko) *	2006-04-07	2009-03-20	더 가브먼트 오브 더 유나이티드 스테이츠 오브 아메리카, 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈	항체 조성물 및 신생물성 질병의 치료 방법
AU2007242061B2 (en)	2006-04-21	2012-11-29	Intervet International B.V.	Pestivirus species
FR2900341B1 (fr) *	2006-04-27	2012-09-14	Centre Nat Rech Scient	Utilisation de ligands synthetiques multivalents de la nucleoline de surface pour le traitement du cancer
US8790871B2 (en) *	2006-05-09	2014-07-29	Musc Foundation For Research Development	Detecting diastolic heart failure by protease and protease inhibitor plasma profiling
KR101442209B1 (ko) *	2006-05-19	2014-11-18	테크니온 리서치 엔드 디벨로프먼트 화운데이션 엘티디.	융합 단백질, 이의 용도 및 이의 제조방법
WO2007137300A2 (en)	2006-05-23	2007-11-29	Bellicum Pharmaceuticals, Inc.	Modified dendritic cells having enhanced survival and immunogenicity and related compositions and methods
US20070281883A1 (en) *	2006-06-05	2007-12-06	Hanna Rosenfeld	Development of follicle stimulating hormone agonists and antagonists in fish
CA2656347A1 (en)	2006-07-03	2008-01-10	Charles David Adair	Composition for modulating the expression of cell adhesion molecules
KR20090046825A (ko) *	2006-07-11	2009-05-11	무스크 파운데이션 포 리서치 디벨롭먼트	프로테아제 및 프로테아제 저해제 프로파일링으로 심근 경색 후 심부전을 예측하는 방법
US20080026394A1 (en) *	2006-07-11	2008-01-31	Antara Biosciences Inc.	Methods of detecting one or more cancer markers
WO2008010934A2 (en)	2006-07-14	2008-01-24	Chemocentryx, Inc.	Triazolyl phenyl benzenesulfonamides
US8629259B2 (en)	2006-07-20	2014-01-14	Yeda Research And Development Co. Ltd.	Photosynthetic organisms and compositions and methods of generating same
WO2008021954A2 (en) *	2006-08-09	2008-02-21	Biogen Idec Ma Inc.	Method for distribution of a drug
JP2008043332A (ja)	2006-08-17	2008-02-28	Panomics Inc	組織スライドからの核酸定量
ES2570153T3 (es)	2006-08-22	2016-05-17	Novo Nordisk As	Anticuerpos anti-C5aR con propiedades mejoradas
EP2061900A2 (en)	2006-08-25	2009-05-27	Oncotherapy Science, Inc.	Prognostic markers and therapeutic targets for lung cancer
EP2064319B1 (en)	2006-08-28	2017-02-22	Yeda Research and Development Co. Ltd.	Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the cns
JP2008111824A (ja) *	2006-09-01	2008-05-15	Nox Technologies Inc	腫瘍特異的ｔＮＯＸアイソフォーム及び方法
US7951776B2 (en)	2006-09-01	2011-05-31	American Type Culture Collection	Methods for treatment of type 1 diabetes
US7985542B2 (en)	2006-09-07	2011-07-26	Institut Pasteur	Genomic morse code
EP2469282A1 (en)	2006-09-08	2012-06-27	University of Oxford	Clinical diagnosis of hepatic fibrosis using a novel panel of human serum protein biomarkers
US8055034B2 (en)	2006-09-13	2011-11-08	Fluidigm Corporation	Methods and systems for image processing of microfluidic devices
US8050516B2 (en) *	2006-09-13	2011-11-01	Fluidigm Corporation	Methods and systems for determining a baseline during image processing
US7888059B2 (en) *	2006-10-05	2011-02-15	Yeda Research And Development Co. Ltd.	Highly purified and stabilized Na,K-ATPase isoforms and methods of producing same
AU2007303821B9 (en)	2006-10-05	2013-06-20	Technion Research & Development Foundation Ltd.	Microtubes and methods of producing same
CA2665709C (en)	2006-10-11	2018-04-03	Janssen Pharmaceutica N.V.	Compositions and methods for treating and diagnosing irritable bowel syndrome
EP1912067A1 (en) *	2006-10-12	2008-04-16	Eppendorf Array Technologies S.A.	Method for quantification of a target compound obtained from a biological sample upon chips
EP2426199A3 (en)	2006-10-20	2012-08-22	Danisco US Inc.	Polyol oxidases
US20080305512A1 (en) *	2006-10-26	2008-12-11	Mattingly Phillip G	Assay for cardiac troponin autoantibodies
EP2097750A2 (en) *	2006-10-26	2009-09-09	Abbott Laboratories	Immunoassay of analytes in samples containing endogenous anti-analyte antibodies
US7776605B2 (en) *	2006-10-26	2010-08-17	Abbott Laboratories	Assay for cardiac troponin autoantibodies
JP2010507384A (ja)	2006-10-27	2010-03-11	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	キナーゼ阻害剤のプロファイリング方法
AU2007325931A1 (en)	2006-11-02	2008-06-05	Yale University	Assessment of oocyte competence
US8293684B2 (en) *	2006-11-29	2012-10-23	Exiqon	Locked nucleic acid reagents for labelling nucleic acids
US8473216B2 (en) *	2006-11-30	2013-06-25	Fluidigm Corporation	Method and program for performing baseline correction of amplification curves in a PCR experiment
DK2102239T3 (da)	2006-11-30	2012-05-29	Res Dev Foundation	Forbedrede immunoglobulin-biblioteker
JP5059119B2 (ja)	2006-12-14	2012-10-24	シェーリングコーポレイション	操作された抗ｔｓｌｐ抗体
BRPI0719602B1 (pt)	2006-12-20	2021-05-18	Evogene Ltd	construção de ácido nucléicos, e, métodos para aumentar biomassa de uma planta, para aumentar o vigor de uma planta, para aumentar o rendimento de uma planta, para aumentar a tolerância de uma planta ao stress abiótico, para aprimorar a qualidade de fibra e/ou rendimento de uma planta que produz fibra e para produzir fibras de algodão
WO2008085895A2 (en) *	2007-01-04	2008-07-17	Musc Foundation For Research Development	Predicting atrial fibrillation recurrence by protease and protease inhibitor profiling
PT2121977T (pt) *	2007-01-11	2017-08-18	Erasmus Univ Medical Center	Captura da conformação cromossómica circular (4c)
US9511075B2 (en)	2007-01-12	2016-12-06	The University Of Maryland, Baltimore	Targeting NCCA-ATP channel for organ protection following ischemic episode
WO2008087641A2 (en) *	2007-01-16	2008-07-24	Yissum Research Development Company Of The Hebrew University Of Jerusalem	H19 silencing nucleic acid agents for treating rheumatoid arthritis
WO2008092094A2 (en) *	2007-01-26	2008-07-31	University Of South Florida	Method and materials for detection, diagnosis and management of ovarian cancer
ATE535805T1 (de)	2007-01-26	2011-12-15	Univ Louisville Res Found	Verfahren zur erkennung von autoantikörpern zur diagnostizierung und charakterisierung von erkrankungen
US20100196403A1 (en) *	2007-01-29	2010-08-05	Jacob Hochman	Antibody conjugates for circumventing multi-drug resistance
WO2008093341A2 (en)	2007-01-31	2008-08-07	Technion Research & Development Foundation Ltd.	Electrospun scaffolds and methods of generating and using same
CA2676932C (en)	2007-02-01	2015-11-24	Technion Research & Development Foundation Ltd.	Albumin fibers and fabrics and methods of generating and using same
TW201307390A (zh)	2007-02-02	2013-02-16	Amgen Inc	海帕西啶（ｈｅｐｃｉｄｉｎ）、海帕西啶拮抗劑及使用方法
US8143046B2 (en) *	2007-02-07	2012-03-27	Danisco Us Inc., Genencor Division	Variant Buttiauxella sp. phytases having altered properties
US20080220498A1 (en) *	2007-03-06	2008-09-11	Cervin Marguerite A	Variant Buttiauxella sp. phytases having altered properties
KR100855299B1 (ko) *	2007-02-16	2008-08-29	건국대학교 산학협력단	인간 ｉｌ-32 특이 항원결정기를 갖는 단일클론항체,특이항체분비 융합 세포주 및 항체들을 이용한 ｉｌ-32측정법
JP2008203195A (ja) *	2007-02-22	2008-09-04	Japan Science & Technology Agency	Ｂｓｈの免疫測定用キットおよびｂｓｈの測定方法
ES2708988T3 (es)	2007-02-23	2019-04-12	Merck Sharp & Dohme	Anticuerpos anti-IL-23p19 obtenidos por ingeniería genética
JP2010518858A (ja)	2007-02-23	2010-06-03	シェーリングコーポレイション	操作された抗−ｉｌ−２３ｐ１９抗体
WO2008106149A1 (en) *	2007-02-28	2008-09-04	Children's Medical Center Corporation	Methods for predicting the onset of menarche
NZ579251A (en)	2007-02-28	2012-06-29	Schering Corp	Engineered anti-il-23r antibodies
WO2008104979A2 (en)	2007-02-28	2008-09-04	Yeda Research And Development Co. Ltd.	Nuclear targeting sequences
EP2136843A1 (en)	2007-03-12	2009-12-30	Miraculins Inc.	Biomarkers of prostate cancer and uses thereof
WO2008116150A2 (en)	2007-03-21	2008-09-25	Cedars-Sinai Medical Center	Ileal pouch-anal anastomosis (ipaa) factors in the treatment of inflammatory bowel disease
EP2144935A2 (en)	2007-03-29	2010-01-20	Technion Research & Development Foundation Ltd.	Antibodies, methods and kits for diagnosing and treating melanoma
HRP20150328T1 (hr)	2007-03-30	2015-05-22	Engeneic Molecular Delivery Pty Ltd.	Bakterijski dobivene, intaktne mini-stanice koje obuhvaä†aju funkcionalnu nukleinsku kiselinu, bez plazmida, za in vivo dopremu do stanica sisavaca
CN101702920B (zh)	2007-04-02	2013-03-13	特拉维夫大学拉莫特有限公司	癌细胞的检测方法及其在诊断和监测疾病治疗中的应用
ATE534753T1 (de)	2007-04-06	2011-12-15	Becton Dickinson Co	Zusammensetzungen und verfahren zur identifikation eines carbapenemase-gens
EP2154946B1 (en)	2007-04-09	2013-06-05	Evogene Ltd.	Polynucleotides, polypeptides and methods for increasing oil content, growth rate and biomass of plants
WO2008127707A1 (en) *	2007-04-13	2008-10-23	Dana Farber Cancer Institute, Inc.	Receptor tyrosine kinase profiling
AU2008239594B2 (en)	2007-04-13	2013-10-24	Beth Israel Deaconess Medical Center	Methods for treating cancer resistant to ErbB therapeutics
US8003314B2 (en)	2007-04-16	2011-08-23	Diagnostic Hybrids, Inc.	Methods for direct fluorescent antibody virus detection in liquids
US9556210B2 (en)	2007-04-23	2017-01-31	Sabag-Rfa Ltd.	System for delivering therapeutic agents into living cells and cells nuclei
US9156865B2 (en)	2007-04-23	2015-10-13	Deliversir Ltd	System for delivering therapeutic agents into living cells and cells nuclei
EP2144633B1 (en) *	2007-04-23	2014-07-16	Deliversir Ltd	A system for delivering therapeutic agents into living cells and cells nuclei
ES2564312T3 (es)	2007-05-01	2016-03-21	Tel Hashomer Medical Research Infrastructure And Services Ltd.	Métodos y kits para detectar células fetales en la sangre materna
EP2155789B1 (en)	2007-05-01	2013-07-24	Research Development Foundation	Immunoglobulin fc libraries
EP2152730A4 (en) *	2007-05-02	2011-08-03	Univ Emory	ENLARGEMENT OF GLYCOPROTEININCORPORATION IN VIRUSUAL PARTICLES
EP2150276B1 (en)	2007-05-03	2014-05-21	Agency For Science, Technology And Research	Antibodies binding to an intracellular prl-1 or prl-3 polypeptide
AU2008246928B2 (en)	2007-05-07	2014-04-17	Protalix Ltd.	Large scale disposable bioreactor
US20090081639A1 (en) *	2007-05-31	2009-03-26	Phil Hill	Assay for sensitivity to chemotherapeutic agents
US7776877B2 (en)	2007-06-22	2010-08-17	Chemocentryx, Inc.	N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl) hetaryl arylsulfonamides
US9102754B2 (en) *	2007-06-28	2015-08-11	University Of Saskatchewan	Immunomodulatory compositions and methods for treating disease with modified host defense peptides
WO2009009662A1 (en) *	2007-07-10	2009-01-15	University Of South Florida	Method of predicting non-response to first line chemotherapy
EP2176409B1 (en)	2007-07-11	2012-01-04	Yeda Research And Development Co. Ltd.	Nucleic acid construct systems capable of diagnosing or treating a cell state
JP5306344B2 (ja) *	2007-07-12	2013-10-02	ケモセントリックス，インコーポレイテッド	炎症の治療のためのｃｃｒ２モジュレーターとしての縮合ヘテロアリールピリジルおよびフェニルベンゼンスルホンアミド
EP2200628A2 (en)	2007-07-15	2010-06-30	Yitzchak Hillman	Disease treatment via antimicrobial peptides or their inhibitors
IL184627A0 (en)	2007-07-15	2008-12-29	Technion Res & Dev Foundation	Agents for diagnosing and modulating metastasis and fibrosis as well as inflammation in a mammalian tissue
US8686227B2 (en)	2007-07-24	2014-04-01	Evogene Ltd.	Polynucleotides, polypeptides encoded thereby, and methods of using same for increasing abiotic stress tolerance and/or biomass and/or yield in plants expressing same
US8293685B2 (en)	2007-07-26	2012-10-23	The Regents Of The University Of California	Methods for enhancing bacterial cell display of proteins and peptides
ES2700141T3 (es)	2007-08-02	2019-02-14	Gilead Biologics Inc	Anticuerpos inhibidores LOXL2 y usos de los mismos
AU2008284015B2 (en)	2007-08-03	2014-05-15	Musc Foundation For Research Development	Human monoclonal antibodies and methods for producing the same
KR20140120946A (ko)	2007-08-03	2014-10-14	베링거 인겔하임 베트메디카 게엠베하	브라키스피라 하이오디센테리애의 유전자와 단백질 및 이의 용도
EP2185726B1 (en)	2007-08-06	2014-01-08	Orion Genomics, LLC	Novel single nucleotide polymorphisms and combinations of novel and known polymorphisms for determining the allele-specific expression of the igf2 gene
EP2283028A2 (en)	2007-08-08	2011-02-16	The Board of Regents of The University of Texas System	Vegfr-1/nrp-1 targeting peptides
WO2009023676A1 (en)	2007-08-12	2009-02-19	Integrated Dna Technologies, Inc.	Microarray system with improved sequence specificity
US20090136916A1 (en) *	2007-08-13	2009-05-28	Trustees Of Tufts College	Methods and microarrays for detecting enteric viruses
KR20100071972A (ko)	2007-08-15	2010-06-29	예다 리서치 앤드 디벨럽먼트 캄파니 리미티드	Ｍｍｐ-9의 조절인자 및 그의 용도
WO2009072001A2 (en) *	2007-09-12	2009-06-11	Aurelium Biopharma Inc.	Slc9a3r1 directed diagnostics for neoplastic disease
US8741315B2 (en)	2007-09-12	2014-06-03	Yeda Research And Development Co. Ltd.	Methods of treating tumors in immune-privileged sites
MX2010003019A (es)	2007-09-19	2010-04-30	Pluristem Ltd	Celulas adherentes de los tejidos adiposo y de placenta y uso de las mismas en la terapia.
EP3136103B1 (en)	2007-10-05	2018-08-29	Affymetrix, Inc.	Highly multiplexed assays
EP2781223B1 (en)	2007-10-19	2017-02-22	Rappaport Family Institute for Research in the Medical Sciences	Compositions comprising semaphorins for use in the treatment of cancer
JP2011504374A (ja)	2007-11-26	2011-02-10	イッサムリサーチディベロップメントカンパニーオブザヘブリューユニバーシティーオブエルサレムリミテッド	繊維状ポリペプチドおよび多糖を含む組成物
ES2535419T3 (es)	2007-12-27	2015-05-11	Protiva Biotherapeutics Inc.	Silenciamiento de expresión de quinasa tipo polo usando ARN interferente
AU2008344935C1 (en)	2007-12-27	2016-07-14	Evogene Ltd.	Isolated polypeptides, polynucleotides useful for modifying water user efficiency, fertilizer use efficiency, biotic/abiotic stress tolerance, yield and biomass in plants
BRPI0906429B1 (pt)	2008-01-10	2021-08-03	Research Development Foundation	Método de identificação de uma infecção por e. chaffeensis em um indivíduo, uso de um ou mais polipeptídeo sintético e kit
WO2009094551A1 (en)	2008-01-25	2009-07-30	Amgen Inc.	Ferroportin antibodies and methods of use
US20090233295A1 (en) *	2008-01-29	2009-09-17	Elias Georges	Trim59 directed diagnostics for neoplastic disease
AU2009208607B2 (en) *	2008-01-31	2013-08-01	Compugen Ltd.	Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
EP2712620A1 (en)	2008-02-07	2014-04-02	Cornell University	Methods for Preventing or Treating Insulin Resistance
RU2010138612A (ru)	2008-02-20	2012-03-27	Джи2 ИНФЛЕММЕЙШН ПТИ ЛТД (AU)	ГУМАНИЗИРОВАННЫЕ АНТИТЕЛА ПРОТИВ C5аR
JO2913B1 (en)	2008-02-20	2015-09-15	امجين إنك,	Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses
EP2265751B1 (en)	2008-02-21	2015-04-01	Technion Research & Development Foundation Ltd.	Method for depleting or isolating a molecule from a solution
EP2363407A1 (en)	2008-02-28	2011-09-07	Murdoch University	Novel sequences of Brachyspira, immunogenic compositions, methods for preparation and use thereof
US20090311695A1 (en) *	2008-03-12	2009-12-17	Talat Nasim	Method
EP2271664A4 (en)	2008-03-27	2011-11-23	Prionics Ag	NEW SEQUENCES OF BRACHYSPIRA, IMMUNOGENIC COMPOSITION, METHOD OF MANUFACTURE AND APPLICATION THEREOF
CA2719718C (en)	2008-03-28	2019-07-02	Mdna Life Sciences Inc.	Aberrant mitochondrial dna, associated fusion transcripts and hybridization probes therefor
EP2107125A1 (en)	2008-03-31	2009-10-07	Eppendorf Array Technologies SA (EAT)	Real-time PCR of targets on a micro-array
EP2280731A1 (en) *	2008-04-09	2011-02-09	Technion Research and Development Foundation, Ltd.	Anti human immunodeficiency antibodies and uses thereof
WO2009125395A1 (en) *	2008-04-09	2009-10-15	Technion Research & Development Foundation Ltd.	Anti influenza antibodies and uses thereof
EP2508325A3 (en) *	2008-04-10	2013-05-22	Objet Ltd.	System and method for three dimensional model printing
CA2721333C (en)	2008-04-15	2020-12-01	Protiva Biotherapeutics, Inc.	Novel lipid formulations for nucleic acid delivery
EP2281041B1 (en)	2008-04-15	2014-07-02	Protiva Biotherapeutics Inc.	Silencing of csn5 gene expression using interfering rna
GB0807161D0 (en) *	2008-04-18	2008-05-21	Danisco	Process
US9095569B2 (en)	2008-04-18	2015-08-04	Collplant Ltd.	Methods of generating and using procollagen
AU2009239333A1 (en)	2008-04-21	2009-10-29	Danziger Innovations Ltd.	Plant viral expression vectors and use of same for generating genotypic variations in plant genomes
WO2009132100A2 (en) *	2008-04-23	2009-10-29	Luminex Corporation	Method for creating a standard for multiple analytes found in a starting material of biological origin
WO2009132124A2 (en) *	2008-04-24	2009-10-29	The Trustees Of Columbia University In The City Of New York	Geometric patterns and lipid bilayers for dna molecule organization and uses thereof
WO2009133464A2 (en)	2008-04-30	2009-11-05	Danisco A/S	Oxidation process
US9315577B2 (en)	2008-05-01	2016-04-19	Amgen Inc.	Anti-hepcidin antibodies and methods of use
SG157299A1 (en)	2008-05-09	2009-12-29	Agency Science Tech & Res	Diagnosis and treatment of kawasaki disease
US8847008B2 (en)	2008-05-22	2014-09-30	Evogene Ltd.	Isolated polynucleotides and polypeptides and methods of using same for increasing plant utility
EP2291390B1 (en) *	2008-05-22	2014-11-05	Centre National de la Recherche Scientifique (CNRS)	New optically pure compounds for improved therapeutic efficiency
BRPI0909541A2 (pt)	2008-05-27	2016-10-11	Pluristem Ltd	''método para tratamento de doenças inflamatórias do cólon''
EP2620493B1 (en)	2008-05-28	2019-03-27	Ramot at Tel Aviv University Ltd.	Mesenchymal stem cells for the treatment of CNS diseases
US8791258B2 (en) *	2008-06-10	2014-07-29	The Regents Of The University Of California	Pro-fluorescent probes
EP2326419B1 (en)	2008-06-29	2021-04-07	Realbio Technologies Ltd.	Liquid transfer device particularly useful as a capturing device in a biological assay process
WO2010016806A1 (en)	2008-08-08	2010-02-11	Agency For Science, Technology And Research (A*Star)	Vhz for diagnosis and treatment of cancers
US20120122800A1 (en)	2008-08-08	2012-05-17	Genisphere, LLC Hatfield, Pennsylvania	Long-Acting DNA Dendrimers and Methods Thereof
US9018445B2 (en)	2008-08-18	2015-04-28	Evogene Ltd.	Use of CAD genes to increase nitrogen use efficiency and low nitrogen tolerance to a plant
CN105708862B (zh)	2008-09-02	2020-11-06	普拉里斯坦有限公司	来自胎盘组织的粘附细胞及其在治疗中的用途
US8367392B2 (en) *	2008-09-05	2013-02-05	Transalgae Ltd.	Genetic transformation of algal and cyanobacteria cells by microporation
US20110305682A1 (en)	2008-09-11	2011-12-15	Ben Gurion University Of The Negev Research And Development Authority	Compositions and Methods for Treating S. Pneumonia Infection
EP2331679B1 (en)	2008-09-12	2017-04-19	Cryopraxis Criobiologia LTDA.	Ischemic tissue cell therapy
ES2690348T3 (es)	2008-09-24	2018-11-20	Tel Hashomer Medical Research Infrastructure And Services Ltd.	Péptidos y composiciones para la prevención de la adhesión celular y métodos de uso de los mismos
US9434985B2 (en)	2008-09-25	2016-09-06	University Of Massachusetts	Methods of identifying interactions between genomic loci
US20110178024A1 (en)	2008-09-29	2011-07-21	Ben Gurion University Of The Negev Research And Development Authority	Amyloid beta-peptides and methods of use thereof
US9207242B2 (en)	2008-10-09	2015-12-08	The University Of Hong Kong	Cadherin-17 as diagnostic marker and therapeutic target for liver cancer
EP2347014B1 (en)	2008-10-30	2016-09-21	Evogene Ltd.	Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficieny
EP2350131B1 (en)	2008-11-07	2017-06-07	Research Development Foundation	Compositions and methods for the inhibition of cripto/grp78 complex formation and signaling
US20110229892A1 (en)	2008-11-17	2011-09-22	Yehuda G Assaraf	Method for predicting a patient's responsiveness to anti-folate therapy
WO2010058396A1 (en)	2008-11-19	2010-05-27	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	A cd44vra antibody and diagnostic and therapeutic methods using same
US20110229471A1 (en)	2008-11-26	2011-09-22	Cedars-Sinai Medical Center	Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease
WO2010061383A1 (en)	2008-11-26	2010-06-03	Biodalia Microbiological Technologies Ltd.	A method of in-situ enrichment of foods with fructan
WO2010064231A1 (en)	2008-12-02	2010-06-10	Tel Hashomer Medical Research Infrastructure And Services Ltd.	Methods of analyzing a-i rna editing and nucleic acid constructs capable of same
WO2010064247A1 (en)	2008-12-03	2010-06-10	Tel Hashomer Medical Research Infrastructure And Services Ltd.	Methods and kits for determining predisposition to cancer
WO2010065437A1 (en)	2008-12-03	2010-06-10	Research Development Foundation	Modulation of olfml-3 mediated angiogenesis
ES2554765T3 (es)	2008-12-05	2015-12-23	Yeda Research And Development Co. Ltd.	miRNA-9 o miRNA-9* para uso en el tratamiento de ELA
BRPI0923155A2 (pt)	2008-12-05	2018-10-23	Abraxis Bioscience Llc	scfcs de ligação a sparc
WO2010066252A1 (en)	2008-12-09	2010-06-17	Dako Denmark A/S	Method for evaluating pre-treatment
WO2010068757A1 (en)	2008-12-12	2010-06-17	The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Compositions and methods useful for detecting and treating diseases associated with 16p chromosomal disruptions
WO2010071610A1 (en)	2008-12-19	2010-06-24	Agency For Science, Technology And Research (A*Star)	Severe chikungunya biomarkers
US9580752B2 (en)	2008-12-24	2017-02-28	Cedars-Sinai Medical Center	Methods of predicting medically refractive ulcerative colitis (MR-UC) requiring colectomy
US8552147B2 (en)	2008-12-29	2013-10-08	Tel Hashomer Medical Research, Infrastructure And Services Ltd.	Peptides and compositions for prevention of cell adhesion and methods of using same
MX350550B (es)	2008-12-29	2017-09-08	Evogene Ltd	Polinucleotidos, polipeptidos codificados, y metodos para utilizarlos para aumentar la tolerancia al estres, abiotico, biomasa y/o rendimiento en plantas que los expresan.
EP2808402A3 (en)	2008-12-29	2015-03-25	Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.	Methods of predicting responsiveness to interferon treatment
WO2010076794A1 (en)	2008-12-31	2010-07-08	Technion Research & Development Foundation Ltd.	Method of denitrifying brine and systems capable of same
WO2010080769A2 (en)	2009-01-06	2010-07-15	Arresto Biosciences, Inc.	Chemotherapeutic methods and compositions
IL196820A0 (en)	2009-02-01	2009-11-18	Yissum Res Dev Co	Devitalized, acellular scaffold matrices derived from micro-organs seeded with various cells
EP2391377A2 (en)	2009-02-02	2011-12-07	Ramot at Tel-Aviv University Ltd.	Peptides, pharmaceutical compositions comprising same and uses thereof
WO2010089707A1 (en)	2009-02-04	2010-08-12	Yeda Research And Development Co. Ltd.	Methods and kits for determining sensitivity or resistance of prostate cancer to radiation therapy
EP3722810A3 (en)	2009-02-11	2021-01-13	Caris MPI, Inc.	Molecular profiling of tumors
WO2010093450A2 (en)	2009-02-11	2010-08-19	Ludwing Institute For Cancer Research Ltd.	Pten phosphorylation-driven resistance to cancer treatment and altered patient prognosis
CA2751758A1 (en)	2009-02-11	2010-08-19	Orion Genomics Llc	Combinations of polymorphisms for determining allele-specific expression of igf2
WO2010096658A1 (en)	2009-02-19	2010-08-26	The Cleveland Clinic Foundation	Corin as a marker for heart failure
EP2401362B1 (en)	2009-02-26	2017-04-12	Tel HaShomer Medical Research Infrastructure and Services Ltd.	Isolated populations of renal stem cells and methods of isolating and using same
EP3862433A3 (en)	2009-03-02	2021-11-17	Evogene Ltd.	Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics
HRP20160385T1 (hr)	2009-03-09	2016-05-06	Ramot At Tel-Aviv University Ltd.	Pripravci za prevenciju i liječenje neurodegenerativnih bolesti
WO2010103517A1 (en)	2009-03-12	2010-09-16	Rappaport Family Institute For Research In The Medical Sciences	Soluble compositions for the treatment of cxcr3-ligand associated diseases
US20100240065A1 (en) *	2009-03-18	2010-09-23	Boehringer Ingelheim International Gmbh	Prolyl Hydroxylase Compositions and Methods of Use Thereof
US8481698B2 (en) *	2009-03-19	2013-07-09	The President And Fellows Of Harvard College	Parallel proximity ligation event analysis
WO2010126670A2 (en)	2009-03-27	2010-11-04	Gojo Industries, Inc.	Compositions and methods for screening and using compounds antagonizing spore-surface interactions
RU2011137486A (ru)	2009-03-27	2013-05-10	Митомикс Инк.	Аберрантная митохондриальная днк, ассоциированные с ней слитые транскрипты, продукты трансляции и гибрадизационные зонды
DK2414542T3 (da)	2009-03-30	2017-11-27	Tel Hashomer Medical Res Infrastructure & Services Ltd	Fremgangsmåder til forudsigelse af klinisk forløb for og behandling af multipel sklerose
AU2010231514A1 (en)	2009-04-01	2011-11-03	Rappaport Family Institute For Research In The Medical Sciences	A method of regulating proliferation and differentiation of keratinocytes
WO2010116375A1 (en)	2009-04-08	2010-10-14	Yeda Research And Development Co. Ltd.	Isolated peptides for regulating apoptosis
WO2010121294A1 (en)	2009-04-21	2010-10-28	Genetic Technologies Limited	Methods for obtaining fetal genetic material
GB0908770D0 (en)	2009-04-24	2009-07-01	Danisco	Method
KR20180077322A (ko)	2009-04-30	2018-07-06	텔 하쇼머 메디컬 리서치 인프라스트럭쳐 앤드 서비시스 리미티드．	항-ｃｅａｃａｍ1 항체들과 이를 이용하는 방법들
US9040667B2 (en)	2009-05-01	2015-05-26	Dako Denmark A/S	Antibody cocktail
JP5813630B2 (ja) *	2009-05-14	2015-11-17	ザチャンセラー，マスターズアンドスカラーズオブザユニバーシティオブオックスフォード	微量ヒト血漿タンパク質バイオマーカーの新規なパネルを使用した肝線維症の臨床診断
CN102428177B (zh)	2009-05-19	2015-01-14	杜邦营养生物科学有限公司	提高面包耐码垛性的方法及其产品
WO2010134073A1 (en)	2009-05-19	2010-11-25	Zetiq Technologies Ltd.	Kits for and methods of differential staining of cervical cancer cells and/or tissues
WO2011019423A2 (en)	2009-05-20	2011-02-17	Schering Corporation	Modulation of pilr receptors to treat microbial infections
WO2010137013A1 (en)	2009-05-27	2010-12-02	Ramot At Tel Aviv University Ltd.	Crystallized photosystem i units from the pea plant and their use in solid state devices
EP2435072A2 (en)	2009-05-27	2012-04-04	Yeda Research and Development Co. Ltd.	Proteasome inhibitors and uses thereof
WO2010137021A2 (en)	2009-05-27	2010-12-02	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Method of generating connective tissue
US20120070449A1 (en)	2009-05-28	2012-03-22	Yeda Research And Development Co. Ltd.	Methods of treating inflammation
CA2764153C (en)	2009-06-02	2021-07-27	The Board Of Regents Of The University Of Texas System	Identification of small molecules recognized by antibodies in subjects with neurodegenerative diseases
BRPI1009032B1 (pt)	2009-06-10	2019-05-28	Evogene Ltd.	Método de aumento de eficiência no uso de nitrogênio, biomassa, taxa de crescimento, e/ou tolerância a deficiência de nitrogênio de uma planta
EP2446267A1 (en)	2009-06-24	2012-05-02	Health Corporation - Rambam	Methods and kits for isolating placental derived microparticles and use of same for diagnosis of fetal disorders
CA2766009A1 (en)	2009-06-25	2010-12-29	Danisco A/S	Variant lipolytic enzymes with improved expression, functionality and/or activity
CA2766810C (en)	2009-06-29	2017-10-10	The University Of Western Australia	Terpene synthases from santalum
WO2011000107A1 (en)	2009-07-01	2011-01-06	Protiva Biotherapeutics, Inc.	Novel lipid formulations for delivery of therapeutic agents to solid tumors
US9663778B2 (en)	2009-07-09	2017-05-30	OPKO Biologies Ltd.	Long-acting coagulation factors and methods of producing same
US12203113B2 (en)	2009-07-09	2025-01-21	Opko Biologics Ltd.	Long-acting coagulation factors and methods of producing same
WO2011004379A1 (en)	2009-07-10	2011-01-13	Tel Hashomer Medical Research Infrastructure And Services Ltd.	Compositions and methods for treating cancer
SG10201700096VA (en)	2009-07-17	2017-02-27	Bioatla Llc	Simultaneous, Integrated Selection And Evolution Of Antibody/Protein Performance And Expression In Production Hosts
US8716464B2 (en)	2009-07-20	2014-05-06	Thomas W. Geisbert	Compositions and methods for silencing Ebola virus gene expression
ES2753986T3 (es)	2009-07-21	2020-04-15	Tel Hashomer Medical Res Infrastructure & Services Ltd	Un método de diagnóstico de cáncer
GB0913442D0 (en)	2009-07-31	2009-09-16	Univ Ramot	Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof
WO2011021194A2 (en)	2009-08-17	2011-02-24	Technion Research & Development Foundation Ltd.	Pericyte progenitor cells and methods of generating and using same
MX2012002189A (es)	2009-08-21	2012-03-16	Beeologics Inc	Prevencion y cura de las enfermedades de los insectos beneficiosos a traves de moleculas.
SG178845A1 (en)	2009-08-21	2012-04-27	Gilead Biologics Inc	Catalytic domains from lysyl oxidase and loxl2
WO2011024172A2 (en)	2009-08-27	2011-03-03	Technion Research & Development Foundation Ltd.	Liposomal compositions and uses of same
KR101790802B1 (ko)	2009-09-03	2017-10-27	머크 샤프 앤드 돔 코포레이션	항-ｇｉｔｒ 항체
WO2011030336A1 (en)	2009-09-08	2011-03-17	Ramot At Tel-Aviv University Ltd.	Methods of diagnosing amyotrophic lateral sclerosis (als)
WO2011030332A2 (en)	2009-09-08	2011-03-17	Yeda Research And Development Co. Ltd.	Methods for hematopoietic precursor mobilization
WO2011030329A1 (en)	2009-09-10	2011-03-17	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Method of treating tumors
JP2013505022A (ja)	2009-09-16	2013-02-14	バクサートインコーポレーティッド	Ｈ１ｎ１感染を予防するための免疫戦略の方法
WO2011033506A2 (en)	2009-09-17	2011-03-24	Yeda Research And Development Co. Ltd.	Isolated pon1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
BR112012006005A2 (pt)	2009-09-17	2017-09-19	Univ Ramot	"peptídeos no tratamento de transtorno associados ao estresse oxidativo"
US8735124B2 (en)	2009-09-17	2014-05-27	Yeda Research And Development Co. Ltd.	Isolated PON1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
US9222086B2 (en)	2009-09-23	2015-12-29	Protiva Biotherapeutics, Inc.	Compositions and methods for silencing genes expressed in cancer
WO2011038403A1 (en)	2009-09-28	2011-03-31	Yuling Luo	Methods of detecting nucleic acid sequences with high specificity
US20110076232A1 (en)	2009-09-29	2011-03-31	Ludwig Institute For Cancer Research	Specific binding proteins and uses thereof
WO2011040973A2 (en)	2009-10-02	2011-04-07	Ludwig Institute For Cancer Research Ltd.	Tnf-immunoconjugates with fibroblast activation protein antibodies and methods and uses thereof
US20110081706A1 (en) *	2009-10-02	2011-04-07	TransAlgae Ltd	Method and system for efficient harvesting of microalgae and cyanobacteria
CA2776037A1 (en)	2009-10-02	2011-04-07	Ludwig Institute For Cancer Research Ltd	Anti-fibroblast activation protein antibodies and methods and uses thereof
EP2486049A1 (en)	2009-10-06	2012-08-15	The Board Of Trustees Of The UniversityOf Illinois	Human single-chain t cell receptors
ES2666372T3 (es)	2009-10-11	2018-05-04	Biogen Ma Inc.	Ensayos relacionados con anti-VLA-4
EP3272869B1 (en)	2009-10-14	2020-06-24	Yissum Research Development Company of The Hebrew University of Jerusalem Ltd.	Compositions for controlling varroa mites in bees
US8962584B2 (en)	2009-10-14	2015-02-24	Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd.	Compositions for controlling Varroa mites in bees
ES2609006T3 (es)	2009-10-16	2017-04-18	Rutgers, The State University Of New Jersey	Procedimeinto de tratamiento de lesión crónica de tejido nervioso usando una estrategia de terapia celular
WO2011048600A1 (en)	2009-10-21	2011-04-28	Danziger Innovations Ltd.	Generating genotypic variations in plant genomes by gamete infection
EP2494077A4 (en)	2009-10-27	2013-08-21	Caris Mpi Inc	MOLECULAR PROFILING FOR PERSONALIZED MEDICINE
IL201999A (en)	2009-11-08	2017-10-31	Medical Res & Development Fund For Health Services Bnai Zion Medical Center The State Of Israel	A knockout mouse of the 1 – mo gene, a gene associated with morbidly extreme obesity
US9018010B2 (en)	2009-11-12	2015-04-28	Technion Research & Development Foundation Limited	Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
EP2498806B1 (en)	2009-11-12	2014-12-31	Ramot at Tel-Aviv University Ltd.	Compositions comprising pedf and uses of same in the treatment and prevention of ovary-related syndromes
WO2011058555A1 (en)	2009-11-12	2011-05-19	Yeda Research And Development Co. Ltd.	A method of editing dna in a cell and constructs capable of same
US9260517B2 (en)	2009-11-17	2016-02-16	Musc Foundation For Research Development	Human monoclonal antibodies to human nucleolin
US20120230974A1 (en)	2009-11-17	2012-09-13	Protalix Ltd	Alkaline alpha galactosidase for the treatment of fabry disease
GB0920089D0 (en)	2009-11-17	2009-12-30	Danisco	Method
US8592151B2 (en) *	2009-11-17	2013-11-26	Musc Foundation For Research Development	Assessing left ventricular remodeling via temporal detection and measurement of microRNA in body fluids
EP2504472A1 (en)	2009-11-24	2012-10-03	Collplant Ltd.	Method of generating collagen fibers
US9733242B2 (en)	2012-10-07	2017-08-15	Sevident, Inc.	Devices for capturing analyte
US9910040B2 (en)	2012-07-09	2018-03-06	Sevident, Inc.	Molecular nets comprising capture agents and linking agents
EP2977445B1 (en)	2009-11-30	2018-07-25	Pluristem Ltd.	Adherent cells from placenta and use of same in disease treatment
US8652788B2 (en) *	2009-12-02	2014-02-18	Abbott Laboratories	Assay for diagnosis of cardiac myocyte damage
US8835120B2 (en) *	2009-12-02	2014-09-16	Abbott Laboratories	Assay for cardiac troponin-T (cTnT)
US20110136141A1 (en) *	2009-12-03	2011-06-09	Abbott Laboratories	Peptide reagents and method for inhibiting autoantibody antigen binding
US8183002B2 (en)	2009-12-03	2012-05-22	Abbott Laboratories	Autoantibody enhanced immunoassays and kits
WO2011067745A2 (en)	2009-12-06	2011-06-09	Rosetta Green Ltd.	Compositions and methods for enhancing plants resistance to abiotic stress
EP2862929B1 (en)	2009-12-09	2017-09-06	Quark Pharmaceuticals, Inc.	Compositions and methods for treating diseases, disorders or injury of the CNS
EP2513308B1 (en)	2009-12-17	2017-01-18	Merck Sharp & Dohme Corp.	Modulation of pilr to treat immune disorders
GB0922377D0 (en)	2009-12-22	2010-02-03	Arab Gulf University The	Mutant LDL receptor
AU2010337936B2 (en)	2009-12-28	2016-06-23	Evogene Ltd.	Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficiency
EP3184109B1 (en)	2009-12-29	2020-11-18	Gamida-Cell Ltd.	Methods for enhancing natural killer cell proliferation and activity
US9005579B2 (en)	2010-01-05	2015-04-14	Contrafect Corporation	Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria
NZ601324A (en)	2010-01-05	2014-10-31	Vascular Biogenics Ltd	Methods for use of a specific anti-angiogenic adenoviral agent
US11287423B2 (en)	2010-01-11	2022-03-29	Biogen Ma Inc.	Assay for JC virus antibodies
CN102906278A (zh)	2010-01-11	2013-01-30	比奥根艾迪克Ma公司	用于jc病毒抗体的测定
JP6009357B2 (ja)	2010-01-12	2016-10-19	バスキュラーバイオジェニックスリミテッド	アデノウイルスベクターの生産方法およびそれによって生成されるウイルス調製物
CA2787311C (en)	2010-01-27	2017-08-15	Yeda Research And Development Co. Ltd.	Antibodies that inhibit metalloproteins
US20130171621A1 (en)	2010-01-29	2013-07-04	Advanced Cell Diagnostics Inc.	Methods of in situ detection of nucleic acids
US8574832B2 (en)	2010-02-03	2013-11-05	Massachusetts Institute Of Technology	Methods for preparing sequencing libraries
BR112012019693A2 (pt)	2010-02-04	2017-06-20	Gilead Biologics Inc	anticorpos que se ligam à lisil oxidase-like 2 (loxl2) e métodos de uso para eles.
CN102844045A (zh)	2010-02-08	2012-12-26	艾更斯司股份有限公司	结合于161p2f10b蛋白的抗体药物偶联物(adc)
WO2011099006A2 (en)	2010-02-11	2011-08-18	Yeda Research And Development Co. Ltd.	Enzymatic systems for carbon fixation and methods of generating same
AU2011219426A1 (en)	2010-02-24	2012-10-04	Ben Gurion University Of The Negev Research And Development Authority	Methods for inhibiting necrosis
WO2011107939A1 (en)	2010-03-01	2011-09-09	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Methods of predicting efficacy of an anti-vegfa treatment for solid tumors
WO2011107994A1 (en)	2010-03-04	2011-09-09	Yeda Research And Development Co. Ltd.	Methods of measuring protein stability
WO2011111034A1 (en)	2010-03-08	2011-09-15	Yeda Research And Development Co. Ltd.	Recombinant protein production in heterologous systems
ES2641642T3 (es)	2010-03-08	2017-11-10	Monsanto Technology Llc	Moléculas de polinucleótido para regulación génica en plantas
WO2011111050A2 (en)	2010-03-11	2011-09-15	Jacob Edrei	Methods of generating hydrogen
WO2011114251A1 (en)	2010-03-18	2011-09-22	Danisco A/S	Foodstuff
WO2011125015A2 (en)	2010-04-05	2011-10-13	Bar-Ilan University	Protease-activatable pore-forming polypeptides
US9125931B2 (en)	2010-04-06	2015-09-08	Massachusetts Institute Of Technology	Post-transcriptional regulation of RNA-related processes using encoded protein-binding RNA aptamers
CN103168118A (zh)	2010-04-06	2013-06-19	麻省理工学院	用减少数量的转录物测量进行的基因表达概况分析
WO2011128897A1 (en)	2010-04-12	2011-10-20	Technion Research & Development Foundation Ltd.	Populations of pancreatic progenitor cells and methods of isolating and using same
EP2557913B1 (en)	2010-04-12	2016-08-03	Ben Gurion University Of The Negev Research And Development Authority	Sulfotransferase of a red microalga and uses thereof
WO2011129382A1 (en)	2010-04-16	2011-10-20	Abbott Japan Co. Ltd.	Methods and reagents for diagnosing rheumatoid arthritis
RU2012148398A (ru)	2010-04-18	2014-05-27	Иеда Рисеч Энд Девелопмент Ко. Лтд.	МОЛЕКУЛЫ И СПОСОБЫ ПРИМЕНЕНИЯ МОЛЕКУЛ ДЛЯ ЛЕЧЕНИЯ БОЛЕЗНЕЙ, АССОЦИИРОВАННЫХ С ErbB/ErbB ЛИГАНДАМИ
EP2563112A4 (en)	2010-04-28	2014-03-05	Evogene Ltd	INSULATED POLYNUCLEOTIDES AND POLYPEPTIDES AND METHODS OF USING THE SAME FOR INCREASING PLANT YIELD AND / OR AGRICULTURAL CHARACTERISTICS
WO2011138778A2 (en)	2010-05-04	2011-11-10	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Methods of identifying inhibitors of polypeptides-of-interest
US9352000B2 (en)	2010-05-05	2016-05-31	Rappaport Family Institute For Research In The Medical Sciences	Use of CCL1 in therapy
IL208820A0 (en)	2010-10-19	2011-01-31	Rachel Teitelbaum	Biologic female contraceptives
MX2012012986A (es)	2010-05-07	2013-03-05	Abbvie Inc	Metodos para predecir la sensibilidad al tratamiento con un inhibidor de cinasa de tirosina dirigido.
US20120190563A1 (en)	2010-05-07	2012-07-26	Abbott Laboratories	Methods for predicting sensitivity to treatment with a targeted tyrosine kinase inhibitor
WO2011141914A1 (en)	2010-05-13	2011-11-17	Tel Hashomer Medical Research Infrastructure And Services Ltd.	Isolated populations of adult renal cells and methods of isolating and using same
WO2011146479A1 (en)	2010-05-18	2011-11-24	The Texas A&M University System	Method and composition for the diagnosis and monitoring of inflammatory diseases
EP2576622A4 (en)	2010-06-01	2013-11-27	Univ Monash	ON THE UNPROCESSED RECEPTOR TYROSINE KINASE C-MET TARGETED ANTIBODIES
WO2011151833A1 (en)	2010-06-03	2011-12-08	Ramot At Tel-Aviv University Ltd.	Methods of treating diabetes and compositions capable of same
MX2012014284A (es)	2010-06-07	2013-04-29	Osnat Ashur-Fabian	Metodos y kits para diagnosticar afecciones relacionadas con hipoxia.
BR112012032126A2 (pt)	2010-06-16	2017-10-17	Futuragene Israel Ltd Empresa Isralense	polinucleotídeo isolado, estrutura de ácido nucléico, sistema de estrutura de ácido nucléico, polipeptídeo isolado, planta, composição inseticida, e método para controlar ou exterminar um inseto
WO2011158243A2 (en)	2010-06-16	2011-12-22	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Method of diagnosing and treating cancer
WO2012006056A2 (en)	2010-06-29	2012-01-12	Oregon Health & Science University	Ccr6 as a biomarker of alzheimer's disease
GB201011513D0 (en)	2010-07-08	2010-08-25	Danisco	Method
EP2593468B1 (en)	2010-07-12	2020-06-10	The State of Israel, Ministry of Agriculture and Rural Development, Agricultural Research Organization, (A.R.O.), Volcani Center	Isolated polynucleotides and methods and plants using same for regulating plant acidity
EP2407242A1 (en)	2010-07-13	2012-01-18	Dublin City University	Direct clone analysis and selection technology
CA2805478A1 (en)	2010-07-15	2012-01-19	Technion Research & Development Foundation Ltd.	Isolated high affinity entities with t-cell receptor like specificity towards native complexes of mhc class ii and diabetes-associated autoantigenic peptides
US9695410B2 (en)	2010-07-15	2017-07-04	Technion Research & Development Foundation Limited	Isolated high affinity entities with T-cell receptor like specificity towards native complexes of MHC class II and glutamic acid decarboxylase (GAD) autoantigenic peptides
BR112013000984A2 (pt)	2010-07-15	2017-10-03	Technion Res & Dev Foundation	Estrutura de ácido nucleico para o aumento da tolerância ao estresse abiótico em plantas
WO2012009627A2 (en)	2010-07-16	2012-01-19	Vanderbilt University	Low resource processor using surface tension valves for extracting, concentrating and detecting molecular species
ES2741175T3 (es)	2010-07-16	2020-02-10	Bioatla Llc	Nuevos métodos de evolución de proteínas
WO2012011113A2 (en)	2010-07-22	2012-01-26	Shai Yarkoni	Regulatory immune cells with enhanced targeted cell death effect
CN103026230B (zh)	2010-07-23	2015-01-14	卢米耐克斯公司	共偶联以控制免疫测定中试剂的反应性
US9120862B2 (en)	2010-07-26	2015-09-01	Abbott Laboratories	Antibodies relating to PIVKA-II and uses thereof
WO2012014207A2 (en)	2010-07-27	2012-02-02	Technion Research & Development Foundation Ltd.	Method for generating induced pluripotent stem cells from keratinocytes derived from plucked hair follicles
US20130130311A1 (en)	2010-07-27	2013-05-23	Yeda Research And Development Co., Ltd.	Methods and systems for assessing clonality of cell cultures
WO2012014205A1 (en)	2010-07-27	2012-02-02	Technion Research & Development Foundation Ltd.	Isolated mesenchymal progenitor cells and extracellular matrix produced thereby
WO2012017439A2 (en)	2010-08-04	2012-02-09	Ramot At Tel-Aviv University Ltd.	Methods of treating autoimmune diseases of the central nervous system (cns) and neurodegenerative diseases
US8956859B1 (en)	2010-08-13	2015-02-17	Aviex Technologies Llc	Compositions and methods for determining successful immunization by one or more vaccines
WO2012025914A1 (en)	2010-08-22	2012-03-01	Ramot At Tel-Aviv University Ltd.	Induced pluripotent stem cells derived from human pancreatic beta cells
WO2012025925A1 (en)	2010-08-24	2012-03-01	Rappaport Family Institute For Research In The Medical Sciences	Methods of improving transplantation using sdf-1alpha
BR122019017037B1 (pt)	2010-08-30	2022-05-31	Evogene Ltd	Método de aumento de eficiência do uso de nitrogênio, rendimento, biomassa, taxa de crescimento, vigor e/ou tolerância ao estresse à deficiência de nitrogênio de uma planta
JP6283223B2 (ja)	2010-09-07	2018-02-21	テクニオンリサーチアンドディベロップメントファウンデーションリミテッド	多能性幹細胞を培養するための新規な方法および培養培地
WO2012032510A1 (en)	2010-09-07	2012-03-15	Yeda Research And Development Co. Ltd.	Primers for amplifying dna and methods of selecting same
WO2012032520A1 (en)	2010-09-07	2012-03-15	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Readthrough acetylcholinesterase (ache-r) for treating or preventing parkinson's disease
WO2012032519A2 (en)	2010-09-07	2012-03-15	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Methods of diagnosing parkinson's disease
JP2013540731A (ja)	2010-09-08	2013-11-07	イェダリサーチアンドデベロップメントカンパニーリミテッド	安定かつ長期間の生着のための免疫抑制薬物組合せ
CN103282047B (zh)	2010-09-08	2016-08-24	耶达研究及发展有限公司	抗第三方中枢记忆性t细胞在抗白血病/淋巴瘤治疗中的用途
CN103210082A (zh)	2010-09-15	2013-07-17	雷蒙特亚特特拉维夫大学有限公司	扩增胰岛β细胞和使其再分化的方法
US20130210901A1 (en)	2010-09-20	2013-08-15	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Method of treating neurodegenerative diseases
EP2619321B1 (en)	2010-09-20	2018-08-01	Advanced Cell Diagnostics, Inc.	Biomarkers for differentiating melanoma from benign nevus in the skin
MX347954B (es)	2010-09-29	2017-05-19	Agensys Inc	Conjugados de anticuerpo farmaco (adc) que enlazan a proteinas 191p4d12.
EP2624848A2 (en)	2010-10-04	2013-08-14	Centre National De La Recherche Scientifique CNRS	Compositions comprising multivalent synthetic ligands of surface nucleolin and glycosaminoglycans
EP2441520A1 (en)	2010-10-12	2012-04-18	Eppendorf AG	Real-time amplification and micro-array based detection of nucleic acid targets in a flow chip assay
EP2627766B1 (en)	2010-10-17	2016-05-25	Yeda Research and Development Co. Ltd.	Methods and compositions for the treatment of insulin-associated medical conditions
WO2012052878A1 (en)	2010-10-19	2012-04-26	Vascular Biogenics Ltd.	Isolated polynucleotides and nucleic acid constructs for directing expression of a gene-of-interest in cells
US8658361B2 (en)	2010-10-21	2014-02-25	Advanced Cell Diagnostics, Inc.	Ultra sensitive method for in situ detection of nucleic acids
US20130216603A1 (en)	2010-10-27	2013-08-22	Nanocyte (Israel) Ltd.	Pharmaceutical compositions and delivery devices comprising stinging cells or capsules
WO2012056455A1 (en)	2010-10-28	2012-05-03	Yeda Research And Development Co. Ltd.	Methods of generating antibodies to metalloenzymes
CN103237895A (zh)	2010-11-03	2013-08-07	耶路撒冷希伯来大学伊森姆研究发展有限公司	具有提高的糖化产率的转基因植物以及产生其的方法
US9410132B2 (en)	2010-11-04	2016-08-09	Ben-Gurion University Of The Negev Research And Development Authority	Acyl-CoA: diacylglycerol acyltransferase 1-like gene (PtDGAT1) and uses thereof
TW201225972A (en)	2010-11-15	2012-07-01	Univ Ramot	Dipeptide analogs for treating conditions associated with amyloid fibril formation
WO2012066495A2 (en)	2010-11-17	2012-05-24	Ben Gurion University Of The Negev Research And Development Authority	T-cell therapy to neurodegenerative diseases
JP6139410B2 (ja)	2010-12-02	2017-05-31	テクニオンリサーチアンドディベロップメントファウンデーションリミテッド	角膜細胞の作製方法および該角膜細胞を含む細胞集団
AU2011253984A1 (en)	2010-12-07	2012-06-28	Biobalance Llc	Method For Identifying E. Coli M-17
EP2652125B1 (en)	2010-12-15	2017-04-26	Kadimastem Ltd.	Insulin producing cells derived from pluripotent stem cells
WO2012085862A2 (en)	2010-12-22	2012-06-28	Evogene Ltd.	Isolated polynucleotides and polypeptides, and methods of using same for increasing abiotic stress tolerance, yield, growth rate, vigor, biomass, oil content, and/or nitrogen use efficiency of plants
AR084358A1 (es)	2010-12-27	2013-05-08	Lilly Co Eli	Composiciones y metodos para identificar y diferenciar componentes virales de vacunas multivalentes de la “fiebre de embarque” (complejo de enfermedad respiratoria bovina (brdc))
KR101947126B1 (ko)	2010-12-28	2019-02-13	카메디스 리미티드	감염의 치료 및 예방을 위한 식물 추출물
AU2011352207B2 (en)	2010-12-31	2016-03-03	Bioatla, Llc	Comprehensive monoclonal antibody generation
EP3567121B1 (en)	2011-01-17	2023-08-30	Life Technologies Corporation	Workflow for detection of ligands using nucleic acids
KR101883803B1 (ko)	2011-01-20	2018-07-31	프로탈릭스 리미티드	식물 및 식물 세포에서 알파-갈락토시다제의 발현용 핵산 작제물
EP2668290B1 (en)	2011-01-28	2017-05-31	Advanced Cell Diagnostics, Inc.	Rnascope® hpv assay for determining hpv status in head and neck cancers and cervical lesions
US20130316358A1 (en)	2011-01-31	2013-11-28	Yeda Research And Development Co. Ltd.	Methods of diagnosing disease using overlap extension pcr
EP2671086B1 (en)	2011-02-03	2018-04-25	Pop Test Oncology LLC	System and method for diagnosis and treatment
US8952132B2 (en)	2011-02-07	2015-02-10	Research Development Foundation	Engineered immunoglobulin FC polypeptides
WO2012114339A1 (en)	2011-02-23	2012-08-30	Rappaport Family Institute For Research In The Medical Sciences	High affinity molecules capable of binding a type a plexin receptor and uses of same
US9212258B2 (en)	2011-02-23	2015-12-15	The Board Of Trustees Of The University Of Illinois	Amphiphilic dendron-coils, micelles thereof and uses
UA113843C2 (xx)	2011-03-02	2017-03-27		Стійка до бактерій трансгенна рослина, яка містить дисфункціональні білки t3ss
WO2012117373A1 (en)	2011-03-03	2012-09-07	Ramot At Tel-Aviv University Ltd.	Genetically modified muscle cells which express neurotrophic factors
CA2829110C (en)	2011-03-06	2019-01-15	Merck Serono S.A.	Low fucose cell lines and uses thereof
US9061006B2 (en)	2011-03-08	2015-06-23	Ramot At Tel-Aviv University Ltd.	Compositions and methods for diagnosing and treating phenylketonuria (PKU)
AU2012226530B2 (en)	2011-03-08	2016-12-01	King Abdullah University Of Science And Technology	Molecular biomarker set for early detection of ovarian cancer
CN105388287A (zh)	2011-03-11	2016-03-09	内布拉斯加大学董事委员会	冠状动脉疾病的生物标志物
IN2013MN01438A (da)	2011-03-17	2015-06-12	Univ Ramot
US20140086839A1 (en)	2011-03-17	2014-03-27	Tel Hashomer Medical Research Infrastructure And Services Ltd.	Quinolone analogs for treating autoimmune diseases
JP2014511677A (ja)	2011-03-22	2014-05-19	コーネル・ユニバーシティー	鑑別困難な良性甲状腺病変と悪性甲状腺病変との識別法
EP3260533B1 (en)	2011-03-22	2019-09-11	Pluristem Ltd.	Methods for treating radiation or chemical injury
US20140045764A1 (en)	2011-03-24	2014-02-13	Neurim Pharmaceuticals (1991) Ltd.	Neuroprotective peptides
US20140005070A1 (en)	2011-03-28	2014-01-02	Novartis Ag	Markers associated with cyclin-dependent kinase inhibitors
WO2012131680A2 (en)	2011-03-28	2012-10-04	Yeda Research And Development Co. Ltd.	Compositions and methods for treating inflammation
BR112013025415B1 (pt)	2011-04-01	2021-03-16	Immunogen, Inc	uso de um imunoconjugado antirreceptor de folato 1 (folr1)
DK2694095T3 (da)	2011-04-05	2018-05-28	Longevity Biotech Inc	Sammensætninger omfattende glucagon-analoger og fremgangsmåder til fremstilling og anvendelse af samme
WO2012137202A1 (en)	2011-04-05	2012-10-11	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Composition comprising an iron indicator attached to a microparticle and uses of same for quantifying non-transferrin bound iron (ntbi) and cellular labile iron (lci)
JP5990254B2 (ja)	2011-04-06	2016-09-07	ラモット・アット・テル・アビブ・ユニバーシテイ・リミテッドＲａｍｏｔＡｔＴｅｌＡｖｉｖＵｎｉｖｅｒｓｉｔｙＬｔｄ．	代謝活性プロフィルのモニタリング方法および分析方法ならびにそれらの診断使用および治療使用
CA2830579A1 (en)	2011-04-08	2012-10-11	Danisco Us Inc.	Compositions
US9150644B2 (en)	2011-04-12	2015-10-06	The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II
CN103476924A (zh)	2011-04-15	2013-12-25	普拉里斯坦有限公司	收获细胞的方法和系统
CA2833409A1 (en)	2011-04-21	2012-10-26	The Rockefeller University	Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteria
CA2834027C (en)	2011-05-03	2021-12-21	Evogene Ltd.	Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficiency
EP2704793B1 (en)	2011-05-04	2019-07-17	Ramot at Tel Aviv University, Ltd.	Regulation of amyloid beta molecular composition for the treatment of alzheimer's disease
WO2012153333A1 (en)	2011-05-09	2012-11-15	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Regeneration and repair of mesenchymal tissue using amelogenin
WO2012153336A2 (en)	2011-05-12	2012-11-15	Rakuto Bio Technologies Ltd.	Methods and device for lightening skin complexion
WO2012156976A1 (en)	2011-05-16	2012-11-22	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Methods of producing artemisinin in non-host plants and vectors for use in same
JP6457263B2 (ja)	2011-05-20	2019-01-23	オリゴメリックスインコーポレイテッド	タウプロテアーゼ組成物および使用方法
CN107102135A (zh)	2011-05-20	2017-08-29	阿波特日本有限公司	用于减少非特异性结合的免疫检验方法和试剂
WO2012160526A2 (en)	2011-05-23	2012-11-29	Ofir Menashe	Formulations of microorganism comprising particles and uses of same
CA2836503C (en)	2011-05-23	2020-09-22	Yeda Research And Development Co. Ltd.	Use of akt phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same
SG10201604103SA (en)	2011-05-31	2016-07-28	Hutchison Biofilm Medical Solutions Ltd	Dispersion and detachment of cell aggregates
DK2715352T3 (da)	2011-05-31	2019-05-20	Biogen Ma Inc	Fremgangsmåde til vurdering af risiko for pml
WO2012164565A1 (en)	2011-06-01	2012-12-06	Yeda Research And Development Co. Ltd.	Compositions and methods for downregulating prokaryotic genes
US10166295B2 (en)	2011-06-02	2019-01-01	Opko Biologics Ltd.	Pegylated OXM variants
DK3424953T3 (en)	2011-06-06	2020-11-02	Novo Nordisk As	Terapeutiske antistoffer
US9415103B2 (en)	2011-06-14	2016-08-16	Yeda Research And Development Co. Ltd.	Combination therapy to prevent DCIS formation and progression to breast cancer
US20140130199A1 (en)	2011-06-23	2014-05-08	Kaiima Bio Agritech Ltd.	Common wheat, plants or parts thereof having partially or fully multiplied genome, hybrids and products thereof and methods of generating and using same
US9835621B2 (en)	2011-07-14	2017-12-05	University Of Kentucky Research Foundation	Process for detection of alzheimer's disease from a serum sample
GB201112091D0 (en)	2011-07-14	2011-08-31	Gt Biolog Ltd	Bacterial strains isolated from pigs
AU2012284097B2 (en)	2011-07-18	2017-08-03	President And Fellows Of Harvard College	Engineered microbe-targeting molecules and uses thereof
US20140143905A1 (en)	2011-07-20	2014-05-22	Amit Avidov	Maize plants having a partially or fully multiplied genome and uses thereof
EP2550982A1 (en)	2011-07-27	2013-01-30	Technion Research & Development Foundation Ltd.	Devices for surgical applications
CN107115352B (zh)	2011-08-04	2020-10-30	耶达研究及发展有限公司	微rna和包含微rna的组合物
HUE039009T2 (hu)	2011-08-05	2018-12-28	Res Found Dev	Javított eljárások és készítmények Olfml3-mediált angiogenesis modulálására
EP2741753A2 (en)	2011-08-09	2014-06-18	Yeda Research and Development Co. Ltd.	Downregulation of mir-7 for promotion of beta cell differentiation and insulin production
AR087524A1 (es)	2011-08-14	2014-03-26	Kaiima Bio Agritech Ltd	Plantas de trigo durum que tienen un genoma parcial completamente multiplicado y sus usos
BR112014003315A2 (pt)	2011-08-15	2017-03-01	Univ Chicago	composições e métodos relacionados a anticorpos para a proteína a estafilocócica
WO2013025479A1 (en)	2011-08-16	2013-02-21	Emory University	Jaml specific binding agents, antibodies, and uses related thereto
EP2753367A4 (en)	2011-09-07	2015-10-14	Yeda Res & Dev	OLFACTORY SIGNATURE AND ODORING MIXTURE THEREWITH
WO2013035099A1 (en)	2011-09-08	2013-03-14	Yeda Research And Development Co. Ltd.	Anti third party central memory t cells, methods of producing same and use of same in transplantation and disease treatment
CN103890195A (zh)	2011-09-08	2014-06-25	耶达研究及发展有限公司	用于肺癌的新型风险生物标志物
BR112014005958A2 (pt)	2011-09-13	2020-10-13	Monsanto Technology Llc	métodos e composições químicas agrícolas para controle de planta, método de redução de expressão de um gene accase em uma planta, cassete de expressão microbiana, método para fazer um polinucleotídeo, método de identificação de polinucleotídeos úteis na modulação de expressão do gene accase e composição herbicida
CN103974967A (zh)	2011-09-13	2014-08-06	孟山都技术公司	用于杂草控制的方法和组合物
US10829828B2 (en)	2011-09-13	2020-11-10	Monsanto Technology Llc	Methods and compositions for weed control
MX342856B (es)	2011-09-13	2016-10-13	Monsanto Technology Llc	Metodos y composiciones para el control de malezas.
UA116089C2 (uk)	2011-09-13	2018-02-12	Монсанто Текнолоджи Ллс	Спосіб та композиція для боротьби з бур'янами (варіанти)
US10806146B2 (en)	2011-09-13	2020-10-20	Monsanto Technology Llc	Methods and compositions for weed control
US9840715B1 (en)	2011-09-13	2017-12-12	Monsanto Technology Llc	Methods and compositions for delaying senescence and improving disease tolerance and yield in plants
US10760086B2 (en)	2011-09-13	2020-09-01	Monsanto Technology Llc	Methods and compositions for weed control
US9920326B1 (en)	2011-09-14	2018-03-20	Monsanto Technology Llc	Methods and compositions for increasing invertase activity in plants
US9249467B2 (en)	2011-09-16	2016-02-02	Steven Goodison	Bladder cancer detection composition, kit and associated methods
EP2764093B1 (en)	2011-10-05	2018-04-18	The Rockefeller University	Dimeric bacteriophage lysins
GB201117313D0 (en)	2011-10-07	2011-11-16	Gt Biolog Ltd	Bacterium for use in medicine
WO2013054320A1 (en)	2011-10-11	2013-04-18	Tel Hashomer Medical Research Infrastructure And Services Ltd.	Antibodies to carcinoembryonic antigen-related cell adhesion molecule (ceacam)
PT2768851T (pt)	2011-10-21	2017-09-08	Augurex Life Sciences Corp	Antigénios derivados de 14-3-3 citrulinada e utilizações dos mesmos no diagnóstico de artrite reumatoide
WO2013061328A2 (en)	2011-10-27	2013-05-02	Yeda Research And Development Co. Ltd.	Method of treating cancer
WO2013064163A1 (en)	2011-11-01	2013-05-10	Academisch Medisch Centrum	Methylation markers for colorectal cancer
AU2012332517B9 (en)	2011-11-03	2017-08-10	Quark Pharmaceuticals, Inc.	Methods and compositions for neuroprotection
US20140323549A1 (en)	2011-11-08	2014-10-30	Quark Pharmaceuticals, Inc.	Methods and compositions for treating diseases, disorders or injury of the nervous system
WO2013076729A1 (en)	2011-11-23	2013-05-30	Danziger Dan Flower Farm	Otomeria plants
US9617331B2 (en)	2011-11-27	2017-04-11	Yeda Research And Development Co. Ltd.	Methods of regulating angiogenesis by administering agents which increase apoB-100 polypeptide
PT2788009T (pt)	2011-12-08	2016-08-31	Yeda Res & Dev	Células pulmonares fetais de mamíferos e uso terapêutico das mesmas
WO2013090407A2 (en)	2011-12-12	2013-06-20	Step Ahead Innovations, Inc.	Aquatic environment monitoring and dosing systems and apparatuses, and methods and software relating thereto
WO2013093921A1 (en)	2011-12-20	2013-06-27	Collplant Ltd.	Collagen coated synthetic polymer fibers
US9035039B2 (en)	2011-12-22	2015-05-19	Protiva Biotherapeutics, Inc.	Compositions and methods for silencing SMAD4
WO2013095729A1 (en)	2011-12-22	2013-06-27	Life Technologies Corporation	Sequential lateral flow capillary device for analyte determination
JP2015504047A (ja)	2011-12-22	2015-02-05	イェダリサーチアンドデベロップメントカンパニーリミテッド	安定かつ長期の生着のための併用療法
WO2013098820A1 (en)	2011-12-28	2013-07-04	Kaiima Bio Agritech Ltd.	Cultivated sorghum plant having a partially or fully multiplied genome and uses of same
CN104160039B (zh)	2011-12-29	2021-08-03	贝勒研究院	川崎病的生物标志物
JP2015509085A (ja)	2012-01-01	2015-03-26	キュービーアイエンタープライゼズリミテッドＱｂｉＥｎｔｅｒｐｒｉｓｅｓＬｔｄ．	治療剤および診断剤の選択的送達のためのｅｎｄｏ１８０を標的とする粒子
AU2012367247B2 (en)	2012-01-24	2018-04-05	Cd Diagnostics, Inc.	System for detecting infection in synovial fluid
WO2013114363A2 (en)	2012-01-30	2013-08-08	Yeda Research And Development Co.Ltd.	Antimicrobial agents
US9603907B2 (en)	2012-02-01	2017-03-28	Protalix Ltd.	Dry powder formulations of dNase I
WO2013118120A2 (en)	2012-02-06	2013-08-15	Rosetta Green Ltd.	Isolated polynucleotides expressing or modulating micrornas or targets of same, transgenic plants comprising same and uses thereof in improving nitrogen use efficiency, abiotic stress tolerance, biomass, vigor or yield of a plant
HK1202581A1 (en)	2012-02-13	2015-10-02	Gamida-Cell Ltd.	Mesenchymal stem cells conditioned medium and methods of generating and using the same
PL3791890T3 (pl)	2012-02-14	2025-04-14	Opko Biologics Ltd.	Długo działające czynniki krzepnięcia i ich zastosowania
EP2814838A1 (en)	2012-02-19	2014-12-24	Protalix Ltd.	Oral unit dosage forms and uses of same for the treatment of gaucher disease
WO2013124817A2 (en)	2012-02-22	2013-08-29	Brainstem Biotec Ltd.	MicroRNAS FOR THE GENERATION OF ASTROCYTES
EP2844745A2 (en)	2012-02-22	2015-03-11	Brainstem Biotec Ltd.	Generation of neural stem cells and motor neurons
EP2817287B1 (en)	2012-02-24	2018-10-03	Arbutus Biopharma Corporation	Trialkyl cationic lipids and methods of use thereof
RU2627268C2 (ru)	2012-02-29	2017-08-04	Хемоцентрикс, Инк.	Аза-арил-1Н-пиразол-1-ил-сульфонамиды
WO2013128454A1 (en)	2012-03-01	2013-09-06	The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization, (A.R.O.), Volcani Center	Male sterile garlic plants, hybrid offspring of same and methods of generating and using same
EP3483184A1 (en)	2012-03-07	2019-05-15	Yeda Research and Development Co. Ltd	Compositions for inhibition of quiescinsulfhydryl oxidase (qsox1) and uses of same
ES2731757T3 (es)	2012-03-20	2019-11-18	Biogen Ma Inc	Anticuerpos neutralizantes de JCV
EP2828280B1 (en)	2012-03-22	2018-05-02	Ramot at Tel-Aviv University Ltd.	Plif multimeric peptides and uses thereof
CA2868883C (en)	2012-03-30	2022-10-04	Sorrento Therapeutics Inc.	Fully human antibodies that bind to vegfr2
US20140178869A1 (en)	2012-04-05	2014-06-26	Advanced Cell Diagnostics, Inc.	Detection of immunoglobulin light chain restriction by rna in situ hybridization
CA2868238A1 (en)	2012-04-18	2013-10-24	Ramot At Tel Aviv University Ltd.	Lipidated glycosaminoglycan particles for the delivery of nucleic acids
HK1207564A1 (en)	2012-04-19	2016-02-05	Opko Biologics Ltd	Long-acting oxyntomodulin variants and methods of producing same
US20130280696A1 (en)	2012-04-23	2013-10-24	Elliott Millenson	Devices and methods for detecting analyte in bodily fluid
EP2841084B1 (en)	2012-04-24	2018-05-30	Biokine Therapeutics Ltd.	Cxcr4 antagonist peptide for use in the treatment of large cell lung cancer
CN104703622B (zh)	2012-04-26	2017-05-24	芝加哥大学	与金黄色葡萄球菌疾病期间抵消凝固酶活性的抗体相关的组合物和方法
WO2013168164A1 (en)	2012-05-09	2013-11-14	Yeda Research And Development Co. Ltd.	Variants of tace pro-domain as tnf-a inhibitor and their medical use
AU2013259276B2 (en)	2012-05-10	2018-03-22	Bioatla Llc	Multi-specific monoclonal antibodies
US8865158B2 (en)	2012-05-22	2014-10-21	Ramot At Tel-Aviv University Ltd.	Bacteriophages for reducing toxicity of bacteria
IN2014KN02831A (da)	2012-05-24	2015-05-08	Mountgate Group Ltd
US10240161B2 (en)	2012-05-24	2019-03-26	A.B. Seeds Ltd.	Compositions and methods for silencing gene expression
KR20220084444A (ko)	2012-05-31	2022-06-21	소렌토 쎄라퓨틱스, 인코포레이티드	Pd-l1에 결합하는 항원 결합 단백질
ES2897825T3 (es)	2012-06-01	2022-03-02	Icahn School Med Mount Sinai	Niveles de ceramida en el tratamiento y prevención de infecciones
EP2855507B1 (en)	2012-06-03	2018-01-03	Ben-Gurion University of The Negev Research and Development Authority	Functionalized titanium binding peptides and implants coated with same
EA201492269A1 (ru)	2012-06-04	2016-02-29	Опко Байолоджикс Лтд.	Пегилированные варианты oxm
CN105050618B (zh)	2012-06-21	2018-11-16	索伦托治疗有限公司	与c-Met结合的抗原结合蛋白
WO2013192596A2 (en)	2012-06-22	2013-12-27	Sorrento Therapeutics Inc.	Antigen binding proteins that bind ccr2
US9758829B2 (en)	2012-06-22	2017-09-12	Htg Molecular Diagnostics, Inc.	Molecular malignancy in melanocytic lesions
WO2014006621A1 (en)	2012-07-03	2014-01-09	Nanospun Technologies Ltd.	Methods and devices for adsorption and biodegradation of petroleum
EP2870261B1 (en)	2012-07-09	2017-12-06	Novartis AG	Biomarkers associated with cdk inhibitors
JP6277187B2 (ja)	2012-07-11	2018-02-07	イムステムバイオテクノロジー，インコーポレイテッド	ヒト胚性幹細胞由来の間葉系様幹細胞、方法およびその使用
EP3327090A1 (en)	2012-07-18	2018-05-30	President and Fellows of Harvard College	Modification of surfaces for simulataneous repellency and targeted binding of desired moieties
WO2014018375A1 (en)	2012-07-23	2014-01-30	Xenon Pharmaceuticals Inc.	Cyp8b1 and uses thereof in therapeutic and diagnostic methods
US9175266B2 (en)	2012-07-23	2015-11-03	Gamida Cell Ltd.	Enhancement of natural killer (NK) cell proliferation and activity
US9567569B2 (en)	2012-07-23	2017-02-14	Gamida Cell Ltd.	Methods of culturing and expanding mesenchymal stem cells
KR102499753B1 (ko)	2012-07-27	2023-02-16	더 보오드 오브 트러스티스 오브 더 유니버시티 오브 일리노이즈	Ｔ 세포 수용체 조작
EP3594331A1 (en)	2012-07-29	2020-01-15	Yeda Research and Development Co. Ltd.	Use of the reductive glycine pathway for generating formatotrophic and autotrophic microorganisms
JP6340366B2 (ja)	2012-07-31	2018-06-06	イェダリサーチアンドデベロップメントカンパニーリミテッド	運動ニューロン疾患を診断および処置する方法
ES2742285T3 (es)	2012-07-31	2020-02-13	Novartis Ag	Marcadores asociados con la sensibilidad a inhibidores del doble minuto humano 2 (MDM2)
DK2880151T3 (da)	2012-08-06	2020-08-17	Brainstorm Cell Therapeutics Ltd	Fremgangsmåder til frembringelse af mesenkymale stemceller, som udskiller neurotrofiske faktorer
TWI606063B (zh)	2012-08-23	2017-11-21	艾澤西公司	結合至１５８ｐ１ｄ７蛋白之抗體藥物結合物（ａｄｃ）
WO2014033723A1 (en)	2012-09-03	2014-03-06	A.B. Seeds Ltd.	Method of improving abiotic stress tolerance of plants and plants generated thereby
US10543278B2 (en)	2012-09-12	2020-01-28	Ramot At Tel-Aviv University Ltd.	Immunoparticles and methods of generating and using same
EP3677310A1 (en)	2012-10-08	2020-07-08	St. Jude Children's Research Hospital	Therapies based on control of regulatory t cell stability and function via a neuropilin-1:semaphorin axis
EP2906954B1 (en)	2012-10-09	2018-04-11	Ramot at Tel-Aviv University Ltd.	Methods and kits for predicting prognosis of cancer using soluble mortalin in blood
EP2906596B1 (en)	2012-10-12	2023-12-27	Arizona Board of Regents on behalf of Arizona State University	Antibody based reagents that specifically recognize toxic oligomeric forms of tau
MX364070B (es)	2012-10-18	2019-04-10	Monsanto Technology Llc	Métodos y composiciones para el control de plagas vegetales.
US9395369B2 (en)	2012-10-19	2016-07-19	Regents Of The University Of Minnesota	Guinea pig cytomegalovirus (CIDMTR strain)
WO2014063097A1 (en)	2012-10-19	2014-04-24	Danisco Us Inc.	Stabilization of biomimetic membranes
US20150354006A1 (en)	2012-10-19	2015-12-10	Novartis Ag	Markers for acute lymphoblastic leukemia
AU2013336237A1 (en)	2012-10-22	2015-06-11	Sabag-Rfa Ltd	A system for delivering therapeutic agents into living cells and cells nuclei
WO2014066590A1 (en)	2012-10-24	2014-05-01	Research Development Foundation	Jam-c antibodies and methods for treatment of cancer
EP2912062A1 (en)	2012-10-24	2015-09-02	Yeda Research and Development Co. Ltd.	Combinations of epidermal growth factor receptor targeting antibodies for treating cancer
WO2014068553A1 (en)	2012-10-29	2014-05-08	Yeda Research And Development Co. Ltd.	Aptamers, multimeric aptamers and uses thereof
HUE055348T2 (hu)	2012-11-20	2021-11-29	Opko Biologics Ltd	Eljárás polipeptidek hidrodinamikus térfogatának növelésére gonadotropin karboxil-terminális peptidekhez való kapcsolással
CA2877847A1 (en)	2012-11-29	2014-06-05	Yeda Research And Development Co. Ltd.	Methods of preventing tumor metastasis, treating and prognosing cancer and identifying agents which are putative metastasis inhibitors
US10683505B2 (en)	2013-01-01	2020-06-16	Monsanto Technology Llc	Methods of introducing dsRNA to plant seeds for modulating gene expression
WO2014106837A2 (en)	2013-01-01	2014-07-10	A. B. Seeds Ltd.	ISOLATED dsRNA MOLECULES AND METHODS OF USING SAME FOR SILENCING TARGET MOLECULES OF INTEREST
US10047399B2 (en)	2013-01-07	2018-08-14	The Cleveland Clinic Foundation	ABCA1 downregulation in prostate cancer
WO2014108854A1 (en)	2013-01-09	2014-07-17	Fusimab Ltd.	Monospecific anti-hgf and anti-ang2 antibodies and bispecific anti-hgf/anti-ang2 antibodies
WO2014108850A2 (en)	2013-01-09	2014-07-17	Yeda Research And Development Co. Ltd.	High throughput transcriptome analysis
CN104937412B (zh)	2013-01-17	2018-05-25	诺威尔卢斯德克有限公司	用于鉴定患者特定驱动突变物的方法和系统
US10125373B2 (en)	2013-01-22	2018-11-13	Arizona Board Of Regents On Behalf Of Arizona State University	Geminiviral vector for expression of rituximab
US10000767B2 (en)	2013-01-28	2018-06-19	Monsanto Technology Llc	Methods and compositions for plant pest control
EP2951290B1 (en)	2013-02-01	2017-11-29	The United States of America, as represented by The Secretary, Department of Health and Human Services	Method for generating retinal pigment epithelium (rpe) cells from induced pluripotent stem cells (ipscs)
US9411930B2 (en)	2013-02-01	2016-08-09	The Regents Of The University Of California	Methods for genome assembly and haplotype phasing
WO2014121091A1 (en)	2013-02-01	2014-08-07	The Regents Of The University Of California	Methods for genome assembly and haplotype phasing
US10000737B2 (en)	2013-02-04	2018-06-19	Ramot At Tel-Aviv University Ltd.	Generation of cytotoxic tumor specific cell lines and uses thereof
WO2014130846A1 (en)	2013-02-22	2014-08-28	Seungpyo Hong	Transdermal drug delivery using amphiphilic dendron-coil micelles
US20160017021A1 (en)	2013-03-06	2016-01-21	Protalix Ltd.	TNF alpha INHIBITOR POLYPEPTIDES, POLYNUCLEOTIDES ENCODING SAME, CELLS EXPRESSING SAME AND METHODS OF PRODUCING SAME
AU2014224174B2 (en)	2013-03-06	2018-08-30	Hadasit Medical Research Services And Development Ltd.	Use of plant cells expressing a TNFalpha polypeptide inhibitor in therapy
TWI582239B (zh)	2013-03-11	2017-05-11	諾華公司	與ｗｎｔ抑制劑相關之標記
BR112015022797A2 (pt)	2013-03-13	2017-11-07	Monsanto Technology Llc	método para controle de ervas daninhas, composição herbicida, cassete de expressão microbiano e método de produção de polinucleotídeo
EP2971185A4 (en)	2013-03-13	2017-03-08	Monsanto Technology LLC	Methods and compositions for weed control
EP3611189A1 (en)	2013-03-14	2020-02-19	Novartis AG	Antibodies against notch 3
US9273349B2 (en)	2013-03-14	2016-03-01	Affymetrix, Inc.	Detection of nucleic acids
PE20151893A1 (es)	2013-03-14	2015-12-30	Parkash Gill	Tratamiento del cancer usando anticuerpos que se unen a grp78 en la superficie celular
WO2014159242A1 (en)	2013-03-14	2014-10-02	Novartis Ag	Notch 3 mutants and uses thereof
US20140283211A1 (en)	2013-03-14	2014-09-18	Monsanto Technology Llc	Methods and Compositions for Plant Pest Control
US9944992B2 (en)	2013-03-15	2018-04-17	The University Of Chicago	Methods and compositions related to T-cell activity
WO2014145718A2 (en)	2013-03-15	2014-09-18	Longevity Biotech, Inc.	Peptides comprising non-natural amino acids and methods of making and using the same
US10568328B2 (en)	2013-03-15	2020-02-25	Monsanto Technology Llc	Methods and compositions for weed control
US20140273031A1 (en)	2013-03-15	2014-09-18	The Cleveland Clinic Foundation	In-vitro method for monoclonal antibody production
BR112015021866A2 (pt)	2013-03-15	2017-08-29	Bayer Healthcare Llc	Domínios de gla como agentes direcionadores
ES2883580T3 (es)	2013-03-21	2021-12-09	Collplant Ltd	Composiciones que comprenden colágeno y PRP para la regeneración de tejidos y su método de producción
US20160051693A1 (en)	2013-03-21	2016-02-25	Genisphere, Llc	Cellular Delivery of DNA Intercalating Agents
JP6294459B2 (ja)	2013-03-24	2018-03-14	バイオカイン・セラピューティクス・リミテッドＢｉｏｋｉｎｅＴｈｅｒａｐｅｕｔｉｃｓＬｔｄ．	骨髄性白血病の処置方法
KR20230109779A (ko)	2013-03-27	2023-07-20	세다르스-신나이 메디칼 센터	Tl1a 기능 및 관련된 신호전달 경로의 저해에 의한섬유증 및 염증의 완화 및 반전
GB201306536D0 (en)	2013-04-10	2013-05-22	Gt Biolog Ltd	Polypeptide and immune modulation
RU2015149680A (ru)	2013-04-21	2017-05-24	Йеда Ресеарч Энд Девелопмент Ко. Лтд.	Агенты для подавления активности и/или снижения количества bcl-xl и/или bcl-w
CN105531365A (zh)	2013-04-23	2016-04-27	耶达研究及发展有限公司	分离的幼稚多能干细胞和产生所述细胞的方法
WO2014176047A1 (en)	2013-04-25	2014-10-30	Novartis Ag	Markers for ezh2 inhibitors
US9714268B2 (en)	2013-04-25	2017-07-25	Yeda Research And Development Co. Ltd.	Use of inhibitory peptides for the treatment of inflammatory diseases
WO2014188423A1 (en)	2013-05-21	2014-11-27	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Treatment of mast cell related pathologies
JP6649250B2 (ja)	2013-05-21	2020-02-19	プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ	操作されたヘム結合性構成物およびその使用
ES2771048T3 (es)	2013-05-27	2020-07-06	Rakuto Bio Tech Ltd	Composiciones cosméticas que contienen sistemas enzimáticos
WO2014193804A1 (en)	2013-05-28	2014-12-04	Biogen Idec Ma Inc.	Method of assessing risk of pml
ES2754177T3 (es)	2013-06-12	2020-04-16	Massachusetts Gen Hospital	Métodos para la detección multiplexada de moléculas diana y sus usos
EP3010519B1 (en)	2013-06-18	2021-04-07	Dnatrix Inc.	Oncolytic adenovirus for use in a treatment of brain cancer
WO2014205230A1 (en)	2013-06-19	2014-12-24	Step Ahead Innovations Inc.	Aquatic environment water parameter testing systems and methods
ES2938044T3 (es)	2013-06-24	2023-04-04	Univ Ramot	Estructura a base de epiplón y sistema de suministro
CN105555303A (zh)	2013-06-28	2016-05-04	贝勒研究院	用于多发性硬化症的树突细胞asgpr靶向免疫治疗剂
EP3022295A4 (en)	2013-07-19	2017-03-01	Cedars-Sinai Medical Center	Signature of tl1a (tnfsf15) signaling pathway
US9850496B2 (en)	2013-07-19	2017-12-26	Monsanto Technology Llc	Compositions and methods for controlling Leptinotarsa
RU2703498C2 (ru)	2013-07-19	2019-10-17	Монсанто Текнолоджи Ллс	Композиции и способы борьбы с leptinotarsa
WO2015015489A1 (en)	2013-07-30	2015-02-05	Biolinerx Ltd.	Antibody for treating diabetes and autoimmune diseases
WO2015017552A1 (en)	2013-08-01	2015-02-05	Agensys, Inc.	Antibody drug conjugates (adc) that bind to cd37 proteins
CA2921652A1 (en)	2013-08-21	2015-02-26	Manuel A. Riquelme	Compositions and methods for targeting connexin hemichannels
US9938316B2 (en)	2013-08-29	2018-04-10	Yeda Research And Development Co. Ltd.	Selective inhibitors of α2 isoform of Na,K-ATPase and use thereof for reduction of intra-ocular pressure and as cardiotonic agents
CN113150145B (zh)	2013-08-30	2025-02-14	伊缪诺金公司	用于检测叶酸受体1的抗体和测定
WO2015033343A1 (en)	2013-09-03	2015-03-12	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Compositions and methods for expressing recombinant polypeptides
IL228284A (en)	2013-09-03	2016-12-29	Technion Res & Dev Foundation	Implants from cellular scaffolding and blood vessel stalk
WO2015033344A1 (en)	2013-09-05	2015-03-12	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Methods and kits for inhibiting pathogenicity of group a streptococcus (gas) or group g streptococcus (ggs)
WO2015037009A1 (en)	2013-09-16	2015-03-19	Plexicure Ltd.	Isolated proteins capable of binding plexin-a4 and methods of producing and using same
US9695402B2 (en)	2013-09-17	2017-07-04	Yeda Research And Development Co. Ltd.	ERK-derived peptides and uses thereof
CN119587584A (zh)	2013-10-01	2025-03-11	卡迪马干细胞有限公司	从人多能干细胞定向分化星形胶质细胞用于肌萎缩侧索硬化(als)的治疗和药物筛选
MX2016004283A (es)	2013-10-03	2016-10-12	Oklahoma Med Res Found	Biomarcadores para la actividad, e intesidad y arrebato de la enfermedad lupus eritematoso sistemico.
US9476884B2 (en)	2013-10-04	2016-10-25	University Of Massachusetts	Hybridization- independent labeling of repetitive DNA sequence in human chromosomes
US11396012B2 (en)	2013-10-07	2022-07-26	Yeda Research And Development Co. Ltd.	Microfluidic device for analyzing gene expression
EP3060239B1 (en)	2013-10-21	2020-05-13	OPKO Biologics Ltd.	Long-acting polypeptides and methods of producing and administering same
US20150158926A1 (en)	2013-10-21	2015-06-11	Opko Biologics, Ltd.	Long-acting polypeptides and methods of producing and administering same
WO2015059690A1 (en)	2013-10-24	2015-04-30	Yeda Research And Development Co. Ltd.	Polynucleotides encoding brex system polypeptides and methods of using s ame
ES2811804T3 (es)	2013-10-31	2021-03-15	Biokine Therapeutics Ltd	Un inhibidor peptídico de CXCR4 para su uso en el tratamiento de la leucemia mieloide aguda con una mutación de FLT3
HUE070313T2 (hu)	2013-11-04	2025-05-28	Greenlight Biosciences Inc	Ízeltlábú paraziták és kártevõfertõzöttség szabályozására szolgáló készítmények és eljárások
US20170002064A1 (en)	2013-11-08	2017-01-05	The Board Of Regents Of The University Of Texas System	Vh4 antibodies against gray matter neuron and astrocyte
CA2930693A1 (en)	2013-11-15	2015-05-21	The Board Of Trustees Of The Leland Stanford Junior Unversity	Methods of treating heart failure with agonists of hypocretin receptor 2
IL245703B (en)	2013-11-20	2022-07-01	Univ Iowa Res Found	Methods and compositions for treating amyloid deposits
KR102415259B1 (ko)	2013-11-22	2022-06-30	더 보오드 오브 트러스티스 오브 더 유니버시티 오브 일리노이즈	조작된 고-친화도의 인간 t 세포 수용체
EP3074044A2 (en)	2013-11-28	2016-10-05	Yeda Research and Development Co., Ltd.	Synaptojanin-2 inhibitors and uses thereof
ES2754207T3 (es)	2013-11-28	2020-04-16	Tel Hashomer Medical Res Infrastructure & Services Ltd	Inhibidores de la ARN polimerasa I y usos de los mismos
UA119253C2 (uk)	2013-12-10	2019-05-27	Біолоджикс, Інк.	Спосіб боротьби із вірусом у кліща varroa та у бджіл
US10053712B2 (en)	2013-12-10	2018-08-21	Yeda Research And Development Co. Ltd.	Use of enzymes which catalyze pyruvate synthesis from formate and acetyl-CoA and bacteria expressing same
US20150191744A1 (en)	2013-12-17	2015-07-09	University Of Massachusetts	Cas9 effector-mediated regulation of transcription, differentiation and gene editing/labeling
US10513546B2 (en)	2013-12-18	2019-12-24	President And Fellows Of Harvard College	CRP capture/detection of gram positive bacteria
EP3083936B1 (en)	2013-12-19	2018-07-04	Danisco US Inc.	Use of hydrophobins to increase gas transfer in aerobic fermentation processes
EP3447493B1 (en)	2014-01-07	2020-05-13	Bioatla, LLC	Proteins targeting orthologs
CN120939216A (zh)	2014-01-13	2025-11-14	贝勒研究院	抗hpv和hpv相关的疾病的新疫苗
AU2015206585A1 (en)	2014-01-15	2016-07-21	Monsanto Technology Llc	Methods and compositions for weed control using EPSPS polynucleotides
WO2015116753A1 (en)	2014-01-29	2015-08-06	Dana-Farber Cancer Institute, Inc.	Antibodies against the muc1-c/extracellular domain (muc1-c/ecd)
US20160340659A1 (en)	2014-01-30	2016-11-24	Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd.	Actin binding peptides and compositions comprising same for inhibiting angiogenesis and treating medical conditions associated with same
AU2015212341A1 (en)	2014-02-03	2016-09-08	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Use of Casein kinase I inhibitors for depleting stem cells
CA2936158C (en)	2014-02-05	2023-06-13	Yeda Research And Development Co. Ltd.	Use of mir-135 or precursor thereof for the treatment and diagnosis of a bipolar disease
CN106573976B (zh)	2014-02-06	2020-05-05	耶达研究及发展有限公司	抗cd84抗体、包含所述抗体的组合物及其用途
WO2015120273A1 (en)	2014-02-07	2015-08-13	The General Hospital Corporation	Differential diagnosis of hepatic neoplasms
US20170101633A1 (en)	2014-02-10	2017-04-13	Protalix Ltd.	Method of maintaining disease stability in a subject having gaucher's disease
EP3105587B1 (en)	2014-02-11	2023-09-06	Brainstorm Cell Therapeutics Ltd.	Method of qualifying cells
WO2015123565A1 (en)	2014-02-14	2015-08-20	The General Hospital Corporation	Methods for diagnosing igg4-related disease
WO2015131099A1 (en)	2014-02-28	2015-09-03	The General Hospital Corporation	Diagnosis of multiple myeloma and lymphoma
WO2015132784A1 (en)	2014-03-03	2015-09-11	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Method and device for detection of pseudomonas aeruginosa
EP2923709A1 (en)	2014-03-28	2015-09-30	Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.	Multi-component-multistage malaria vaccine
BR112016022711A2 (pt)	2014-04-01	2017-10-31	Monsanto Technology Llc	composições e métodos para controle de pragas de inseto
US11433163B2 (en)	2014-04-10	2022-09-06	Bonus Therapeutics Ltd.	Bone repair compositions
WO2015159292A2 (en)	2014-04-14	2015-10-22	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	A method and kit for determining the tissue or cell origin of dna
WO2015159295A1 (en)	2014-04-17	2015-10-22	Yeda Research And Development Co. Ltd.	Methods and kits for analyzing dna binding moieties attached to dna
US11427647B2 (en)	2014-04-27	2022-08-30	Famewave Ltd.	Polynucleotides encoding humanized antibodies against CEACAM1
US10550196B2 (en)	2014-04-27	2020-02-04	Famewave Ltd.	Humanized antibodies against CEACAM1
ES2870658T3 (es)	2014-04-28	2021-10-27	Yeda Res & Dev	Respuesta del microbioma a agentes
CA2945736A1 (en)	2014-05-04	2015-11-12	Forrest Innovations Ltd.	Compositions for mosquito control and uses of same
US10247729B2 (en)	2014-05-05	2019-04-02	Microbplex, Inc.	Media elaborated with newly synthesized antibodies (MENSA) and uses thereof
DK3140653T3 (da)	2014-05-08	2022-06-20	Novodiax Inc	Direkte immunhistokemianalyse
WO2015179435A1 (en)	2014-05-19	2015-11-26	Bayer Healthcare Llc	Optimized humanized monoclonal antibodies against activated protein c and uses thereof
US10294482B2 (en)	2014-05-22	2019-05-21	Yeda Research And Development Co. Ltd.	Recombinant microorganisms capable of carbon fixation
EP3149155B1 (en)	2014-06-02	2020-09-23	Kadimastem Ltd.	Methods of inducing myelination and maturation of oligodendrocytes
US20170253881A1 (en)	2014-06-02	2017-09-07	Technion Research & Development Foundation Limited	Compositions and methods of selectively inhibiting irp1 and treating inflammation
US10988764B2 (en)	2014-06-23	2021-04-27	Monsanto Technology Llc	Compositions and methods for regulating gene expression via RNA interference
WO2015198320A1 (en)	2014-06-24	2015-12-30	Insight Biopharmaceuticals Ltd.	Methods of purifying antibodies
US10883994B2 (en)	2014-06-25	2021-01-05	Tel Hashomer Medical Research Infrastructure And Services Ltd.	Identification of cancer stem cells markers and use of same for diagnosis and treatment
EP3161138A4 (en)	2014-06-25	2017-12-06	Monsanto Technology LLC	Methods and compositions for delivering nucleic acids to plant cells and regulating gene expression
EP3160448B1 (en)	2014-06-26	2025-08-06	Ramot at Tel-Aviv University Ltd.	Liposomal formulations for delivery of nucleic acids
WO2016005985A2 (en)	2014-07-09	2016-01-14	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Method for reprogramming cells
EP3169343B1 (en)	2014-07-15	2020-03-25	Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd.	Isolated polypeptides of cd44 and uses thereof
CA2955411A1 (en)	2014-07-21	2016-01-28	Novellusdx Ltd.	Methods for determining drug response of patient specific mutations
WO2016013008A1 (en)	2014-07-21	2016-01-28	Novellusdx Ltd.	Methods and systems for determining oncogenic index of patient specific mutations
RU2021123470A (ru)	2014-07-29	2021-09-06	Монсанто Текнолоджи Ллс	Композиции и способы борьбы с насекомыми-вредителями
CN108064274A (zh)	2014-07-30	2018-05-22	耶达研究及发展有限公司	用于培养多能干细胞的培养基
US10526641B2 (en)	2014-08-01	2020-01-07	Dovetail Genomics, Llc	Tagging nucleic acids for sequence assembly
BR112017002884A2 (pt)	2014-08-14	2018-01-30	Memed Diagnostics Ltd	?análise computacional de dados biológicos por meio do uso de variedade e hiperplano?
EA201790437A1 (ru)	2014-08-22	2017-08-31	Сорренто Терапьютикс, Инк.	Антигенсвязывающие белки, связывающиеся с cxcr3
WO2016030899A1 (en)	2014-08-28	2016-03-03	Yeda Research And Development Co. Ltd.	Methods of treating amyotrophic lateral scleroses
WO2016038609A1 (en)	2014-09-08	2016-03-17	Yeda Research And Development Co. Ltd.	Anti-her3 antibodies and uses of same
EP2992895A1 (en)	2014-09-08	2016-03-09	Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.	Three-component-multistage malaria vaccine
EP3191523B1 (en)	2014-09-08	2019-08-07	Yeda Research and Development Co., Ltd.	Compositions and methods for treating cancer resistant to a tyrosine kinase inhibitor (tki)
US20170283844A1 (en)	2014-09-11	2017-10-05	The State of Israel, Ministry of Agriculture & Rural Development, Argricultural Research Organiza	Methods of producing mogrosides and compositions comprising same and uses thereof
EP3191592A1 (en)	2014-09-11	2017-07-19	Novartis AG	Inhibition of prmt5 to treat mtap-deficiency-related diseases
IL234638A0 (en)	2014-09-14	2014-12-02	Yeda Res & Dev	NMDA receptor antagonists for the treatment of Gaucher disease
JP6214790B2 (ja)	2014-09-16	2017-10-18	イースチャームリミテッド	抗ｅｇｆｒ抗体および同抗体の使用法
EP3230453B1 (en)	2014-09-21	2020-05-20	Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd.	Downregulating mir-132 for the treatment of lipid related disorders
WO2016057424A1 (en)	2014-10-06	2016-04-14	Chemocentryx, Inc.	Combination therapy of inhibitors of c-c chemokine receptor type 9 (ccr9) and anti-alha4beta7 integrin blocking antibodies
US20170253921A1 (en)	2014-10-13	2017-09-07	Life Technologies Corporation	Methods, kits & compositions for determining gene copy numbers
US10093989B2 (en)	2014-10-20	2018-10-09	Gen-Probe Incorporated	Red blood cell lysis solution
WO2016065238A1 (en)	2014-10-24	2016-04-28	Danisco Us Inc.	Method for producing alcohol by use of a tripeptidyl peptidase
RU2741080C2 (ru)	2014-10-24	2021-01-22	ДюПон НЬЮТРИШН БАЙОСАЙЕНСИЗ АпС	Трипептидилпептидазы, способные воздействовать на связи с участием пролина, и их применения
CN107406825B (zh)	2014-11-13	2022-04-08	恩祖迪克控股有限公司	甲壳纲十足目雌性动物的功能性别反转
CN107429291A (zh)	2014-11-17	2017-12-01	耶达研究及发展有限公司	分析微生物组的方法
WO2016079736A2 (en)	2014-11-17	2016-05-26	Yeda Research And Development Co. Ltd.	Methods of treating diseases related to mitochondrial function
RU2758608C2 (ru)	2014-11-19	2021-11-01	Конинклейке Филипс Н.В.	Способ диагностики с использованием hnl
WO2016079739A2 (en)	2014-11-20	2016-05-26	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Compositions and methods for producing polypeptides with a modified glycosylation pattern in plant cells
CN107208070B (zh)	2014-11-26	2021-09-07	技术创新动力基金（以色列）有限合伙公司	细菌基因的靶向消除
KR20170081268A (ko)	2014-11-27	2017-07-11	단지거 이노베이션즈 엘티디.	게놈 편집용 핵산 구조체
WO2016089920A1 (en)	2014-12-01	2016-06-09	The Broad Institute, Inc.	Method for in situ determination of nucleic acid proximity
WO2016089883A1 (en)	2014-12-01	2016-06-09	Novartis Ag	Compositions and methods for diagnosis and treatment of prostate cancer
US10539566B2 (en)	2014-12-08	2020-01-21	Berg Llc	Use of markers including filamin A in the diagnosis and treatment of prostate cancer
EP3230309B1 (en)	2014-12-10	2023-03-29	OPKO Biologics Ltd.	Methods of producing long acting ctp-modified growth hormone polypeptides
CN107209184B (zh)	2014-12-11	2020-04-24	米密德诊断学有限公司	用于诊断多种感染的标记组合及其使用方法
US10688330B2 (en)	2014-12-11	2020-06-23	Yeda Research And Development Co. Ltd.	Isolated phosphotriesterase polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
WO2016103269A1 (en)	2014-12-23	2016-06-30	Ramot At Tel-Aviv University Ltd.	Populations of neural progenitor cells and methods of producing and using same
AR103260A1 (es)	2014-12-23	2017-04-26	4D Pharma Res Ltd	Modulación inmunitaria
EP3400953A1 (en)	2014-12-23	2018-11-14	4D Pharma Research Limited	Pirin polypeptide and immune modulation
EP3916085A1 (en)	2014-12-30	2021-12-01	Cell Cure Neurosciences Ltd.	Assessing retinal pigment epithelial cell populations
EP3240612B1 (en)	2014-12-30	2020-12-23	Cell Cure Neurosciences Ltd.	Methods of treating retinal diseases
CA2972575A1 (en)	2014-12-30	2016-07-07	Cell Cure Neurosciences Ltd.	Rpe cell populations and methods of generating same
US11225648B2 (en)	2015-01-04	2022-01-18	Protalix Ltd.	Modified DNase and uses thereof
WO2016116935A1 (en)	2015-01-21	2016-07-28	Yeda Research And Development Co. Ltd.	Use of rasa2 as a prognostic and therapeutic marker for melanoma
JP6942632B2 (ja)	2015-01-22	2021-09-29	モンサントテクノロジーエルエルシー	Ｌｅｐｔｉｎｏｔａｒｓａ防除用組成物及びその方法
WO2016130516A1 (en)	2015-02-09	2016-08-18	Research Development Foundation	Engineered immunoglobulin fc polypeptides displaying improved complement activation
EP3256165B1 (en)	2015-02-13	2021-07-14	Sorrento Therapeutics, Inc.	Antibody therapeutics that bind ctla4
WO2016134034A1 (en)	2015-02-17	2016-08-25	Dovetail Genomics Llc	Nucleic acid sequence assembly
WO2016138312A2 (en)	2015-02-25	2016-09-01	Vanderbilt University	Antibody-mediated neutralization of marburg virus
WO2016135732A1 (en)	2015-02-26	2016-09-01	Yeda Research And Development Co. Ltd.	Method of promoting hair growth
EP3268038B1 (en)	2015-03-09	2021-05-05	Agensys, Inc.	Antibody drug conjugates (adc) that bind to flt3 proteins
EP3268475B1 (en)	2015-03-11	2020-10-21	Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd.	Decoy oligonucleotides for the treatment of diseases
US11873483B2 (en)	2015-03-11	2024-01-16	The Broad Institute, Inc.	Proteomic analysis with nucleic acid identifiers
IL237852A0 (en)	2015-03-19	2016-03-24	Yeda Res & Dev	Antibodies against amphigoline, medical preparations containing them and their use
US11807896B2 (en)	2015-03-26	2023-11-07	Dovetail Genomics, Llc	Physical linkage preservation in DNA storage
WO2016160618A2 (en)	2015-03-27	2016-10-06	University Of Southern California	Car t-cell therapy directed to lhr for the treatment of solid tumors
US20180064748A1 (en)	2015-03-27	2018-03-08	Yeda Research And Development Co. Ltd.	Methods of treating motor neuron diseases
BR112017021016A2 (pt)	2015-03-31	2018-07-03	Yeda Research And Development Co Ltd	preparação de proteína, composição farmacêutica, proteína de fusão, polinucleotídeo isolado, estrutura de ácido nucleico, método para tratamento de doença ou condição associada ao excesso de glutamato, e método de purificação de um polipeptídeo
US9612534B2 (en)	2015-03-31	2017-04-04	Tokyo Electron Limited	Exposure dose homogenization through rotation, translation, and variable processing conditions
US10960035B2 (en)	2015-04-01	2021-03-30	The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Voleaui Center)	Erodium crassifolium L'Her plant extracts and uses thereof
CN114716390A (zh)	2015-04-07	2022-07-08	Ela制药有限公司	用于治疗和/或预防细胞或组织坏死的组合物和方法
US9951144B2 (en)	2015-04-08	2018-04-24	Sorrento Therapeutics, Inc.	Antibody therapeutics that bind CD38
EP3081575A1 (en)	2015-04-12	2016-10-19	Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.	Anti-plasmodium parasite antibodies
IL255290B2 (en)	2015-04-27	2024-01-01	Medical Res Infrastructure & Health Services Fund Tel Aviv Medical Ct	Substances that bind to EGF1 and their use in the treatment of inflammatory diseases and tumors
CA2984202A1 (en)	2015-04-29	2016-11-03	The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center)	Anti-phytopathogenic compositions
WO2016174652A1 (en)	2015-04-30	2016-11-03	Technion Research & Development Foundation Limited	Chimeric antigen receptors and methods of their use
WO2016178207A1 (en)	2015-05-04	2016-11-10	Ramot At Tel-Aviv University Ltd.	Methods and kits for fragmenting dna
EP3091026B1 (en)	2015-05-08	2019-02-20	Centrillion Technology Holdings Corporation	Disulfide-linked reversible terminators
EP3294280A1 (en)	2015-05-11	2018-03-21	Yeda Research and Development Co., Ltd.	Citrin inhibitors for the treatment of cancer
US11219636B2 (en)	2015-05-17	2022-01-11	The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center	Compositions and methods for treating cancer
WO2016187354A1 (en)	2015-05-18	2016-11-24	Agensys, Inc.	Antibodies that bind to axl proteins
EP4679095A3 (en)	2015-05-18	2026-05-06	Agensys, Inc.	Antibodies that bind to axl proteins
WO2016185457A1 (en)	2015-05-19	2016-11-24	Yeda Research And Development Co. Ltd.	Methods of promoting lymphangiogenesis
WO2016185481A2 (en)	2015-05-20	2016-11-24	Yeda Research And Development Co. Ltd.	Method of targeting senescent cells
EA201792547A1 (ru)	2015-05-21	2018-04-30	Иеда Рисеч Энд Девелопмент Ко. Лтд.	Популяции бактерий для стимуляции состояния здоровья
KR20180014754A (ko)	2015-05-29	2018-02-09	옵코 바이오로직스 리미티드	페길화된 옥신토모둘린 변이체
US10883103B2 (en)	2015-06-02	2021-01-05	Monsanto Technology Llc	Compositions and methods for delivery of a polynucleotide into a plant
EP3302030A4 (en)	2015-06-03	2019-04-24	Monsanto Technology LLC	METHOD AND COMPOSITIONS FOR INTRODUCING NUCLEIC ACIDS IN PLANTS
WO2016197064A1 (en)	2015-06-04	2016-12-08	Epstein Alan L	Lym-1 and lym-2 targeted car cell immunotherapy
NL2014935B1 (en)	2015-06-08	2017-02-03	Applied Immune Tech Ltd	T cell receptor like antibodies having fine specificity.
WO2016203221A1 (en)	2015-06-15	2016-12-22	4D Pharma Research Limited	Compositions comprising bacterial strains
NZ737752A (en)	2015-06-15	2022-02-25	4D Pharma Res Ltd	Compositions comprising bacterial strains
SMT201900588T1 (it)	2015-06-15	2019-11-13	4D Pharma Res Limited	Blautia stercoris e wexlerae per uso nel trattamento di malattie infiammatorie ed autoimmuni
MA41010B1 (fr)	2015-06-15	2020-01-31	4D Pharma Res Ltd	Compositions comprenant des souches bactériennes
MA41060B1 (fr)	2015-06-15	2019-11-29	4D Pharma Res Ltd	Compositions comprenant des souches bactériennes
WO2016203476A1 (en)	2015-06-18	2016-12-22	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Methods and compositions for diagnosing and treating urothelial cancer
EP4026563B1 (en)	2015-06-18	2025-10-29	Yeda Research and Development Co. Ltd	Conditioning protocols and use of same for tissue regeneration
PL3310347T3 (pl)	2015-06-19	2021-12-27	Opko Biologics Ltd.	Długo działające czynniki krzepnięcia i sposoby wytwarzania
EP3314004A1 (en)	2015-06-26	2018-05-02	DuPont Nutrition Biosciences ApS	Aminopeptidases for protein hydrolyzates
AU2016291558A1 (en)	2015-07-10	2018-02-08	West Virginia University	Markers of stroke and stroke severity
US10786547B2 (en)	2015-07-16	2020-09-29	Biokine Therapeutics Ltd.	Compositions, articles of manufacture and methods for treating cancer
EP3322424B1 (en)	2015-07-16	2023-10-11	Yeda Research and Development Co., Ltd.	Use of anti third party central memory t cells
WO2017013648A1 (en)	2015-07-19	2017-01-26	Yeda Research And Development Co. Ltd.	SELECTIVE INHIBITORS OF Alpha2-CONTAINING ISOFORMS OF Na,K-ATPase AND USE THEREOF FOR REDUCTION OF INTRAOCULAR PRESSURE
WO2017015334A1 (en)	2015-07-21	2017-01-26	Saint Louis University	Compositions and methods for diagnosing and treating endometriosis-related infertility
JP6976242B2 (ja)	2015-07-22	2021-12-08	フィトファーマインターナショナルリミテッドPhytopharma International Ltd.	ハナバチ摂取組成物、ハチミツの製造におけるその使用方法、およびそれにより製造されたハチミツ
WO2017017686A1 (en)	2015-07-29	2017-02-02	Hadasit Medical Research Services And Development Ltd.	Large scale production of retinal pigment epithelial cells
ES2965461T3 (es)	2015-08-03	2024-04-15	Biokine Therapeutics Ltd	Inhibidor de CXCR4 para el tratamiento del cáncer
WO2017021961A1 (en)	2015-08-04	2017-02-09	Yeda Research And Development Co. Ltd.	Methods of screening for riboswitches and attenuators
CN108136051A (zh)	2015-08-04	2018-06-08	Cd诊断股份有限公司	检测不良局部组织反应(altr)坏死的方法
EP3331995A1 (en)	2015-08-05	2018-06-13	Cell Cure Neurosciences Ltd.	Preparation of photoreceptors for the treatment of retinal diseases
US11066642B2 (en)	2015-08-05	2021-07-20	Cell Cure Neurosciences Ltd	Preparation of retinal pigment epithelium cells
EP3331549B1 (en)	2015-08-06	2020-12-23	President and Fellows of Harvard College	Improved microbe-binding molecules and uses thereof
EP3334449B1 (en)	2015-08-10	2021-09-29	The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center	Methods and pharmaceutical compositions for improving wound healing using cd24
EP3334831A1 (en)	2015-08-13	2018-06-20	Forrest Innovations Ltd.	Formulations and compositions for delivery of nucleic acids to plant cells
WO2017031370A1 (en)	2015-08-18	2017-02-23	The Broad Institute, Inc.	Methods and compositions for altering function and structure of chromatin loops and/or domains
WO2017033188A1 (en)	2015-08-24	2017-03-02	Yeda Research And Development Co. Ltd.	Algal oil and biofuel and methods of producing same
EP3341725B1 (en)	2015-08-25	2021-08-18	Prothena Biosciences Limited	Methods for detecting phosphorylated alpha-synuclein
US10526408B2 (en)	2015-08-28	2020-01-07	Research Development Foundation	Engineered antibody FC variants
US11390908B2 (en)	2015-09-02	2022-07-19	University Of Massachusetts	Detection of gene loci with CRISPR arrayed repeats and/or polychromatic single guide ribonucleic acids
US10765706B2 (en)	2015-09-03	2020-09-08	University Of South Florida	Method of stem cell delivery into the brain during chronic disease using blood brain barrier permeabilizers
CA3036409C (en)	2015-09-08	2023-07-11	Erik J. Sontheimer	Dnase h activity of neisseria meningitidis cas9
WO2017042814A1 (en)	2015-09-10	2017-03-16	Yeda Research And Development Co. Ltd.	Use of perforin positive immature dendritic cells in disease treatment
WO2017053567A1 (en)	2015-09-22	2017-03-30	Delta Tm Technologies	Designing customized protein-specific buffer systems
WO2017059108A1 (en)	2015-09-29	2017-04-06	Htg Molecular Diagnostics, Inc.	Methods for subtyping diffuse b-cell lymphoma (dlbcl)
WO2017062953A1 (en)	2015-10-10	2017-04-13	Intrexon Corporation	Improved therapeutic control of proteolytically sensitive, destabilized forms of interleukin-12
EP3362462B1 (en)	2015-10-12	2021-07-21	Advanced Cell Diagnostics, Inc.	In situ detection of nucleotide variants in high noise samples, and compositions and methods related thereto
CA3002740A1 (en)	2015-10-19	2017-04-27	Dovetail Genomics, Llc	Methods for genome assembly, haplotype phasing, and target independent nucleic acid detection
WO2017072757A1 (en)	2015-10-25	2017-05-04	Yeda Research And Development Co. Ltd.	Antibodies targeting quiescin sulfhydryl oxidase (qsox1) and uses of same
JP6987769B2 (ja)	2015-10-26	2022-01-05	セルキュアニューロサイエンシズリミテッド	網膜色素上皮細胞の調製法
EP3368024B1 (en)	2015-10-27	2023-09-20	Akos Biosciences, Inc.	Compositions comprising cannabidiol and second therapeutic agents for the treatment of cancer
IL242380A0 (en)	2015-10-29	2016-02-01	Yeda Res & Dev	A method of inducing cardiomyocytes proliferation and treating heart diseases
US20180303974A1 (en)	2015-11-03	2018-10-25	Ariel-University Research And Development Company Ltd.	Compositions for regeneration and repair of neural tissue
RS65666B1 (sr)	2015-11-09	2024-07-31	Childrens Hospital Philadelphia	Glipikan 2 kao tumor marker i terapijski cilj
EP3374524B1 (en)	2015-11-11	2025-01-29	Ramot at Tel-Aviv University Ltd.	Methods of detecting 5-hydroxymethylcytosine and diagnosing of cancer
CN108513545B (zh)	2015-11-20	2020-11-03	4D制药研究有限公司	包含细菌菌株的组合物
GB201520497D0 (en)	2015-11-20	2016-01-06	4D Pharma Res Ltd	Compositions comprising bacterial strains
GB201520638D0 (en)	2015-11-23	2016-01-06	4D Pharma Res Ltd	Compositions comprising bacterial strains
GB201520631D0 (en)	2015-11-23	2016-01-06	4D Pharma Res Ltd	Compositions comprising bacterial strains
HK1254740A1 (zh)	2015-11-30	2019-07-26	Kadimastem Ltd.	分化和纯化胰腺内分泌细胞的方法
EP3383911B1 (en)	2015-12-02	2021-01-20	STCube & Co. Inc.	Antibodies and molecules that immunospecifically bind to btn1a1 and the therapeutic uses thereof
EP3383908A1 (en)	2015-12-02	2018-10-10	Stsciences, Inc.	Antibodies specific to glycosylated btla (b- and t- lymphocyte attenuator)
EP3176183A1 (en)	2015-12-02	2017-06-07	Yeda Research and Development Co. Ltd	Compositions and methods for treating cancer not resistant to a tyrosine kinase inhibitor (tki)
CA3007301A1 (en)	2015-12-04	2017-06-08	Board Of Regents, The University Of Texas System	Slc45a2 peptides for immunotherapy
EP4059507B1 (en)	2015-12-16	2024-06-05	Ramot at Tel-Aviv University Ltd.	Particles comprising decellularized omentum
PH12018501207B1 (en)	2015-12-21	2024-02-23	Novartis Ag	Compositions and methods for decreasing tau expression
EP3393524B1 (en)	2015-12-22	2022-04-06	The Regents of The University of Colorado, A Body Corporate	Protecting rnas from degradation using engineered viral rnas
WO2017115367A1 (en)	2015-12-28	2017-07-06	The National Institute for Biotechnology in the Negev Ltd.	Composition and method for treating amyotrophic lateral sclerosis
US10828318B2 (en)	2016-01-06	2020-11-10	Yeda Research And Development Co. Ltd.	Compositions and methods for treating malignant, autoimmune and inflammatory diseases
EP3403091B1 (en)	2016-01-11	2021-12-22	Technion Research & Development Foundation Limited	Methods of determining prognosis of sepsis and treating same
JP7019580B2 (ja)	2016-01-21	2022-02-15	ザステイトオブイスラエルミニストリーオブアグリカルチャーアンドルーラルディベロップメントアグリカルチュラルリサーチオーガニゼイション（エー．アール．オー．）（ボルカニセンター）	単為結実植物およびその製造方法
IL243839B (en)	2016-01-28	2018-01-31	Sp Nano Ltd	Conductive wires
IL243838A (en)	2016-01-28	2017-07-31	Sp Nano Ltd	The composition containing sp1 protein and carbon nanoparticles and its uses
WO2017132562A1 (en)	2016-01-29	2017-08-03	Heyue Zhou	Antigen binding proteins that bind pd-l1
US11261433B2 (en)	2016-01-31	2022-03-01	Hadasit Medical Research Services And Development Ltd.	Autosomal-identical pluripotent stem cell populations having non-identical sex chromosomal composition and uses thereof
CN108884137B (zh)	2016-02-04	2022-04-05	耶达研究及发展有限公司	肽及其在治疗与突变型p53相关的疾病、病症或病况中的用途
WO2017139415A2 (en)	2016-02-11	2017-08-17	Qiagen Waltham, Inc.	Scavenger compounds for improved sequencing-by-synthesis
EP3414338B1 (en)	2016-02-11	2022-12-21	Qiagen Sciences, LLC	Polyphenolic additives in sequencing-by-synthesis
EP3414346B1 (en)	2016-02-14	2019-11-13	Yeda Research and Development Co. Ltd.	Microbiome-based diagnosis, prediction and treatment of relapsing obesity
WO2017138008A2 (en)	2016-02-14	2017-08-17	Yeda Research And Development Co. Ltd.	Methods of modulating protein exocytosis and uses of same in therapy
WO2017141253A1 (en)	2016-02-16	2017-08-24	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Non-protein phenylalanine analogues for inhibiting cyanobacteria and plant growth
EP3416671A4 (en)	2016-02-19	2019-10-30	Genisphere, LLC	NUCLEIC ACID CARRIER AND THERAPEUTIC METHODS OF USE
US20200200735A9 (en)	2016-02-22	2020-06-25	Ursure, Inc.	System and method for detecting therapeutic agents to monitor adherence to a treatment regimen
EP3420075A4 (en)	2016-02-23	2019-10-16	Chaya Brodie	GENERATION OF CANCER STEM CELLS AND USE THEREOF
SG11201807117WA (en)	2016-02-23	2018-09-27	Dovetail Genomics Llc	Generation of phased read-sets for genome assembly and haplotype phasing
CA3013383A1 (en)	2016-02-25	2017-08-31	Dupont Nutrition Biosciences Aps	Method for producing a protein hydrolysate employing an aspergillus fumigatus tripeptidyl peptidase
EP3419998A4 (en)	2016-02-26	2019-09-25	The Board of Regents of The University of Texas System	CONNEXIN (CX) 43 HEMICANAL BINDING ANTIBODIES AND USES THEREOF
CA3015619A1 (en)	2016-03-01	2017-09-08	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Antibodies specific to human poliovirus receptor (pvr)
IL294121B2 (en)	2016-03-03	2023-09-01	Memed Diagnostics Ltd	An RNA test to diagnose the type of infection
ME03487B (me)	2016-03-04	2020-01-20	4D Pharma Plc	Kompozicije koje sadrže blautia bakterijske sojeve za liječenje visceralne hipersenzitivnosti
GB201612191D0 (en)	2016-07-13	2016-08-24	4D Pharma Plc	Compositions comprising bacterial strains
US20190216891A1 (en)	2016-03-06	2019-07-18	Yeda Research And Development Co., Ltd.	Method for modulating myelination
IL244649A0 (en)	2016-03-17	2016-06-30	Yeda Res & Dev	Methods for the isolation of barrel-like proteases and the identification of peptides that are cleaved by Alidan
KR20240095481A (ko)	2016-03-17	2024-06-25	세다르스-신나이 메디칼 센터	Rnaset2를 통한 염증성 장 질환의 진단 방법
WO2017165438A1 (en)	2016-03-25	2017-09-28	Muralidhar Reddy Moola	Combinatorial synthesis and biomarker development
ES2883297T3 (es)	2016-03-29	2021-12-07	Stcube Inc	Anticuerpos de función doble específicos para PD-L1 glucosilado y métodos de uso de los mismos
EP3436480A4 (en)	2016-03-30	2019-11-27	Musc Foundation for Research Development	METHOD FOR THE TREATMENT AND DIAGNOSIS OF CANCER BY TARGETING GLYCOPROTEIN A REPETITION PREDOMINANT (GARP) AND FOR EFFECTIVE IMMUNOTHERAPY ALONE OR IN COMBINATION
WO2017175228A1 (en)	2016-04-06	2017-10-12	Technion Research & Development Foundation Limited	Infiltrating immune cell proportions predict anti-tnf response in colon biopsies
EP3448998B1 (en)	2016-04-27	2020-06-03	Gen-Probe Incorporated	Blood cell lysis reagent
WO2017194589A1 (en)	2016-05-10	2017-11-16	Vib Vzw	Inhibition of tau-mediated early synaptic dysfunction
KR102412442B1 (ko)	2016-05-13	2022-06-22	더브테일 제노믹스 엘엘씨	보존된 샘플로부터의 장범위 링키지 정보의 회수
CA3024490A1 (en)	2016-05-16	2017-11-23	President And Fellows Of Harvard College	Aqueous biomolecule coupling on co2-plasma-activated surfaces
EP3463402B1 (en)	2016-05-22	2021-06-23	Yeda Research and Development Co. Ltd.	Methods of using pulmonary cells for transplantation and induction of tolerance
IL245861A0 (en)	2016-05-25	2016-09-04	Yeda Res & Dev	Use of substances to treat drug-resistant tumors
WO2017201731A1 (en)	2016-05-27	2017-11-30	Beijing Vdjbio Co., Ltd.	Antibodies, composition and kits comprising same, and methods of use thereof
US20190100732A1 (en)	2016-06-02	2019-04-04	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Assay for the removal of methyl-cytosine residues from dna
US20200185063A1 (en)	2016-06-05	2020-06-11	Berg Llc	Systems and methods for patient stratification and identification of potential biomarkers
US11820833B2 (en)	2016-06-05	2023-11-21	Tel Hashomer Medical Research Infrastructure And Services Ltd.	Peptides that inhibit binding of EPCR to its ligand to treat inflammation
EP3468610A1 (en)	2016-06-09	2019-04-17	OPKO Biologics Ltd.	Long-acting oxyntomodulin formulation and methods of producing and administering same
EP3472342A1 (en)	2016-06-19	2019-04-24	Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.	Screening for chemotherapy resistance in human haploid cells
WO2017222911A1 (en)	2016-06-20	2017-12-28	The Board Of Trustees Of The Leland Stanford Junior University	Circular rnas and their use in immunomodulation
IL263924B2 (en)	2016-06-27	2025-03-01	Yeda Res & Dev	Voto cells produced from memory T cells
WO2018001932A1 (en)	2016-06-30	2018-01-04	Koninklijke Philips N.V.	Device, system and method for detecting an analyte in a body fluid sample containing a plurality of cells
WO2018011796A1 (en)	2016-07-10	2018-01-18	Memed Diagnostics Ltd.	Early diagnosis of infections
CA3027341A1 (en)	2016-07-10	2018-01-18	Memed Diagnostics Ltd.	Protein signatures for distinguishing between bacterial and viral infections
IL246722A0 (en)	2016-07-11	2016-09-29	Yeda Res & Dev	Combination therapy to increase endogenous nitric oxide (no) synthesis
IL264205B2 (en)	2016-07-11	2023-12-01	Bonus Therapeutics Ltd	Cellular compounds for tissue regeneration
MY206271A (en)	2016-07-11	2024-12-06	Opko Biologics Ltd	Long-acting coagulation factor vii and methods of producing same
EP3481191A2 (en)	2016-07-11	2019-05-15	Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd.	Systems and methods for growing cells in vitro
TWI802545B (zh)	2016-07-13	2023-05-21	英商４Ｄ製藥有限公司	包含細菌菌株之組合物
US11708421B2 (en)	2016-07-18	2023-07-25	Ramot At Tel-Aviv University Ltd.	Modular platform for targeted therapeutics
CN109715666B (zh)	2016-07-20	2023-02-21	斯特库比股份有限公司	癌症治疗方法和使用结合糖基化pd-l1的抗体的组合的疗法
EP3488242B1 (en)	2016-07-20	2025-06-11	Vib Vzw	Therapeutic agents for neurological and psychiatric disorders
US20190203270A1 (en)	2016-07-24	2019-07-04	Yeda Research And Development Co., Ltd.	Methods and kits for analyzing dna binding moieties attached to dna
ES2965761T3 (es)	2016-08-08	2024-04-16	Tech Innovation Momentum Fund Israel Limited Partnership	Sistemas bacterianos para el análisis de polipéptidos ubiquitilados
EP3504553B1 (en)	2016-08-10	2022-04-20	Memed Diagnostics Ltd.	System and method for analysis of biological data
WO2018029693A1 (en)	2016-08-10	2018-02-15	Ramot At Tel-Aviv University Ltd.	Analysis of methylation status and copy number
IL264825B (en)	2016-08-14	2022-08-01	Univ Ramot	Mesenchymal cell-derived exosomes to treat neurological disorders
IL247368A0 (en)	2016-08-18	2016-11-30	Yeda Res & Dev	Diagnostic and therapeutic uses of exosomes
WO2018037416A1 (en)	2016-08-25	2018-03-01	Yeda Research And Development Co. Ltd.	Methods and compositions for treating autoimmune diseases
BR112019004180A2 (pt)	2016-08-28	2019-05-28	The State Of Israel Ministry Of Agriculture & Rural Development Agricultural Res Organization A R O	método de controle de infecções fúngicas em plantas.
WO2018047154A1 (en)	2016-09-07	2018-03-15	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Anti-nkp46 antibodies and therapeutic use of same
WO2018051347A1 (en)	2016-09-14	2018-03-22	Yeda Research And Development Co. Ltd.	Crisp-seq, an integrated method for massively parallel single cell rna-seq and crispr pooled screens
US11385241B2 (en)	2016-09-29	2022-07-12	Memed Diagnostics Ltd.	Methods of prognosis and treatment
IL248468A0 (en)	2016-10-13	2017-01-31	Technion Res & Dev Foundation	Use of caspase-3 inhibitors and caspase-3 activators in the manufacture of medicament for treating cancer and wound healing
IL248385A0 (en)	2016-10-18	2017-02-01	Yeda Res & Dev	Treatment of circadian rhythm disorder
EP3534953A4 (en)	2016-11-02	2020-10-07	Vanderbilt University	ANTIBODIES AGAINST HUMAN ZIKA VIRUS AND THEIR USE PROCEDURES
EP3535409B1 (en)	2016-11-04	2024-03-20	CD Diagnostics, Inc.	Direct detection of microorganisms in patient samples by immunoassay
JP7075937B2 (ja)	2016-11-09	2022-05-26	キアゲンサイエンシーズ，エルエルシー	Ｓｅｑｕｅｎｃｉｎｇ－Ｂｙ－Ｓｙｎｔｈｅｓｉｓ法におけるイメージング試薬としての光防護性混合物
US20190359956A1 (en)	2016-11-10	2019-11-28	Yeda Research And Development Co. Ltd.	Phosphotriesterases for treating or preventing organophosphate exposure associated damage
RU2765737C2 (ru)	2016-11-23	2022-02-02	Хемоцентрикс, Инк.	Способ лечения фокально-сегментарного гломерулосклероза
CN110234765A (zh)	2016-11-28	2019-09-13	耶达研究及发展有限公司	分离的多核苷酸和多肽及使用它们来表达感兴趣的表达产物的方法
CN110199031A (zh)	2016-11-29	2019-09-03	基因组影像公司	设计用于分析感兴趣的遗传区域中的特定事件的一组多核苷酸序列的方法
WO2018100574A1 (en)	2016-11-30	2018-06-07	Yeda Research And Development Co. Ltd.	Methods of treating liver toxicity and disorders
KR20190091192A (ko)	2016-12-01	2019-08-05	라모트 앳 텔-아비브 유니버시티 리미티드	신경 손상의 병용 치료제
MX388822B (es)	2016-12-05	2025-03-20	Nuritas Ltd	Composiciones que comprenden peptido wkdeagkplvk.
EP3329930A1 (en)	2016-12-05	2018-06-06	Nuritas Limited	Pharmaceuctical compositions
EP3329905A1 (en)	2016-12-05	2018-06-06	Nuritas Limited	Topical cosmetic compositions comprising an oligopeptide against anti-aging of the skin
GB201621123D0 (en)	2016-12-12	2017-01-25	4D Pharma Plc	Compositions comprising bacterial strains
ES3064681T3 (en)	2017-01-18	2026-04-28	Yeda Res And Development Co Ltd	Genetically modified veto cells and use of same in immunotherapy
US11519914B2 (en)	2017-01-25	2022-12-06	St Innovative Diagnostics Ltd	Methods of diagnosing malignant diseases
AU2018213315A1 (en)	2017-01-26	2019-07-25	Oklahoma Medical Research Foundation	Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare
WO2018137705A1 (en)	2017-01-26	2018-08-02	Zai Lab (Shanghai) Co., Ltd.	Cd47 antigen binding unit and uses thereof
CA3051466A1 (en)	2017-01-31	2018-08-09	Vanderbilt University	Generation of human allergen-and helminth-specific ige monoclonal antibodies for diagnostic and therapeutic use
IL250479A0 (en)	2017-02-06	2017-03-30	Sorek Rotem	Genetically engineered cells expressing a disarm system that confers resistance to phages and methods for their production
WO2018146162A1 (en)	2017-02-07	2018-08-16	Academisch Medisch Centrum	Molecular biomarker for prognosis of sepsis patients
CN110520139A (zh)	2017-02-08	2019-11-29	哈达西特医疗研究服务和开发有限公司	用于治疗视网膜疾病的感光细胞
IL250916A0 (en)	2017-03-02	2017-06-29	Geiger Benjamin	Methods for growing t cells in culture and their use
WO2018163051A1 (en)	2017-03-06	2018-09-13	Novartis Ag	Methods of treatment of cancer with reduced ubb expression
US20200150125A1 (en)	2017-03-12	2020-05-14	Yeda Research And Development Co., Ltd.	Methods of diagnosing and prognosing cancer
WO2018167780A1 (en)	2017-03-12	2018-09-20	Yeda Research And Development Co. Ltd.	Methods of prognosing and treating cancer
WO2018170494A1 (en)	2017-03-16	2018-09-20	Bio Time, Inc.	Methods for measuring therapeutic effects of retinal disease therapies
WO2018185760A1 (en)	2017-04-05	2018-10-11	Yeda Research And Development Co. Ltd.	Ex-vivo culture system and methods of using same
IL252151A0 (en)	2017-05-07	2017-07-31	Fainzilber Michael	Treatment of stress disorders
WO2018207184A2 (en)	2017-05-10	2018-11-15	Ariel Scientific Innovations Ltd.	Methods of purifying antibodies
EP3622291A4 (en)	2017-05-10	2021-04-21	Rowan University	Diagnostic biomarkers for detecting, subtyping, and/or assessing progression of multiple sclerosis
WO2018216006A1 (en)	2017-05-21	2018-11-29	The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center	Combination of markers for diagnosing cancer
DK3630136T3 (da)	2017-05-22	2021-05-25	4D Pharma Res Ltd	Sammensætninger, der omfatter bakteriestammer
WO2018216011A1 (en)	2017-05-23	2018-11-29	Technion Research & Development Foundation Limited	Agents which inhibit gads dimerization and methods of use thereof
EP3630942B1 (en)	2017-05-24	2022-11-30	4D Pharma Research Limited	Compositions comprising bacterial strain
CN111051346A (zh)	2017-05-31	2020-04-21	斯特库伯株式会社	使用免疫特异性结合btn1a1的抗体和分子治疗癌症的方法
KR20200015602A (ko)	2017-05-31	2020-02-12	주식회사 에스티큐브앤컴퍼니	Btn1a1에 면역특이적으로 결합하는 항체 및 분자 및 이의 치료적 용도
WO2018220582A1 (en)	2017-05-31	2018-12-06	Tropic Biosciences UK Limited	Methods of selecting cells comprising genome editing events
GB201708665D0 (en)	2017-05-31	2017-07-12	Tropic Biosciences Uk Ltd	Compositions and methods for increasing extractability of solids from coffee beans
GB201708662D0 (en)	2017-05-31	2017-07-12	Tropic Biosciences Uk Ltd	Compositions and methods for increasing shelf-life of banana
KR20200026209A (ko)	2017-06-06	2020-03-10	주식회사 에스티큐브앤컴퍼니	Btn1a1 또는 btn1a1-리간드에 결합하는 항체 및 분자를 사용하여 암을 치료하는 방법
WO2018229764A1 (en)	2017-06-13	2018-12-20	Yeda Research And Development Co. Ltd.	Treatment of advanced or progressive multiple sclerosis
SMT202000695T1 (it)	2017-06-14	2021-01-05	4D Pharma Res Limited	Composizioni comprendenti ceppi batterici
SMT202000555T1 (it)	2017-06-14	2020-11-10	4D Pharma Res Limited	Composizioni comprendenti un ceppo batterico del genere megaspaera e loro usi
CA3066189A1 (en)	2017-06-14	2018-12-20	4D Pharma Research Limited	Compositions comprising bacterial strains
US12140592B2 (en)	2017-06-16	2024-11-12	Oklahoma Medical Research Foundation	Biomarkers for assessing risk of transitioning to systemic lupus erythematosus classification and disease pathogenesis
WO2019012544A1 (en)	2017-07-13	2019-01-17	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	STRATEGY FOR DOUBLE PROBE DROPLETS FOR SPECIFIC DETECTION OF CIRCULATING DNA MOLECULES SPECIFIC TO A TISSUE
WO2019012542A1 (en)	2017-07-13	2019-01-17	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	DETECTION OF SPECIFIC DNA FROM A FABRIC
EP3652344A1 (en)	2017-07-13	2020-05-20	Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd.	Dna targets as tissue-specific methylation markers
WO2019018747A1 (en)	2017-07-20	2019-01-24	Trustees Of Boston University	DETECTION ASSAY OF TENOFOVIR
US11530413B2 (en)	2017-07-21	2022-12-20	Novartis Ag	Compositions and methods to treat cancer
IL253642A0 (en)	2017-07-24	2017-09-28	Seger Rony	Combined treatment for cancer
WO2019030759A1 (en)	2017-08-08	2019-02-14	Technology Innovation Momentum Fund (Israel) Limited Partnership	CHLORAMPHENICOL-RESISTANT TRUNCATED PROTEIN AND USES THEREOF
IL253984A0 (en)	2017-08-14	2017-09-28	Yeda Res & Dev	Immunotherapy against aranviruses that bind through transferrin receptor 1 (tfr1
IL272810B2 (en)	2017-08-21	2025-10-01	Savicell Diagnostic Ltd	Methods for diagnosing and treating lung cancer
WO2019038771A1 (en)	2017-08-23	2019-02-28	Technion Research & Development Foundation Limited	COMPOSITIONS AND METHODS FOR ENHANCING ALCOHOL TOLERANCE IN YEAST
US11306144B2 (en)	2017-08-25	2022-04-19	Five Prime Therapeutics, Inc.	B7-H4 antibodies and methods of use thereof
CN110799546B (zh)	2017-09-01	2023-01-24	四川科伦博泰生物医药股份有限公司	重组双特异性抗体
EP3679129A1 (en)	2017-09-05	2020-07-15	GLAdiator Biosciences, Inc.	A method of intracellular delivery
DE112018005145T5 (de)	2017-09-15	2020-07-23	The Regents Of The University Of California	Hemmung von aminoacylase 3 (aa3) bei der behandlung von krebs
JP2020536580A (ja)	2017-09-19	2020-12-17	ザステートオブイスラエル，ミニストリーオブアグリカルチャーアンドルーラルディヴェロプメント，アグリカルチュラルリサーチオーガニゼーション（エーアールオー）（ボルカニセンター）	ゲノム編集された鳥
SG11202002481RA (en)	2017-09-19	2020-04-29	Tropic Biosciences Uk Ltd	Modifying the specificity of non-coding rna molecules for silencing gene expression in eukaryotic cells
CN111868039A (zh)	2017-09-26	2020-10-30	加利福尼亚大学董事会	用于治疗癌症的组合物和方法
WO2019071054A1 (en)	2017-10-04	2019-04-11	The Broad Institute, Inc.	METHODS AND COMPOSITIONS FOR MODIFYING THE FUNCTION AND STRUCTURE OF BUCKLES AND / OR CHROMATIN DOMAINS
RU2020113612A (ru)	2017-10-11	2021-11-12	Хемоцентрикс, Инк.	Лечение фокально-сегментарного гломерулосклероза антагонистами ccr2
US11525002B2 (en)	2017-10-11	2022-12-13	Board Of Regents, The University Of Texas System	Human PD-L1 antibodies and methods of use therefor
JP2021500878A (ja)	2017-10-12	2021-01-14	ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム	免疫療法のためのｔ細胞受容体
EP3700543A4 (en)	2017-10-24	2021-08-25	Elani, Dalia	ISCHEMIC DISEASE TREATMENT METHODS
EP3706795A4 (en)	2017-11-09	2021-10-13	Pinteon Therapeutics Inc.	METHODS AND COMPOSITIONS FOR GENERATING AND USING HUMANIZED CONFORMATION SPECIFIC PHOSPHORYLATED TAU ANTIBODIES
IL255664A0 (en)	2017-11-14	2017-12-31	Shachar Idit	Hematopoietic stem cells with enhanced properties
BR112020010830A2 (pt)	2017-11-29	2020-11-10	Weedout Ltd.	composições, kits e métodos para controlar erva daninha do gênero amaranthus
IL274979B2 (en)	2017-11-29	2024-07-01	Univ Ramot	Methods for the prevention and treatment of neurogenic seizures
WO2019106680A1 (en)	2017-12-03	2019-06-06	Yeda Research And Development Co. Ltd.	Treatment of an ischemic heart disease
CN109870581B (zh)	2017-12-04	2021-05-04	厦门万泰凯瑞生物技术有限公司	一种定量检测HBsAg的试剂盒及方法
US11714090B2 (en)	2017-12-15	2023-08-01	Syngenta Participations Ag	Non-antibody ligands for detecting target proteins
EP3723785A1 (en)	2017-12-17	2020-10-21	Yeda Research and Development Co. Ltd	Cop9 signalosome (csn) complex modulators and uses thereof
WO2019130313A1 (en)	2017-12-28	2019-07-04	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Method to reproduce circadian rhythms on a microfluidic chip
WO2019130061A2 (en)	2017-12-29	2019-07-04	Cell Cure Neurosciences Ltd.	Retinal pigment epithelium cell compositions
US11851478B2 (en)	2018-01-05	2023-12-26	Vanderbilt University	Antibody-mediated neutralization of chikungunya virus
CA3087291A1 (en)	2018-01-29	2019-08-01	Lavie Bio Ltd.	Plant microbial preparations, compositions and formulations comprising same and uses thereof
IL257225A (en)	2018-01-29	2018-04-09	Yeda Res & Dev	Treatment of sarcoma
IL257269A (en)	2018-01-31	2018-04-09	Olender Tsviya	Signaling is directed to the endoplasmic reticulum
EP3746566A1 (en)	2018-01-31	2020-12-09	Dovetail Genomics, LLC	Sample prep for dna linkage recovery
WO2019155465A1 (en)	2018-02-08	2019-08-15	Yeda Research And Development Co. Ltd.	Methods of identifying and using agents for treating diseases associated with intestinal barrier dysfunction
WO2019155459A1 (en)	2018-02-08	2019-08-15	Yeda Research And Development Co. Ltd.	Inhibitors of the 20s proteasome
WO2019155041A1 (en)	2018-02-12	2019-08-15	Vib Vzw	Gβγ COMPLEX ANTIBODIES AND USES THEREOF
BR112020016986A2 (pt)	2018-02-21	2021-03-02	Five Prime Therapeutics, Inc.	formulações de anticorpo contra b7-h4
WO2019165217A1 (en)	2018-02-22	2019-08-29	The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Cd153 and/or cd30 in infection
EP3755340A4 (en)	2018-02-23	2021-11-17	Carmel-Haifa University Economic Corporation Ltd.	METHODS OF TREATING MEMORY DISORDER AND COGNITIVE DYSFUNCTION
EP3759493A1 (en)	2018-02-28	2021-01-06	The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center	Methods of diagnosing and treating bladder cancer
KR20200144094A (ko)	2018-03-02	2020-12-28	파이브 프라임 테라퓨틱스, 인크.	B7-h4 항체 및 이의 사용 방법
WO2019175869A1 (en)	2018-03-12	2019-09-19	Yeda Research And Development Co. Ltd	Treatment of a heart disease
CN119930831A (zh)	2018-03-14	2025-05-06	纪念斯隆凯特琳癌症中心	抗聚唾液酸抗体及其用途
EP4501355A3 (en)	2018-03-23	2025-04-30	Board Of Regents, The University Of Texas System	Dual specificity antibodies to pd-l1 and pd-l2 and methods of use therefor
SG11202009258RA (en)	2018-03-23	2020-10-29	Univ Texas	Dual specificity antibodies to human pd-l1 and pd-l2 and methods of use therefor
US11648260B2 (en)	2018-03-29	2023-05-16	Technion Research And Development Foundation Limitted	Vesicles comprising a PTEN inhibitor and uses of same
IL258467A (en)	2018-03-29	2018-07-04	Ilana Kolodkin Gal	Methods of disrupting a biofilm and/or preventing formation of same
EP3774047A1 (en)	2018-03-29	2021-02-17	Yeda Research and Development Co. Ltd	Use of electric field gradients to control gene expression
EP4063519B1 (en)	2018-04-09	2023-09-13	Advanced Cell Diagnostics, Inc.	Methods to further enhance signal amplification for the in situ detection of nucleic acids
AU2019258468B2 (en)	2018-04-24	2023-06-29	Ampsource Biopharma Shanghai Inc.	Antibody against TIM-3 and application thereof
GB201807192D0 (en)	2018-05-01	2018-06-13	Tropic Biosciences Uk Ltd	Compositions and methods for reducing caffeine content in coffee beans
WO2019213276A1 (en)	2018-05-02	2019-11-07	Novartis Ag	Regulators of human pluripotent stem cells and uses thereof
IL259392A (en)	2018-05-15	2018-08-01	Yeda Res & Dev	Vaccination with cancer neoantigens
WO2019220441A1 (en)	2018-05-15	2019-11-21	Hadasit Medical Research Services And Development Ltd.	Compositions and methods for treating cancer resistant to an anti-cancer agent
US20210292400A1 (en)	2018-05-17	2021-09-23	Yiping W. Han	Methods for treating, preventing and detecting the prognosis of colorectal cancer
AU2019277908A1 (en)	2018-05-27	2021-01-07	Biolinerx Ltd.	AGI-134 combined with a checkpoint inhibitor for the treatment of solid tumors
JP7350019B2 (ja)	2018-05-31	2023-09-25	イミュニティファルマリミテッド	筋萎縮性側索硬化症（ａｌｓ）を治療するための組成物、及び治療のためにそれを使用する方法
EP3802839A1 (en)	2018-06-07	2021-04-14	The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center)	Nucleic acid constructs and methods of using same
EP3800998A1 (en)	2018-06-07	2021-04-14	The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center)	Methods of regenerating and transforming cannabis
WO2019238962A1 (en)	2018-06-14	2019-12-19	University College Cork - National University Of Ireland, Cork	Peptide for disease treatment
TW202016144A (zh)	2018-06-21	2020-05-01	日商第一三共股份有限公司	包括cd3抗原結合片段之組成物及其用途
WO2020003311A1 (en)	2018-06-25	2020-01-02	Yeda Research And Development Co. Ltd.	Systems and methods for increasing efficiency of genome editing
WO2020008412A1 (en)	2018-07-04	2020-01-09	Ukko Inc.	Methods of de-epitoping wheat proteins and use of same for the treatment of celiac disease
US20210269860A1 (en)	2018-07-08	2021-09-02	Yeda Research And Development Co. Ltd.	Person-specific assessment of probiotics responsiveness
IL280101B2 (en)	2018-07-11	2025-05-01	Immunity Pharma Ltd	Peptide compounds and their therapeutic uses
KR102945860B1 (ko)	2018-07-11	2026-03-31	카 메디컬 리미티드	SIRPalpha-4-1BBL 변이체 융합 단백질 및 이의 사용 방법
AU2019315054A1 (en)	2018-07-31	2021-03-18	Collplant Ltd.	Tobacco transgenic event and methods for detection and use thereof
IL261156A (en)	2018-08-14	2020-02-27	Fass Deborah	Chimeric quiescin sulfhydryl oxidase (qsox1) antibodies and uses of same
EP3841201A1 (en)	2018-08-24	2021-06-30	Yeda Research and Development Co. Ltd	Methods of modulating m2 macrophage polarization and use of same in therapy
CA3109366A1 (en)	2018-09-13	2020-03-19	The Board Of Regents Of The University Of Texas System	Novel lilrb4 antibodies and uses thereof
CA3112135A1 (en)	2018-09-20	2020-03-26	Yeda Research And Development Co. Ltd.	Methods of treating amyotrophic lateral sclerosis
US20210338767A1 (en)	2018-09-25	2021-11-04	Biolinerx Ltd.	Methods of selecting treatment for cxcr4-associated cancer
WO2020069424A1 (en)	2018-09-28	2020-04-02	Centrillion Technologies, Inc.	Disulfide-linked reversible terminators
IL282267B2 (en)	2018-10-15	2026-03-01	Univ Massachusetts	Programmed DNA editing by chimeric deaminase-nme2cas9 proteins
US20210349088A1 (en)	2018-10-18	2021-11-11	Oklahoma Medical Research Foundation	Biomarkers For A Systemic Lupus Erythematosus (SLE) Disease Activity Immune Index That Characterizes Disease Activity
US12510539B2 (en)	2018-10-18	2025-12-30	Progentec Diagnostics, Inc.	Biomarkers for a systemic lupus erythematosus (SLE) disease activity immune index that characterizes disease activity
EP3872093A4 (en)	2018-10-22	2022-10-19	Shanghai Genbase Biotechnology Co., Ltd.	ANTI-CLDN18.2 ANTIBODIES AND USES THEREOF
MX2021004684A (es)	2018-10-23	2021-06-04	Glycardial Diagnostics S L	Anticuerpos especificos para apoj glucosilada y usos de los mismos.
IL262658A (en)	2018-10-28	2020-04-30	Memorial Sloan Kettering Cancer Center	Prevention of age related clonal hematopoiesis and diseases associated therewith
WO2020088645A1 (en)	2018-11-02	2020-05-07	Beijing Vdjbio Co., Ltd.	Modified ctla4 and methods of use thereof
WO2020102660A1 (en)	2018-11-16	2020-05-22	President And Fellows Of Harvard College	Molecules and methods for improved immunodetection of small molecules, such as histamine
CN111196851B (zh)	2018-11-20	2021-11-16	厦门万泰凯瑞生物技术有限公司	针对人抗缪勒管激素的特异性抗体及其应用
IL263184A (en)	2018-11-21	2020-05-31	Yarden Yosef	Method of treating cancer and compositions for same
US12134657B2 (en)	2018-11-28	2024-11-05	Oregon Health & Science University	Therapeutic factor XII antibody
US12441776B2 (en)	2018-11-30	2025-10-14	Eirgen Pharma Ltd.	Oxyntomodulin peptide analog formulations
EP3888021B1 (en)	2018-11-30	2024-02-21	Caris MPI, Inc.	Next-generation molecular profiling
US12478571B2 (en)	2018-12-17	2025-11-25	Pontis Biologics, Inc.	Enzyme based compositions and methods for removing dental calculi
CN119350498A (zh)	2018-12-28	2025-01-24	四川科伦博泰生物医药股份有限公司	一种抗体及其用途
EP3914698B1 (en)	2019-01-23	2024-12-11	Yeda Research and Development Co. Ltd	Culture media for pluripotent stem cells
CN113454238B (zh)	2019-01-25	2025-02-11	哈佛大学校长及研究员协会	用于合成核酸的组合物和方法
SG11202107720UA (en)	2019-01-31	2021-08-30	Agency Science Tech & Res	Cnx/erp57 inhibitor for use in the treatment or prevention of cancer
IL264768A (en)	2019-02-10	2020-08-31	Sagi Irit	Anti-matrix metalloproteinase 7 (mmp-7) inhibitory antibody and uses thereof
IL264854A (en)	2019-02-14	2020-08-31	Bahat Anat	Spt5 inhibitors and methods of use thereof
SG11202108618VA (en)	2019-02-15	2021-09-29	Advanced Cell Diagnostics Inc	Methods for multiplex detection of nucleic acids by in situ hybridization
WO2020170239A1 (en)	2019-02-21	2020-08-27	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Methods of generating organoids for high throughput screening of drugs
WO2020170240A1 (en)	2019-02-21	2020-08-27	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Method for reduction drug-induced nephrotoxicity
KR20210137499A (ko)	2019-03-05	2021-11-17	더 스테이트 오브 이스라엘, 미니스트리 오브 애그리컬처 & 루럴 디벨로프먼트, 애그리컬처럴 리서치 오거니제이션, (에이.알.오.), 볼카니 센터	게놈-편집 조류
EP3938400B1 (en)	2019-03-11	2025-07-30	Memorial Sloan Kettering Cancer Center	Cd22 antibodies and methods of using the same
GB201903519D0 (en)	2019-03-14	2019-05-01	Tropic Biosciences Uk Ltd	Introducing silencing activity to dysfunctional rna molecules and modifying their specificity against a gene of interest
GB201903521D0 (en)	2019-03-14	2019-05-01	Tropic Biosciences Uk Ltd	No title
GB201903520D0 (en)	2019-03-14	2019-05-01	Tropic Biosciences Uk Ltd	Modifying the specificity of non-coding rna molecules for silencing genes in eukaryotic cells
IL265486A (en)	2019-03-19	2020-09-30	Yeda Res & Dev	Type II stable opsins and methods of using them
WO2020194317A1 (en)	2019-03-28	2020-10-01	Yeda Research And Development Co. Ltd.	Method of treating lipid-related disorders
WO2020202142A2 (en)	2019-03-31	2020-10-08	Yeda Research And Development Co. Ltd.	Anti-viral and anti-tumoral compounds
KR20210151774A (ko)	2019-04-16	2021-12-14	쓰촨 케룬-바이오테크 바이오파마수티컬 컴퍼니 리미티드	항-FXI/FXIa 항체 및 그 용도
CN121610569A (zh)	2019-04-30	2026-03-06	拉利玛生物医药公司	用于测定共济蛋白替代疗法的疗效的共济蛋白敏感性标志物
IL266433B (en)	2019-05-02	2020-11-30	Sagi Irit	Preparations containing the propeptide of lysyl oxidase and their uses
WO2020230133A1 (en)	2019-05-13	2020-11-19	Yeda Research And Development Co. Ltd.	Cell-free mirna biomarkers for prognosis and diagnosis of neurodegenerative diseases
IL266728B (en)	2019-05-19	2020-11-30	Yeda Res & Dev	Identification of recurrent mutant neopeptides
WO2020234888A1 (en)	2019-05-22	2020-11-26	Hadasit Medical Research Services And Development Ltd.	Methods of culturing human pluripotent cells
IT201900007222A1 (it)	2019-05-24	2020-11-24	Univ Degli Studi Di Torino	Composizione di liposomi e metodo di dosaggio basato sull'uso degli stessi
US20220251179A1 (en)	2019-05-28	2022-08-11	Shanghaitech University	Composition and methods to treat ectodermal dysplasia 2, clouston type
AU2020291694B2 (en)	2019-06-12	2025-10-02	Hadasit Medical Research Services And Development Ltd.	Methods of generating oligodendrocytes
US12516313B2 (en)	2019-06-16	2026-01-06	Yeda Research And Development Co. Ltd.	Method for stabilizing intracellular RNA
US12509512B2 (en)	2019-06-27	2025-12-30	Ramot At Tel-Aviv University Ltd.	Semaphorin 3A antibodies and uses thereof
EP4545965A3 (en)	2019-06-27	2025-06-11	Dovetail Genomics, LLC	Methods and compositions for proximity ligation
WO2021001784A1 (en)	2019-07-04	2021-01-07	Ukko Inc.	De-epitoped alpha gliadin and use of same for the management of celiac disease and gluten sensitivity
US20220267409A1 (en)	2019-07-11	2022-08-25	Kahr Medical Ltd.	Heterodimers and methods of use thereof
IL268111A (en)	2019-07-16	2021-01-31	Fainzilber Michael	Methods of treating pain
US20220281960A1 (en)	2019-07-16	2022-09-08	Ramot At Tel-Aviv University Ltd.	Compositions and methods for the treatment of tuberculosis
CN120484131A (zh)	2019-07-19	2025-08-15	费城儿童医院	包含磷脂酰肌醇蛋白聚糖2结合结构域的嵌合抗原受体
US12410241B2 (en)	2019-07-26	2025-09-09	Vanderbilt University	Human monoclonal antibodies to enterovirus D68
EP4004548B1 (en)	2019-07-29	2026-01-14	Yeda Research and Development Co. Ltd	Methods of treating and diagnosing lung cancer
CA3148950A1 (en)	2019-07-30	2021-02-04	The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (A.R.O.), Volcani Center	Methods of controlling cannabinoid synthesis in plants or cells and plants and cells produced thereby
WO2021028909A1 (en)	2019-08-12	2021-02-18	Yeda Research And Development Co. Ltd.	Dna repair blood test for predicting response of lung cancer patients to immunotherapy
EP4218787A3 (en)	2019-08-20	2023-12-20	Nuritas Limited	Peptides for treating muscle atrophy
EP3783012A1 (en)	2019-08-20	2021-02-24	Nuritas Limited	An antimicrobial peptide
WO2021033176A1 (en)	2019-08-22	2021-02-25	Ariel Scientific Innovations Ltd.	Scaled-up methods for purifying antibodies
EP4021463A1 (en)	2019-08-27	2022-07-06	Yeda Research and Development Co. Ltd	Treatment of bacterial vaginosis
WO2021048852A1 (en)	2019-09-11	2021-03-18	Yeda Research And Development Co. Ltd.	Methods of treating breast cancer
US20220296622A1 (en)	2019-09-16	2022-09-22	The Children's Hospital Of Philadelphia	Compositions and methods for the treatment of swi-snf mutant tumors
EP4032907A4 (en)	2019-09-20	2023-07-05	Shanghai Genbase Biotechnology Co., Ltd.	Bcma-targeted antibody and chimeric antigen receptor
IL269674B (en)	2019-09-25	2020-08-31	Roy Bar Ziv	Assembling protein complexes on a chip
US20220411511A1 (en)	2019-09-26	2022-12-29	Stcube & Co.	Antibodies specific to glycosylated ctla-4 and methods of use thereof
WO2021063201A1 (zh)	2019-09-30	2021-04-08	四川科伦博泰生物医药股份有限公司	抗pd-1抗体及其用途
EP4041392A1 (en)	2019-10-08	2022-08-17	Nectin Therapeutics Ltd.	Antibodies against the poliovirus receptor (pvr) and uses thereof
EP4041768A1 (en)	2019-10-09	2022-08-17	StCube & Co.	Antibodies specific to glycosylated lag3 and methods of use thereof
US12590950B2 (en)	2019-10-11	2026-03-31	University Of Massachusetts	Methods for predicting ER-mediated DNA damage
JP2022553367A (ja)	2019-10-22	2022-12-22	ニューリタスリミテッド	非アルコール性脂肪肝の治療
IL270306A (en)	2019-10-30	2021-05-31	Yeda Res & Dev	Prevention and treatment of pre-myeloid and myeloid malignancies
WO2021084526A1 (en)	2019-10-31	2021-05-06	Yeda Research And Development Co. Ltd.	Engineered autotrophic bacteria for co2 conversion to organic materials
CA3160506A1 (en)	2019-11-11	2021-05-20	Ibi-Ag Innovative Bio Insecticides Ltd.	Insect control nanobodies and uses thereof
WO2021100034A1 (en)	2019-11-19	2021-05-27	Protalix Ltd.	Removal of constructs from transformed cells
IL270800A (en)	2019-11-20	2021-05-31	Yeda Res & Dev	A method for treating Alzheimer's disease
US10792360B1 (en)	2019-11-21	2020-10-06	Chemocentryx, Inc.	Compositions and methods for treating inflammatory bowel disease using CCR9 inhibitor and anti-TNF-alpha blocking antibodies
CA3163319A1 (en)	2019-12-02	2021-06-10	Caris Mpi, Inc.	Pan-cancer platinum response predictor
EP4073246A4 (en)	2019-12-12	2023-12-06	President And Fellows Of Harvard College	COMPOSITIONS AND METHODS FOR LIGHT-DIRECTED BIOMOLECULAR BARCODING
AU2020400221A1 (en)	2019-12-13	2022-05-19	Harbour Biomed (Shanghai) Co., Ltd.	Anti-TSLP antibody and uses thereof
JP7758672B2 (ja)	2019-12-20	2025-10-22	ノヴァロックバイオセラピューティクス，リミテッド	抗インターロイキン－２３ｐ１９抗体およびそれの使用方法
IL271656A (en)	2019-12-22	2021-06-30	Yeda Res & Dev	System and methods for identifying cells that have undergone genome editing
WO2021130753A1 (en)	2019-12-22	2021-07-01	Yeda Research And Development Co. Ltd.	Diagnosis of frontotemporal dementia
EP3842452A1 (en)	2019-12-26	2021-06-30	Universitat Autònoma de Barcelona	Scaffold proteins and therapeutic nanoconjugates based on nidogen
US20230048361A1 (en)	2019-12-31	2023-02-16	Kahr Medical Ltd.	Methods of culturing t cells and uses of same
WO2021137231A1 (en)	2019-12-31	2021-07-08	Kahr Medical Ltd.	Methods of culturing t cells with a 4-1bbl fusion polypeptide and uses of same
IL271778A (en)	2019-12-31	2021-06-30	Ichilov Tech Ltd	Methods for treating atopic dermatitis
CN113061165B (zh)	2020-01-02	2026-04-21	厦门大学	EB病毒BNLF2b基因编码多肽及其检测用途
IL272074B2 (en)	2020-01-15	2024-12-01	Immunity Pharma Ltd	Peptide compounds and methods of treating diseases using same
WO2021149040A1 (en)	2020-01-22	2021-07-29	Ramot At Tel-Aviv University Ltd.	Anti-ide antibodies and uses of same
IL272194A (en)	2020-01-22	2021-07-29	Yeda Res & Dev	Multispecific antibodies for use in treating diseases
WO2021152584A1 (en)	2020-01-28	2021-08-05	Ariel Scientific Innovations Ltd.	Methods of analyzing cell membranes
IL295179A (en)	2020-01-29	2022-09-01	Memed Diagnostics Ltd	Methods for diagnosis and classification of viral infections
WO2021152586A1 (en)	2020-01-30	2021-08-05	Yeda Research And Development Co. Ltd.	Methods of analyzing microbiome, immunoglobulin profile and physiological state
EP4096647A1 (en)	2020-01-30	2022-12-07	Yeda Research and Development Co. Ltd	Treating acute liver disease with tlr-mik inhibitors
IL272389A (en)	2020-01-30	2021-08-31	Yeda Res & Dev	Kits containing antibodies to PD-L1 and their uses in therapy
IL272390A (en)	2020-01-30	2021-08-31	Yeda Res & Dev	Cancer treatment methods
BR102020002165A2 (pt)	2020-01-31	2021-11-30	Fundação Oswaldo Cruz	Anticorpo, seu uso, composição farmacêutica o compreendendo, método de diagnóstico de infecções fúngicas, kit de diagnóstico de infecções fúngicas e método para tratamento de infecções fúngicas.
WO2021156490A2 (en)	2020-02-06	2021-08-12	Vib Vzw	Corona virus binders
EP3862014A1 (en)	2020-02-07	2021-08-11	Nuritas Limited	Treatment of panx1 associated diseases
KR20220151168A (ko)	2020-02-09	2022-11-14	엔엘씨 파르마 엘티디	Sars-cov-2에 대한 신속한 검출 테스트
IL272586A (en)	2020-02-10	2021-08-31	Yeda Res & Dev	A method for cell cluster analysis
JP2023519105A (ja)	2020-02-11	2023-05-10	ヴァンダービルトユニバーシティ	重症急性呼吸器症候群コロナウイルス２（ｓａｒｓ－ｃｏｖ－２）に対するヒトモノクローナル抗体
CA3168337A1 (en)	2020-02-17	2021-08-26	Marie-Andree Forget	Methods for expansion of tumor infiltrating lymphocytes and use thereof
KR20230012464A (ko)	2020-02-25	2023-01-26	브이아이비 브이지더블유	류신-풍부 반복 키나제 2 알로스테릭 조절제
EP4110823A1 (en)	2020-02-26	2023-01-04	A2 Biotherapeutics, Inc.	Polypeptides targeting mage-a3 peptide-mhc complexes and methods of use thereof
US20230127559A1 (en)	2020-03-16	2023-04-27	Yeda Research And Development Co. Ltd.	Peptide analogs and use of same in treating diseases, disorders or conditions associated with mutant p53 protein
EP4121018A4 (en)	2020-03-17	2024-07-03	Genevant Sciences Gmbh	CATIONIC LIPIDS FOR LIPID DNANOPARTICLE DELIVERY OF THERAPEUTICS TO HEPATIC STELLA CELLS
WO2021195385A1 (en)	2020-03-26	2021-09-30	Vanderbilt University	HUMAN MONOCLONAL ANTIBODIES TO SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-GoV-2)
HRP20240182T1 (hr)	2020-03-26	2024-04-26	Vanderbilt University	Ljudska monoklonska protutijela za teški akutni respiratorni sindrom koronavirusa 2 (sars-cov-2)
CN115348884B (zh)	2020-03-29	2024-07-30	耶达研究及发展有限公司	用于治疗戈谢病的β-葡糖脑苷脂酶变体
WO2021199047A1 (en)	2020-03-31	2021-10-07	Biomuse Ltd.	Bacteria for the prevention and treatment of smoke-induced lung damage
TWI904146B (zh)	2020-03-31	2025-11-11	美商卡默森屈有限公司	使用ｃｃｒ９抑制劑及抗ｉｌ-２３阻斷抗體治療發炎性腸道疾病的組成物及方法
EP4133107A1 (en)	2020-04-06	2023-02-15	Yeda Research and Development Co. Ltd	Methods of diagnosing cancer and predicting responsiveness to therapy
EP4132479A1 (en)	2020-04-07	2023-02-15	Ramot at Tel-Aviv University Ltd.	Cannabidiol-containing compositions and uses thereof
JP2023521356A (ja)	2020-04-07	2023-05-24	アドヴァンスドセルダイアグノスティクス，インコーポレイテッド	ｉｎｓｉｔｕハイブリダイゼーションによって標的核酸を検出する方法及びそのキット
US20230135456A1 (en)	2020-04-13	2023-05-04	Exoprother Medical Ltd.	Cell-derived vesicles comprising wild-type p53 protein for antiviral therapy
US20210322483A1 (en)	2020-04-16	2021-10-21	Ichilov Tech Ltd.	Cell-derived particles presenting heterologous cd24 and use thereof in therapy
CA3176545A1 (en)	2020-04-22	2021-10-28	President And Fellows Of Harvard College	Isothermal methods, compositions, kits, and systems for detecting nucleic acids
WO2021229577A1 (en)	2020-05-12	2021-11-18	Collplant Ltd.	Collagen as a delivery tool for metal-based anti-viral agents
CN115715202B (zh)	2020-05-15	2025-11-04	四川科伦博泰生物医药股份有限公司	抗体药物缀合物及其制备方法和用途
IL274811B (en)	2020-05-20	2021-05-31	Yeda Res & Dev	Spatial information is developed for the analysis of individual cells
EP4161653A1 (en)	2020-06-03	2023-04-12	Bionecure Therapeutics, Inc.	Trophoblast cell-surface antigen-2 (trop-2) antibodies
EP4521115A3 (en)	2020-06-10	2025-06-11	Ramot at Tel-Aviv University Ltd.	Methods of detecting methylated cpg
JP2023530182A (ja)	2020-06-22	2023-07-13	ラモット・アット・テル・アビブ・ユニバーシテイ・リミテッド	多重サブユニットタンパク質モジュール、それを発現する細胞、及びその使用
US20230293530A1 (en)	2020-06-24	2023-09-21	Yeda Research And Development Co. Ltd.	Agents for sensitizing solid tumors to treatment
EP3939999A1 (en)	2020-07-14	2022-01-19	Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III (F.S.P. CNIO)	Interleukin 11 receptor alpha subunit (il11ra) neutralizing antibodies and uses thereof
IL276599A (en)	2020-08-09	2022-03-01	Yeda Res & Dev	T cell receptor unique to mage-a1 and its uses
IL276627A (en)	2020-08-10	2022-03-01	Yeda Res & Dev	Compositions for diagnosis and treatment of coronavirus infections
EP4228656A4 (en)	2020-08-18	2024-09-04	Yeda Research and Development Co. Ltd	ANTI-VIRAL AND ANTI-TUMOR COMPOUNDS
WO2022038536A1 (en)	2020-08-18	2022-02-24	International Rice Research Institute	Methods of increasing outcrossing rates in gramineae
WO2022040455A1 (en)	2020-08-21	2022-02-24	Advanced Cell Diagnostics, Inc.	Compositions and methods for determining t cell clonality
WO2022047359A1 (en)	2020-08-31	2022-03-03	Berg Llc	Protein biomarkers for pancreatic cancer
EP4208259A2 (en)	2020-09-04	2023-07-12	NovaRock Biotherapeutics, Ltd.	Nectin-4 antibodies and uses thereof
IL277488A (en)	2020-09-21	2022-04-01	Yeda Res & Dev	Weight regulation method
WO2022064494A2 (en)	2020-09-23	2022-03-31	Yeda Research And Development Co. Ltd.	Methods and compositions for treating coronaviral infections
IL277743A (en)	2020-10-01	2022-04-01	Yeda Res & Dev	A method for diagnosing breast cancer
WO2022074646A1 (en)	2020-10-05	2022-04-14	Protalix Ltd.	Dicer-like knock-out plant cells
EP4225903A1 (en)	2020-10-07	2023-08-16	Protalix Ltd.	Long-acting dnase
KR102860080B1 (ko)	2020-10-09	2025-09-15	더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템	융합전-안정화된 hmpv f 단백질
EP4228637A1 (en)	2020-10-15	2023-08-23	Yeda Research and Development Co. Ltd	Method of treating myeloid malignancies
IL278401A (en)	2020-10-29	2022-05-01	Yeda Res & Dev	Polynucleotides for editing RNA and a method for using them
KR20230107296A (ko)	2020-11-09	2023-07-14	1이 테라퓨틱스 엘티디.	촉매 서열에 기반한 박테리아 감염을 치료 또는 예방하는 방법
GB202105804D0 (en)	2020-11-20	2021-06-09	Univ Cape Town	Use of microvirin in the identification of mycobacterium tuberculosis mannose-capped lipoarabinomannan
IL302707A (en)	2020-11-26	2023-07-01	Ukko Inc	Modified high molecular weight glutenin subunit and uses thereof
EP4255451A4 (en)	2020-12-03	2025-01-01	The Board Of Regents Of The University Of Texas System	Methods for identifying lilrb-blocking antibodies
KR20230144525A (ko)	2020-12-04	2023-10-16	유니버시티 오브 테네시 리서치 파운데이션	아밀로이드 질환을 진단하기 위한 방법
IL279559A (en)	2020-12-17	2022-07-01	Yeda Res & Dev	Controlling ubiquitination of mlkl for treatment of disease
AU2021403156A1 (en)	2020-12-18	2023-07-13	Genevant Sciences Gmbh	Peg lipids and lipid nanoparticles
KR20230126725A (ko)	2020-12-28	2023-08-30	1이 테라퓨틱스 엘티디.	침묵화를 위한 P21 mRNA 표적 부위
KR20230133859A (ko)	2020-12-28	2023-09-19	1이 테라퓨틱스 엘티디.	p21 mRNA 표적화 DNA자임
JP7691668B2 (ja)	2020-12-31	2025-06-12	諾納生物（蘇州）有限公司	ヒトｌｉｆｒ抗原結合タンパク質、その製造方法及び応用
AU2022206415A1 (en)	2021-01-10	2023-08-17	Supermeat The Essence Of Meat Ltd.	Pluripotent stem cell aggregates and microtissues obtained therefrom for the cultured meat industry
WO2022153286A1 (en)	2021-01-14	2022-07-21	Yeda Research And Development Co. Ltd.	Methods of producing vitamin d
IL280340B (en)	2021-01-21	2022-04-01	Yeda Res & Dev	Antibodies, peptides and combinations of same for the treatment or prevention of coronavirus infection
US20240101717A1 (en)	2021-01-22	2024-03-28	Bionecure Therapeutics, Inc.	Anti-her-2/trop-2 constructs and uses thereof
GB2603166A (en)	2021-01-29	2022-08-03	Thelper As	Therapeutic and Diagnostic Agents and Uses Thereof
EP4257154A4 (en)	2021-02-09	2026-04-22	Medilink Therapeutics Suzhou Co Ltd	CONJUGATED WITH A BIOACTIVE SUBSTANCE, ITS PREPARATION PROCESS AND ITS USE
WO2022175951A1 (en)	2021-02-18	2022-08-25	Yeda Research And Development Co. Ltd.	Genetically modified bacteria for generating vaccines
IL305315A (en)	2021-02-18	2023-10-01	Yeda res & development co ltd	Methods for producing vaccines
EP4294516A1 (en)	2021-02-19	2023-12-27	Vib Vzw	Cation-independent mannose-6-phosphate receptor binders
KR20230154317A (ko)	2021-03-05	2023-11-07	상하이 젠베이스 바이오테크놀로지 씨오., 엘티디.	항-cldn6 항체 및 이의 용도
TW202302155A (zh)	2021-03-08	2023-01-16	美商伊繆諾金公司	用於增加靶向ａｄａｍ９之免疫結合物治療癌症之功效的方法
WO2022188652A1 (zh)	2021-03-09	2022-09-15	四川科伦博泰生物医药股份有限公司	Ror1结合蛋白及其用途
IL281561A (en)	2021-03-16	2022-10-01	Yeda Res & Dev	Methods and devices for ex-utero mouse embryonic development
WO2022208369A1 (en)	2021-03-30	2022-10-06	Biomx Ltd.	Pseudomonas bacteriophage and uses thereof
WO2022216841A1 (en)	2021-04-06	2022-10-13	Berg Llc	Protein markers for estrogen receptor (er)-positive luminal a(la)-like and luminal b1 (lb1)-like breast cancer
CA3214833A1 (en)	2021-04-06	2022-10-13	Bpgbio, Inc.	Protein markers for the prognosis of breast cancer progression
WO2022216846A1 (en)	2021-04-06	2022-10-13	Berg Llc	Protein markers for estrogen receptor (er)-positive-like and estrogen receptor (er)-negative-like breast cancer
IL282188A (en)	2021-04-08	2022-11-01	Yeda Res & Dev	Combined use of ketamine and bretigabine for the treatment of psychiatric disorders
US20240197827A1 (en)	2021-04-14	2024-06-20	University College Cork - National University Of Ireland, Cork	Psg1 for use in the treatment of osteoarthritis
JP2024514195A (ja)	2021-04-14	2024-03-28	ユニバーシティ・カレッジ・コークーナショナル・ユニバーシティ・オブ・アイルランド，コーク	脳血管イベントおよび神経障害の治療
US20240212150A1 (en)	2021-04-16	2024-06-27	Advanced Cel Diagnostics, Inc.	Materials and methods related to image processing
CA3215979A1 (en)	2021-04-19	2022-10-27	Ghassan SAED	Methods for detecting or treating endometrial and ovarian hyperproliferative disorders
EP4337764A1 (en)	2021-05-12	2024-03-20	Biomx Ltd.	Staphylococcus bacteriophage and uses thereof
IL283563A (en)	2021-05-30	2022-12-01	Yeda Res & Dev	Profiling of amps for the diagnosis, monitoring and treatment of microbiome-related diseases
CA3219233A1 (en)	2021-06-06	2022-12-15	Ravid STRAUSSMAN	Combined treatment for cancer
IL309333A (en)	2021-06-13	2024-02-01	Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd	A method for reprogramming cells
MX2023015233A (es)	2021-06-16	2024-01-31	Seedx Tech Inc	Metodos de clasificacion de semillas de matthiola.
NL2028466B1 (en)	2021-06-16	2022-12-21	Sakata Holland B V	Methods of sorting matthiola seeds
KR20240031315A (ko)	2021-07-02	2024-03-07	트로픽 바이오사이언시즈 유케이 리미티드	바나나 과실의 갈변 지연 또는 예방
EP4370134A4 (en)	2021-07-13	2025-08-06	Technion Res & Dev Foundation	COMPOSITIONS AND METHODS FOR TREATING A HEALTH CONDITION
WO2023288046A1 (en)	2021-07-15	2023-01-19	President And Fellows Of Harvard College	Compositions and methods relating to cells with adhered particles
JP2024526837A (ja)	2021-07-18	2024-07-19	ガミダセルリミテッド	治療用ｎｋ細胞集団
WO2023002492A1 (en)	2021-07-22	2023-01-26	Yeda Research And Development Co. Ltd.	Codon optimization of nucleic acids
EP4377352A2 (en)	2021-07-30	2024-06-05	Vib Vzw	Cation-independent mannose-6-phosphate receptor binders for targeted protein degradation
EP4380973A2 (en)	2021-08-02	2024-06-12	Yeda Research and Development Co. Ltd.	Anti-matrix metalloproteinase-14 antibodies for the treatment of cancer
CA3226947A1 (en)	2021-08-03	2023-02-09	Muhammad YASSIN	Engineered tcr complex and methods of using same
EP4130028A1 (en)	2021-08-03	2023-02-08	Rhazes Therapeutics Ltd	Engineered tcr complex and methods of using same
AU2022325816A1 (en)	2021-08-10	2024-03-21	Gamida-Cell Ltd.	Engineered nk cells, methods of their production and uses thereof
GB202112865D0 (en)	2021-09-09	2021-10-27	Tropic Biosciences Uk Ltd	Resistance to black sigatoka disease in banana
GB202112866D0 (en)	2021-09-09	2021-10-27	Tropic Biosciences Uk Ltd	Resistance to fusarium wilt in a banana
IL286430A (en)	2021-09-14	2023-04-01	Yeda Res & Dev	Multispecific antibodies for use in the treatment of diseases
WO2023056361A1 (en)	2021-09-29	2023-04-06	Board Of Regents, The University Of Texas System	Anti-hsp70 antibodies and therapeutic uses thereof
EP4426821A1 (en)	2021-11-02	2024-09-11	University of Massachusetts	Nme2cas9 inlaid domain fusion proteins
CN118284624A (zh)	2021-11-19	2024-07-02	米罗生物有限公司	Pd-1抗体及其用途
US11833503B2 (en)	2021-12-07	2023-12-05	Insilixa, Inc.	Methods and compositions for surface functionalization of optical semiconductor-integrated biochips
EP4444864A1 (en)	2021-12-08	2024-10-16	Yeda Research and Development Co. Ltd	Multipotent lung progenitor cells for lung regeneration
IL314470A (en)	2022-01-25	2024-09-01	Medilink Therapeutics Suzhou Co Ltd	Anti-Her3 antibody, conjugate and use thereof
GB202201137D0 (en)	2022-01-28	2022-03-16	Thelper As	Therapeutic and diagnostic agents and uses thereof
KR20240146674A (ko)	2022-01-31	2024-10-08	제네반트 사이언시즈 게엠베하	지질 나노입자를 위한 이온화 가능한 양이온성 지질
EP4238988A1 (en)	2022-03-01	2023-09-06	Consejo Superior De Investigaciones Científicas	Antibodies against sars-cov-2 and uses thereof
CN114853890B (zh)	2022-03-16	2023-04-28	沈阳三生制药有限责任公司	一种prlr抗原结合蛋白及其制备方法和应用
AU2023243615A1 (en)	2022-04-01	2024-11-14	Board Of Regents, The University Of Texas System	Dual specificity antibodies to human pd-l1 and pd-l2 and methods of use therefor
GB202204813D0 (en)	2022-04-01	2022-05-18	Bradcode Ltd	Human monoclonal antibodies and methods of use thereof
IL315888A (en)	2022-04-06	2024-11-01	Mirobio Ltd	Transgenic CD200R antibodies and their uses
US20230357851A1 (en)	2022-04-06	2023-11-09	Larimar Therapeutics, Inc.	Frataxin-sensitive markers for monitoring frataxin-replacement therapy
WO2023209708A1 (en)	2022-04-25	2023-11-02	Yeda Research And Development Co. Ltd.	Compositions for altering cyclic adp-ribose secondary messenger signalling
WO2023240201A1 (en)	2022-06-08	2023-12-14	Larimar Therapeutics, Inc.	Frataxin-sensitive markers for monitoring progression and treatment of leigh syndrome
AU2023283727A1 (en)	2022-06-08	2024-12-12	Onkure, Inc.	Benzopyrimidin-4(3h)-ones as pi3k inhibitors
EP4536276A1 (en)	2022-06-10	2025-04-16	Research Development Foundation	Engineered fcriib selective igg1 fc variants and uses thereof
CA3259098A1 (en)	2022-06-20	2025-04-18	Sichuan Huiyu Seacross Pharmaceutical Technology Co., Ltd.	ANTIBODIES AND THEIR USES
WO2024012524A1 (zh)	2022-07-14	2024-01-18	苏州宜联生物医药有限公司	抗体药物偶联物及其制备方法和用途
WO2024028794A1 (en)	2022-08-02	2024-02-08	Temple Therapeutics BV	Methods for treating endometrial and ovarian hyperproliferative disorders
WO2024040020A1 (en)	2022-08-15	2024-02-22	Absci Corporation	Quantitative affinity activity specific cell enrichment
WO2024038160A1 (en)	2022-08-18	2024-02-22	Vib Vzw	Means and methods to modulate neuron excitability
KR20250080854A (ko)	2022-09-08	2025-06-05	온쿠레 인코포레이티드	Pi3k 억제제로서의 이소퀴놀론
WO2024064024A1 (en)	2022-09-19	2024-03-28	Onkure, Inc.	((4-oxo-3,4-dihydroquinazolin-8-yl)methyl)amine derivatives as p13k inhibitors for the treatment of cancer
KR20250068694A (ko)	2022-09-20	2025-05-16	온쿠레 인코포레이티드	Mapk 경로 돌연변이로 인한 암의 치료를 위한 hdac 억제제 oki-179
EP4594348A1 (en)	2022-09-27	2025-08-06	Vib Vzw	Antivirals against human parainfluenza virus
WO2024081345A1 (en)	2022-10-14	2024-04-18	Onkure, Inc.	Benzopyrimidin-4(3h)-ones as pi3k inhibitors
CN120379687A (zh)	2022-10-14	2025-07-25	爱尔兰国立科克大学	胎盘表达的蛋白用于治疗肌腱损伤
WO2024102466A2 (en)	2022-11-11	2024-05-16	Igan Biosciences	Iga protease polypeptide agents
WO2024124041A1 (en)	2022-12-07	2024-06-13	Advanced Cell Diagnostics, Inc.	Multiplexed detection of nucleic acid targets
IL321992A (en)	2023-01-09	2025-09-01	Univ Texas	Human parainfluenza virus 3f proteins stabilized before transfusion
KR20250155004A (ko)	2023-02-23	2025-10-29	유니버시티 오브 로체스터	폐쇄 말단 dna 가닥 분자를 제조하기 위한 제제 및 방법
CN121219008A (zh)	2023-04-11	2025-12-26	斯特林知识产权私人有限公司	血液系统癌症的治疗
AU2024304180A1 (en)	2023-06-13	2026-01-08	Adcentrx Therapeutics, Inc.	Methods and compositions related to antibodies and antibody drug conjugates (adcs) that bind nectin-4 proteins
WO2024261344A1 (en)	2023-06-23	2024-12-26	Vib Vzw	Novel binders targeting the multi-drug resistant pathogen acinetobacter baumannii
WO2025031446A1 (zh)	2023-08-09	2025-02-13	厦门大学	瓜氨酸化setdb1多肽及其在诊断类风湿性关节炎中的应用
AU2024325407A1 (en)	2023-08-11	2026-02-19	Onkure Therapeutics, Inc.	Benzopyridinones and benzopyrimidinones as pi3k inhibitors
WO2025052278A1 (en)	2023-09-05	2025-03-13	Genevant Sciences Gmbh	Pyrrolidine based cationic lipids for lipid nanoparticle delivery of therapeutics to hepatic stellate cells
AU2024339036A1 (en)	2023-09-07	2026-03-12	University Of Tennessee Research Foundation	Method for diagnosing amyloid diseases
WO2025125577A1 (en)	2023-12-14	2025-06-19	Vib Vzw	Antibodies against influenza b virus
WO2025133951A1 (en)	2023-12-21	2025-06-26	Genevant Sciences Gmbh	Ionizable lipids suitable for lipid nanoparticles
WO2025150045A1 (en)	2024-01-12	2025-07-17	Gabriel Nussbaum	Bacterial targets, therapeutics, compositions, kits and methods of use in treating and/or preventing cancer
WO2025155991A2 (en)	2024-01-19	2025-07-24	Bpgbio, Inc.	Predictive biomarkers for response to coenzyme q10 treatment in pancreatic cancer
WO2025202871A1 (en)	2024-03-27	2025-10-02	Pfizer Inc.	Methods for identifying biomarkers of treatment response and use thereof with a cdk4 inhibitor
WO2025207755A1 (en)	2024-03-29	2025-10-02	Onkure, Inc.	Quinolizinones as pi3k inhibitors
WO2025212360A1 (en)	2024-04-01	2025-10-09	Onkure, Inc.	Isoquinolones as pi3k inhibitors
WO2025255233A1 (en)	2024-06-07	2025-12-11	Onkure, Inc.	Compounds containing fused tricyclic rings as pi3k inhibitors
WO2025264533A1 (en)	2024-06-17	2025-12-26	Adcentrx Therapeutics Inc.	Methods and compositions related to antibody drug conjugates (adcs) that bind steap-1 proteins
WO2026006151A2 (en)	2024-06-24	2026-01-02	University Of Rochester	Functionalization of ace-trna encoding synthetic linear picovectors
WO2026008665A1 (en)	2024-07-01	2026-01-08	Vib Vzw	Binders of the pd-1•pd-l1 complex and their use
WO2026019976A1 (en)	2024-07-17	2026-01-22	The Broad Institute, Inc.	Universal covalent crosslinker for antibody-oligo conjugates
US20260078179A1 (en)	2024-07-18	2026-03-19	Novarock Biotherapeutics, Ltd.	Cdh17 antibodies and uses thereof
WO2026022656A2 (en)	2024-07-22	2026-01-29	Genevant Sciences Gmbh	Lipid particle formulations with permanently charged cationic lipids
WO2026022677A1 (en)	2024-07-22	2026-01-29	Genevant Sciences Gmbh	Permanently charged cationic lipids
WO2026044000A1 (en)	2024-08-20	2026-02-26	Ethyreal Bio, Inc.	Multispecific antibodies and methods of use thereof
WO2026044153A1 (en)	2024-08-21	2026-02-26	Bpgbio, Inc.	Use of biomarkers in the diagnosis of pancreatic cancer
WO2026058262A1 (en)	2024-09-16	2026-03-19	Esther Priel	Substituted tri-phenyl derivative compounds, compositions comprising same and applications of same
WO2026083241A1 (en)	2024-10-15	2026-04-23	Genevant Sciences Gmbh	Ionizable lipids comprising n,n-substituted hydroxylamine esters

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3615222A (en) *	1968-09-04	1971-10-26	New England Nuclear Corp	Method and apparatus for measuring the amount of a component in a biological fluid
US3654090A (en) *	1968-09-24	1972-04-04	Organon	Method for the determination of antigens and antibodies

1970
- 1970-11-10 NL NL707016396A patent/NL154598B/xx not_active IP Right Cessation
1971
- 1971-10-27 ZA ZA717192A patent/ZA717192B/xx unknown
- 1971-10-28 AU AU35082/71A patent/AU468060B2/en not_active Expired
- 1971-10-29 US US00193702A patent/US3850752A/en not_active Expired - Lifetime
- 1971-11-04 FI FI3155/71A patent/FI54033C/fi active
- 1971-11-06 ES ES396741A patent/ES396741A1/es not_active Expired
- 1971-11-08 DK DK546271AA patent/DK140268B/da not_active IP Right Cessation
- 1971-11-08 CH CH1621671A patent/CH617774A5/de not_active IP Right Cessation
- 1971-11-09 CA CA127,217A patent/CA967464A/en not_active Expired
- 1971-11-09 DE DE2155658A patent/DE2155658C3/de not_active Expired
- 1971-11-09 SE SE7114278A patent/SE451162B/xx unknown
- 1971-11-09 GB GB5196171A patent/GB1348935A/en not_active Expired
- 1971-11-09 BR BR7459/71A patent/BR7107459D0/pt unknown
- 1971-11-09 IT IT53970/71A patent/IT986829B/it active
- 1971-11-10 BE BE775187A patent/BE775187A/nl not_active IP Right Cessation
- 1971-11-10 FR FR7140259A patent/FR2113733A5/fr not_active Expired

Also Published As

Publication number	Publication date
AU468060B2 (en)	1975-12-18
NL7016396A (da)	1972-05-15
BR7107459D0 (pt)	1973-06-21
US3850752A (en)	1974-11-26
DK140268B (da)	1979-07-16
FI54033C (fi)	1978-09-11
DK140268C (da)	1979-12-10
DE2155658A1 (de)	1972-05-18
FI54033B (fi)	1978-05-31
AU3508271A (en)	1973-05-03
SE451162B (sv)	1987-09-07
DE2155658B2 (de)	1976-08-05
IT986829B (it)	1975-01-30
CA967464A (en)	1975-05-13
FR2113733A5 (da)	1972-06-23
NL154598B (nl)	1977-09-15
DE2155658C3 (de)	1978-09-14
ES396741A1 (es)	1975-05-16
CH617774A5 (da)	1980-06-13
ZA717192B (en)	1972-08-30
GB1348935A (en)	1974-03-27

Legal Events

Date

Code

Title

Description

1991-01-01

RE20

Patent expired

Owner name: N.V. ORGANON

Effective date: 19911110

Publication	Publication Date	Title
BE775187A (nl)	1972-03-01	Werkwijze voor het aantonen en bepalen van laagmoleculaire verbindingenen van eiwitten die deze verbindingen specifiek kunnen binden
BE777309A (nl)	1972-04-17	Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen
NL154600B (nl)	1977-09-15	Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
NL143943B (nl)	1974-11-15	Werkwijze voor het polymeriseren van alfa-alkenen.
NL166545C (nl)	1981-08-17	Werkwijze voor het kwantitatief bepalen van triglyceriden.
NL171147C (nl)	1983-02-16	Werkwijze voor het handhaven van de vloeibaarheid van mortel- en betonspecie.
BE790708A (fr)	1973-04-30	Samenstel voor het afscheiden van een gedeelte van een ruimte
NL166664C (nl)	1981-09-15	Inrichting voor het homogeniseren van stortgoed.
NL152484B (nl)	1977-03-15	Werkwijze en inrichting voor het verwerken van gebruikte stoffen.
NL164838B (nl)	1980-09-15	Werkwijze voor het disproportioneren van alkenen.
NL151684B (nl)	1976-12-15	Werkwijze en inrichting voor het vervaardigen van drijfglas.
NL143594B (nl)	1974-10-15	Werkwijze voor het verknopen van acrylamide-polymeren.
NL155526B (nl)	1978-01-16	Werkwijze voor het disproportioneren van alkenen.
BE778981A (nl)	1972-05-30	Werkwijze voor het fractionneren van bloed en middelen voor hetuitvoeren van deze werkwijze
NL7311769A (nl)	1975-03-03	Werkwijze en inrichting voor het vervaardigen van meervoudig geoerienteerde houders.
BE753428A (nl)	1971-01-14	Werkwijze voor het disproportioneren van olefinen
NL143946B (nl)	1974-11-15	Werkwijze voor het polymeriseren van alfa-alkenen.
NL143945B (nl)	1974-11-15	Werkwijze voor het polymeriseren van alfa-alkenen.
NL147121B (nl)	1975-09-15	Werkwijze voor het hydrateren van alkenen.
BE770972A (nl)	1972-02-07	Werkwijze voor het vervaardigen van 3-anilino-pyrazolin-5- onen
NL174140C (nl)	1984-05-01	Werkwijze voor het zuiveren van m-kresol.
NL164568C (nl)	1981-01-15	Werkwijze voor het polymeriseren van alkenen.
NL7508671A (nl)	1976-01-28	Werkwijze voor het bepalen van plastiminogeen.
NL154831B (nl)	1977-10-17	Inrichting voor het vaststellen van de eigenschappen van deeltjes.
BE775698A (nl)	1972-05-23	Werkwijze voor het polymeriseren van etheen